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ABSTRACT

Longitudinal Trends in Postpartum Mental Health, Cognition and Steroid
Hormones
by
Chandler R. Marrs
Dr. Douglas P. Ferraro, Examination Committee Chair
Professor of Psychology
University of Nevada, Las Vegas

The temporal association between psychiatric and cognitive disturbances
during pregnancy and postpartum is clear in the literature. However, associations
between these disturbances and puerperal hormones are equivocal. The present study
followed nine primigravid women from late pregnancy through one year postpartum
to investigate trends in psychiatric and cognitive disturbances relative to postpartum
hormone changes. Participants completed a battery of neuropsychological instruments
at 37 weeks o f pregnancy, at 10 days and four-, eight- and twelve-months postpartum
and provided salivary specimen from which dehydroepiandrosterone sulfate
(DHEAS), testosterone, estradiol and estriol concentrations were quantified. Results
showed psychiatric disturbances and cognitive decrements in late pregnancy that
often worsened following parturition. Psychiatric symptoms generally resolved by
four months postpartum and were associated predominantly with elevated DHEAS.

Ill
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Cognitive performance improved across the year but spatial and verbal working
memory remained impaired. Cognitive performance was not associated with hormone
changes and inconsistently associated with mood symptoms.
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CHAPTER 1

INTRODUCTION
The two years surrounding pregnancy and childbirth are particularly difficult
for many women with the risk of serious mental illness reportedly being 20 times
higher than at any other period in a woman’s life (Panay, Sands & Studd, 1998).
Despite the clear temporal relationship between childbearing and the onset of mental
illness, researchers have yet to identify a causal relationship between them. Although
most agree that the hormonal and metabolic adaptations required to sustain a
pregnancy are profound and often confer significant risk to maternal physical health,
there is no consensus that puerperal hormone changes mediate, or in any way elicit,
disruptions in maternal mental health. Consequently, the prevailing hypothesis
suggests that puerperal mental illness, commonly referred to and investigated as
postpartum depression, is not the result of endocrine pathophysiology, but rather, a
maladaptive psychosocial response to normal changes in reproductive hormones
(Bloch et al., 2000).
This hypothesis, while understandable in light of the inconclusive endocrine
research, contradicts epidemiological data that supports a clear temporal relationship
between childbirth and psychiatric disturbances (Munk-Olsen, Laursen, Pederson,
Mors & Mortensen, 2006). It also disregards a basic tenet of maternal endocrinology,
namely, that the changes in puerperal hormone concentrations are vast and systemic

1
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and, thus, not limited to the traditionally investigated reproductive hormones of
progesterone, estradiol and estriol.
An abundance of epidemiological research shows that the immediate
postpartum period is marked by considerable mood lability that is experienced by
approximately 80% of women (Dalton & Holton, 2001; Miller, 1999; O’Hara,
Schlecte, Lewis & Wright, 1986; Spinelli, 1998). Approximately 15% of women
suffer an episode of clinical depression following parturition (Cooper, Larouche,
Drista & Bender, 2000; Dalton & Holton, 2001; Miller, 1999; Spinelli, 1998; O’Hara
& Swain, 1996). Clinically significant anxiety is estimated to be present in 9-50% of
women following parturition (Austin, 2004; Eberhard-Gran, Tambs, Opjordmoen,
Skrondal & Eskild, 2003; Gard, Handley, Parsons &Waldron, 1986; Heron,
O’Connor, Evans, Golding & Glover, 2004; Ross, Sellers, Evans & Romach, 2002).
Upwards of 30% of women with obsessive compulsive disorder recognize the onset
of their disorder as having coincided with pregnancy (Neziroglu, Anemone &
Yariyura-Tobias, 1992; Abramowitz, Schwartz, Moore & Luenzman, 2003).
Moreover, the postpartum period confers an increased risk for psychosis with 1-2 per
1000 pregnancies resulting in psychiatric hospitalization (Brockington & Meakin
1994, Klompenhouwer & van Hulst, 1991; Kumar, Marks, Platz, Yoshida, 1995
Vedibech & Gouliacv, 1995; Wisner, Peindl & Hanusa, 1993). With postpartum
psychosis suicidality increases some 70-fold (Sharma, 2003).
Given the temporal association between childbirth and significant psychiatric
disturbances, it seems likely that endocrine factors are responsible. However,
according to the published research they are not, with most research showing only
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tenuous connections between changes in the traditional reproductive hormones and
depressed mood, (Harris et al., 1994; Kuevi et al., 1983; Meakin et al., 1995; Nappi,
et al., 2001; Nott et al., 1976; O’Hara, et al., 1996; Paoletti, et al., 2006). Very few
researchers have investigated other hormones potentially altered by pregnancy and
the spectrum o f psychiatric symptoms that might emerge concurrently (Buckwalter et
al., 1999; Marrs 2006). Perhaps because of the paucity of conclusive research,
puerperal psychiatric disturbances are not considered by the Diagnostic and Statistic
Manual Version IV (DSM-IV) (American Psychiatric Association, 1994) to be related
to an organic or general medical condition, but instead, are considered as time course
specifiers attributable to any mood disorder that develops within 30 days following
parturition (AP A, 1994).
In the popular and, indeed, in the scientific press, the DSM-IV designation has
been translated into a rubric of three disorders around which the vast majority of
research is modeled. The mildest form of mood disturbance, called the “baby blues,’’
is marked by mild anhedonia and mood lability and is the most commonly
investigated phenomena within this spectrum (Dalton & Holton, 2001; Miller, 1999;
Spinelli, 1998). A more serious disorder called postpartum depression (PPD)
typically, although not formally designated as such, refers to major depressive
disorder (Andrews-Fike, 1999; Astuler, Hendrick & Cohen, 2000; Dean & Kendell,
1981; Gard, et al. 1986; Miller, 1999; O’Hara & Swain, 1996). This is followed by
the most severe and arguably rarest form of puerperal mental illness, postpartum
psychosis (Brockington, 2004; Brockington & Meakin 1994; Dean & Kendell;
Klompenhouwer & van Hulst, 1991).
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None of these “disorders” carry with them clearly identified or even agreed
upon diagnostic criteria (Kumar, 2001; Kumar, et al., 1995; McGorry & Connell,
1990), nor do they address the probability of co-morbidity or the possibility of
endocrine mediators. Rather, both the baby blues and postpartum depression are
characterized according to varying levels of anhedonic depression, often measured by
the popular 10-item Edinburgh Postnatal Depression Scale (EPDS) (Cox, Holden &
Sagovsky, 1987; Dennis, 2004; Gueyney, Fermanian, Guelfi & Kumar, 2000) and
other depression scales. Postpartum psychosis, on the other hand, has been variously
linked to either bipolar 1 or an ambiguously defined affective psychosis (Brockington
& Meakin 1994; Cooper, Campbell, Day & Kennerly, 1988; Dean & Kendell ,1981;
Dean, Wiliams & Brockington, 1989).
Disagreement regarding the onset and course of these disorders is apparent in
the research literature with psychiatric disturbances considered postpartum when they
develop anytime within the first postpartum year (Andrews-Fike, 1999; Gavin, et al.,
2005; Mowery & Lennon, 2001; Pfühlmann et al., 1998; Sing & Kauer, 1999;
Wisner, Peindl & Hanusa, 1993; Wisner, Peindl & Hanusa, 1995) even though data
exists showing that from 50-70 % of all cases of puerperal mental illness develop
within days of parturition (Klopemhouwer & van Hulst, 1991; Kumar, Marks, Platz
& Yoshida, 1995; Munk-Olsen, Laursen, Pederson, Mors & Mortensen 2006; Stowe,
Hostetter & Newport, 2005).
With the disparities in the definition and onset of puerperal mental illness and
the limited range of psychiatric symptoms and reproductive hormones typically
investigated, it is clear why endocrine antecedents have not been associated
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conclusively with puerperal psychiatric disturbances. Since the medical literature is
replete with evidence that endocrine disturbances elicit a myriad of psychiatric
symptoms (for a review see Brambilla 1992; Hochberg, Pacak & Chourous, 2003),
there is no reason to suspect that the vast hormone changes associated with
pregnancy, parturition an even breastfeeding cessation and menstrual cycle
resumption, would not do the same. It is also reasonable to presume that the sheer
magnitude of hormone changes associated with childbearing, albeit considered
“normal,” might elicit abnormal reactions in other endocrine parameters and that
psychiatric disturbances might be the markers of these changes.
During pregnancy, hormone production is up-regulated significantly and
systemically to support the growing fetus. Steroidogenesis formally under maternal
control becomes a dynamic multi-compartment endeavor with contributions from
fetal, placental and maternal endocrine glands (Carr, 2001; Goland, Conwell, Warren
& Wardlow, 1992; Mastorakos & Illias, 2003; O’Leary, Boyne, Flett, Beilby, James,
1991; Weiss, 2000). Once tightly controlled feedback loops are up-regulated and even
overridden as steroid synthesis increases exponentially to support the pregnancy
(Carr, 2001; Challis & Lye, 1998). Synthesis of hormone binding proteins and
enzymatic metabolism are up-regulated in an attempt to compensate for the increased
steroids, but even so, maternal concentrations of these hormones increase drastically
throughout gestation (Carr, 2001; Challis & Lye, 1998; Harris, Lovett, Roberts, Read,
Riad-Fahmy, 1993; Mastorokas & Illias, 2003)
Upon delivery, the fetal and placental components of this system are removed,
precipitating an abrupt reduction in previously supra-physiological concentrations of
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maternal steroids. Hormone values fall to below pre-pregnancy levels within three to
four days and are thought to remain low until breastfeeding ceases and menstruation
begins (Carr, 2001; Illingworth & McNeilly, 1998). Even under normal
circumstances, such an abrupt change in internal chemistry would be expected to
elicit both physiological and psychological reactions. As such, the widely experienced
baby blues may represent a “normal” and expected response to these changes.
However, inter-individual variability in hormone metabolism is tremendous.
The abrupt withdrawal of puerperal hormones and consequent shift back to maternal
control of steroidogenesis might elicit in some women aberrant compensatory
reactions in steroid metabolism, which in turn might initiate psychiatric disturbances.
Alternatively, puerperal hormone changes could un-mask previously unidentified
impairments in maternal steroidogenesis. Since years of research have not identified
any anomalies in the reproductive hormones related to psychiatric disturbances, it is
likely that “non-reproductive” hormones are culpable. Indeed, new evidence suggests
that this may be the case.
Unlike most investigations of puerperal mental health that examine
relationships between the baby blues or postpartum depression and traditional
reproductive hormones, Marrs (2006) examined a broader range of psychiatric
symptoms using the Symptom Checklist-90-R (SCL-90-R) and administered a
complete battery of neurocognitive instruments to a cohort of healthy, primigravid
women. The SCL-90-R measures nine clusters of psychiatric symptoms including,
anxiety, hostility, phobia, paranoia, psychoticism, somatization, obsessive compulsive
behavior, interpersonal sensitivity and depression as well as a composite score that
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estimates the severity of overall psychiatric distress. The psychiatric symptoms and
cognitive variables were compared to salivary concentrations of progesterone,
dehydroepiandrosterone sulfate (DHEAS), testosterone, estrone, estradiol and estriol
measured concurrently both in late pregnancy (n=32) and in the immediate
postpartum (n=28). With these considerations, Marrs (2006) demonstrated that
puerperal psychiatric disturbances were significantly and uniquely associated with
puerperal hormone changes. Specifically, diminished late pregnancy testosterone and
elevated pre- and postpartal DHEAS concentrations were correlated with the
spectrum of psychiatric symptoms measured by the SCL-90-R. Moreover, these
disturbances developed early, sometimes during pregnancy, were not limited to
depressive symptoms and were significantly more severe and more common than had
previously been reported. Fully 50 % of the women tested by Marrs exhibited
clinically relevant postpartal elevations in four or more symptom clusters including
elevations in psychoticism. SCL-90-R T-scores greater than 60 were considered
elevated.
In addition to identifying correlations between hormones and psychiatric
symptoms, the Marrs study uncovered atypical patterns in adrenal androgen
concentrations, namely elevated DHEAS concurrent with relatively low testosterone.
Serum DHEAS values, which have been investigated in relation to the onset of labor,
are reported to increase in the first two trimesters, remain stable in the third and return
to non-pregnant values following parturition (Milewich et al., 1978; Soldin et al.,
2005; Tagawa et al., 2004). In the Marrs study, salivary DHEAS concentrations were
high in late pregnancy and increased by an average of 34 % following parturition.
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with those participants exhibiting the largest increases in DHEAS also suffering the
most severe psychiatric disturbances. Moreover, four participants exceeded and
others approached the clinical cutoff range that typically merits further testing for
adrenal pathology.
Elevated DHEAS concentrations typically lead to elevated testosterone
concentrations. Testosterone is presumed to increase significantly during pregnancy
but fall to pre-pregnancy concentrations following parturition (Bammann, Coulam &
Jiang, 1980). This appeared not to be the case in the Marrs study. Both pregnancy and
postpartum testosterone concentrations were very low when compared to healthy non
pregnant women and were found to increase rather than decrease in five women
following parturition, although as a group testosterone concentrations fell by 49 %.
In addition, low late pregnancy testosterone concentrations were associated with a
myriad of psychiatric symptoms during pregnancy but more importantly heralded the
onset and exacerbation of postpartal psychiatric disturbances. Thus, lower late
pregnancy testosterone combined with higher pre- and postpartum DHEAS
concentrations not only represented an atypical pattern in hormone metabolism but
also were linked with significant psychopathology.
The Marrs study also investigated cognitive performance and its relationship
to hormone concentrations and psychiatric symptoms. The data revealed moderate
cognitive impairment both pre- and post delivery across multiple cognitive domains
including verbal and spatial memory, attention and cognitive processing speed.
Impairment was most pronounced in verbal and spatial memory. When compared to
age and IQ-adjusted normative standards, participants exhibited single digit to only
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50* percentile rankings, with most verbal recall scores remaining below the 20*
percentile for pregnancy and postpartum. These findings were consistent with results
reported by Buckwalter and colleagues (1999) who reported equally low verbal
memory scores at 36 weeks of pregnancy and one month postpartum. Although
individual hormones were significantly associated with specific cognitive variables,
in both the Buckwalter et al. (1999) and Marrs (2006) there were no consistent
patterns across variables in these relationships. However, elevated hormone
concentrations were significantly related to poorer cognitive performance in general
on multiple cognitive tests (Marrs 2006).
Marrs (2006) provides perhaps the first evidence supporting a relationship
between hormones and psychiatric symptoms. More importantly however, this study
provided preliminary evidence for the development of an endocrine pathophysiology
either related to, or un-masked by, puerperal hormone changes. In order to examine
this possibility further, the current longitudinal research was undertaken. Building
upon the Marrs (2006) study and continuing with women from that cohort, this
research examined the relative changes in puerperal hormones, psychiatric symptoms
and cognitive performance occurring from late pregnancy through the first
postpartum year.
It was hypothesized that if the puerperal psychiatric symptoms were truly
affiliated with endogenous endocrine factors, then the degree to which these hormone
factors changed over the postpartum period would correspond to symptom severity. It
was further hypothesized that elevated DHEAS would contribute significantly to the
severity of psychiatric symptoms, particularly those associated with anxiety type
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disorders, and to the equilibrium of other hormones along the androgen pathway.
Specifically, it was proposed that if DHEAS concentrations remained elevated and
above clinical reference ranges, psychiatric symptoms would continue and other
hormone values would be altered. Finally, it was expected that cognitive deficits
observed during pregnancy and postpartum would improve over the course of the
postpartum year.

10
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CHAPTER 2

LITERATURE REVIEW
Puerperal psychiatric disturbances develop in a significant number of women,
sometimes with tragic consequences, yet their existence as distinct psychiatric entities
remains under debate. Disparate definitions and diagnostic criteria plague much of the
research with etiological investigations limited to a narrowly agreed upon set of
anhedonic symptoms within a broadly defined time of onset. The possibility and,
indeed, the probability that the postpartum period confers at least an equal risk for a
wide range o f psychiatric disorders is summarily disregarded with the vast
preponderance of research focused on the baby blues and postpartum depression.
Nonetheless, there is accumulating evidence suggesting that perinatal psychiatric
disorders are unique phenomena whose symptoms: 1) may be more clearly delineated
along a continuum of symptoms and severity rather than by categorical distinction,
and 2) are temporally, if not causatively, related to the puerperium and the endocrine
changes associated therein. Admittedly, the research is limited and consensus has
been elusive making a thorough review of the literature necessary. The purpose of the
first part of this literature review is: 1) to discern what is known about psychiatric co
morbidity during pregnancy and postpartum; 2) to delineate the onset and course of
said disorders; and 3) to review potential hormonal factors associated therewith.

11
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Marrs (2006) identified an array of neurocognitive decrements temporally
associated with pregnancy and postpartum. As had been the case with other
investigations, cognitive performance did not appear causally related to any one
hormone or specific cluster of psychiatric symptoms. Rather cognitive impairment
was associated with elevated hormones in general and only inconsistently associated
with psychiatric symptoms. Given the degree of cognitive impairment observed by
Marrs, particularly in verbal and spatial memory and the temporal association among
the variables it is difficult to discount a relationship entirely. Thus, second section of
this literature review will address both the short- and long-term cognitive sequelae
associated with pregnancy and parturition and where applicable, with other clinical
endocrine disorders.
Marrs (2006) also identified relationships amongst the adrenal androgens
DHEAS and testosterone and a myriad of puerperal psychiatric symptoms. Inasmuch
as this pattern of adrenal hormones has not been associated with known endocrine
disorders and adrenal hormones in general have not been considered to be major
determinants of pregnancy related psychiatric disruptions, a thorough review of the
literature pertaining to these hormones is presented. The purpose of the final section
of this literature review is: 1) to discuss the biological and pharmacological actions of
these hormones; 2) to provide evidence of endocrine involvement in mental illness
and the mental health issues associated with clinical endocrine disorders; 3) to discuss
the potential physiological mechanism by which high DHEAS and low testosterone
might develop.

12
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Puerperal Mental Illness
Definition and Diagnosis

Heretofore puerperal mental illness has almost exclusively been regarded as
either “baby blues,” postpartum depression (PPD) and/or, in rare cases, postpartum
psychosis. Baby blues, defined loosely as excessive crying and mood lability, is said
to occur in up to 80% of all women in the days following parturition (Miller, 1999;
Spinelli, 1998). Postpartum depression, considered a more severe form of baby blues,
occurs in approximately 10-15% of all women (Miller, 1999; Spinelli, 1998).
Postpartum psychosis on the other hand, occurs in 1-2/1000 births (Brockington,
2004; Jones et al. 2001; Kumar, 2001; Miller, 1999; Spinelli, 1998; Wisner, Peindl &
Hanusa, 1993). Although baby blues are considered a normal consequence of
childbirth, there is no consensus amongst researchers, clinicians or women’s groups
regarding the definition, diagnosis, course or treatment of either postpartum
depression or postpartum psychosis. Accordingly, the postpartum period has only
recently been recognized as a time course specifier applied to mood disorders by the
Diagnostic and Statistical Manual IV (DSM-IV) and the International Classification
of Diseases version 10 (ICD-10) of the World Health Organization when the illness
arises within 30 or 45 days following childbirth, respectively (Kumar, 2001).
Consistent with the prevailing theoretical assumption, that childbirth confers
no special vulnerability or etiological connection to mental illness, previous versions
of both diagnostic manuals allowed for no designation of puerperal onset of mental
illness. In fact, clinicians using the ICD-8 were instructed not to classify psychiatric
disturbances associated with childbirth unless no other classification was deemed

13
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appropriate. It is reported that most psychiatrists ignored those instructions (Kumar,
2001). In response, all mention of puerperal psychosis was deleted from the ICD-9,
only to be reinstated in the ICD-10 in a fashion similar to the ICD-8.
Amongst the research community, the debate is no less controversial and
contentious. The existence o f puerperally induced mental illness was deemed
impossible almost by caveat, based upon the findings of a few researchers.
Specifically, Stecker and Edbaugh (1926) argued that “Old names die hard.. .all
others who have studied this problem are unanimous in the belief that there is no
psychosis which may be diagnosed as puerperal” (Kumar, 2001). This was followed
by Founder et al. (1957) who stated unequivocally that “since these patients whose
mental illness was apparently precipitated by childbirth did not differ substantially
from control groups as regards diagnosis, previous mental illness or prognosis, the
conclusion seems justified that postpartum illness is not a psychiatric entity.”
Fast forward almost fifty years and the debate has yet to be settled. As
recently as 2004, a prominent researcher declared that postpartum psychiatric
disorders were not discrete entities and any notion that this was the case “was
disproved long-ago” (Brockington, 2004). Indeed, if it were not for some highly
publicized tragedies presumably involving postpartum psychosis, it is not likely that
research about this phenomenon would be moving forward at all. What research
there is in this area has focused primarily upon baby blues and PPD. Moreover,
perhaps because postpartum mental illness is not considered a true clinical entity, this
research has involved an exceedingly narrow range of symptoms that occurs within a
very broadly and inconsistently defined period of time.

14
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Both popular and scientific research argue that PPD includes symptoms such
as weeping, irritability, guilt, mood lability, low sex drive, forgetfulness, fatigue and
anxiety (Dalton, 2001; Miller, 1999; Spinelli, 1998). The instrument of choice for
detection of PPD has been the Edinburgh Postnatal Depression Scale (EPDS)
developed by Cox, Holden and Sagovsky, (1987). The EPDS is alO-item self-report
measure that focuses on symptoms associated with anhedonic dysphoria. Each item in
the EPDS is scored on a scale of 0-3 with three being the most severe. The EPDS has
been well validated with over 20 studies published to date and is said to reliably
identify baby blues and postpartum depression in 82% of the cases (Dennis, 2004)
leaving 18% of the women undiagnosed. But what is postpartum depression? Judging
from the accumulated literature it is a form of major or minor depression whose onset
somehow coincides with childbirth. Coinciding with childbirth is variously defined as
occurring during pregnancy (Spinelli, 1998; Johanson et al., 2000) or within 30 days
following parturition (DSM-IV); is sometimes classified as the re-emergence of a
previous depression during pregnancy or postpartum (Wisner et al., 1993); and/or
depression occurring sometime within the first year postpartum (Andrews-Fike, 1999;
Gavin et al., 2005). With such a narrowly defined disorder (depression as measured
by the EPDS) and a vaguely defined onset and course, inconsistencies in research
findings are not unexpected.
Similarly, postpartum psychosis is variously defined as affective psychosis,
non-affective psychosis or mania (Brockington, 1990; Brockington & Meakin, 1993;
Brockington, 2004; Sing & Kaur, 1999; Stewart. Klompenhouwer, Kendell & Hulst,
1991; Wisner et ah, 1993; Wisner et ah, 1995). Unlike PPD, the onset of postpartum
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psychosis is accepted as rapid with research indicating that approximately 50-70% of
all cases occur within the first two weeks following childbirth (Brockington, 1990;
Brockington & Meakin, 1993; Brockington, 2004; Klompenhauer & Van Hulst 1991;
Sing & Kaur, 1999; Stewart et al., 1991; Wisner et al., 1993; Wisner et al., 1995).
However, even given consensus on the time of onset, extant research on postpartum
psychosis is still problematic. For example, many studies are retrospective, based
upon either hospital or physician referral records, and are confounded by the presence
of participants with previous histories of serious mental illness. This necessarily
limits the possibility of discerning a relationship between childbirth and the
precipitation of mental illness. At best, the research can only conclude that the stress
of childbirth, like any other stressor, confers a risk of onset in women so disposed or a
risk of relapse for women with histories of serious mental illness.
There is a small but emerging literature recognizing the need for more precise
definitions of the psychiatric disturbances associated with childbearing. Such research
suggests that psychiatric illnesses related to childbearing are; 1) distinct clinical
entities; 2) are potentially hormonally mediated, although the research has yet to
definitely bear this out; and 3) follow a continuum of severity and symptomatology
from endpoints of baby blues to psychosis with varying degrees of depression,
anxiety and obsessive compulsive behavior in between (Austin, 2004; Cooper &
Murray, 1995; Halbreich, 2005; Pfuhlmann, Stober, Fransek & Beckman, 1998).
Data from Marrs (2006) support these generalizations. Results from this study
indicated that psychiatric morbidity covered the spectrum of clinical disorders and
began appearing in late pregnancy. Using the Symptom SCL-90-R to assess
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psychiatrie symptoms, Marrs found that fully half of the women tested had elevated
postpartum SCL-90-R T-scores (>60) in four or more symptom clusters. The most
severe participants showed significant psychiatric distress across all nine psychiatric
symptom clusters measured. For some of these women SCL-90-R symptom T-scores
were two and three standard deviations above the normative means. The Marrs
research demonstrated that the current investigative focus on baby blues and PPD
may underestimate the prevalence and depth of psychological suffering in otherwise
healthy women.
Prevalence

A vast body o f literature suggests that PPD occurs in 10-15% of all
pregnancies (Bloch, Rotenberg, Koren & Klein, 2005; Gavin et al., 2005). A
frequently cited meta-analysis by O’Hara and Swain (1996) found the prevalence of
PPD to be 13%. Onset of PPD has been variously defined as occurring within the first
month postpartum (DSM-IV), within three months (Wisner et al., 2004), within six
months (Boyce et al., 2000; Ross et al., 2003) or one year following parturition
(Gavin et al., 2005). A report by Stowe, Hostetter and Newport (2005) found that
66% PPD cases developed within three weeks of parturition and argues that a re
appraisal of onset criteria in many research paradigms is needed. The incidence of
postpartum psychosis is estimated at 1-2 per 1000 births (Brockington, 1990;
Brockington & Meakin, 1993; Brockington, 2004; Klompenhauer et al. 1991; Jones et
al., 2001; Klompenhouwer & Van Hulst 1991; Sing and Kaur, 1999; Stewart, et al.
1991; Wisner, et al. 1993; Wisner et al. 1995) and is generally accepted as rapid with
many cases reported in the days following parturition and up to 70% of all cases

17

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

developing within the first two weeks postpartum (Brockington & Meakin, 1993;
Klompehouwer & Van Hulst, 1991; Kumar, Marks, Platz, Yoshida, 1995). Both
postpartum depression and postpartum psychosis are generally accepted as clinical
disorders and researched as such, but are not technically clinical entities. Rather
postpartum is a time course specifier that can be applied to the “current or most recent
major depressive, manic, or mixed episode in major depressive disorder, bipolar 1
disorder or bipolar 2 disorder; or to brief psychotic disorder” (p. 387, DSM-IV) that
occurs within 30 days of parturition. This specifier is not applied to anxiety disorders
or other psychotic disorders such as schizophrenia. This is likely due to the rapidity
with which disorders of postpartum manifest and the consequent failure to meet the
DSM-IV duration of illness criteria for the anxiety and schizophrenic disorders.
Both popular and scientific research suggest that PPD includes symptoms
such as weeping, irritability, guilt, mood lability, low sex drive, forgetfulness, fatigue
and anxiety (Dalton, 2001; Miller, 1991, Spinelli, 1998). The diagnostic instrument of
choice has been the EPDS, which measures symptoms of anhedonic depression, with
three questions regarding anxiety. The Hamilton Depression Rating Scale or the Beck
Depression Inventory are sometimes used concurrently (for a review see Gavin et al.
2005). Most recently, researchers interested in assessing co-morbid anxiety have
begun supplementing EPDS assessments with separate anxiety scales. However, the
many researchers still rely on post hoc analysis of the three anxiety questions
contained in the EPDS. The range of total scores on the EPDS that are considered
symptomatic has varied from as low as 10 to as high as 16 (Heron et al., 2004; Gavin
et al., 2005; Johanson et al., 2000; Nappi et al., 2001; Ross et al., 2003).
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As would be expected, given the limited scope of the EPDS scale, the
discrepancies in scoring and arguments over time of onset, previous attempts to
reliably predict postpartum depression during pregnancy have faltered. Over 70
psychosocial risk factors for PPD have been identified and tested, including but not
limited to, a history o f depression or mental illness, socioeconomic factors and
difficult or abusive family relations (Halbreich, 2005). However, none of these risk
factors has been shown to reliably predict the onset of PPD (Bemaazzani, Saucier,
David & Borgeat, 1996; Bloch et al. 2005; Costa, LaRouche, Drista & Brender, 2000;
Halbeich, 2005; Honey, Bennett & Morgan, 2003).
The lack of methodological consistency amongst researchers has led some to
revisit both the definition and measurement of PPD. Accordingly, there is
accumulating evidence that suggests that a broader definition of the disorder and a
more limited window of onset are warranted (Austin, 2004; Halbreich, 2005;
Pfuhlman, et al. 1998; Reicher-Rossler & Fallahpour, 2003; Stowe, Hostetter &
Newport, 2005). The case for expanding the definition o f potential postpartum
disorders is not difficult, particularly when one considers the prevalence and
distribution of disorders in any given population and the high rates of co-morbidity
within individual diagnoses (Rush et al., 2005). Indeed, one might expect a similar
distribution and pattern of co-morbidity in pregnant women.
In recent years a number of studies have emerged indicating that puerperal
psychiatric co-morbidity exists more often than not. Both epidemiological and
empirical research, particularly with anxiety and obsessive compulsive disorders
(OCD), show that the rate of co-morbid anxiety disorders with both syndromal and
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sub-syndromal major depression is consistently elevated in both community and
hospital populations o f perinatal women (Austin, 2004; Altsuler, Hendrick & Cohen
2000; Brandes, Soares & Cohen, 2004; Britton, 2005; Kumar et ah, 2004; ReicherRossler & Fallahpour, 2003; Ross et ah, 2005). Moreover, some studies indicate that
anxiety based disorders show greater perinatal incidence than do depressive disorders
(Ross et ah, 2005), but the evidence here is limited.
Postpartum Anxiety

Although there is a vast body of literature on postpartum depression and baby
blues, 760 articles from 1995-2002 (Brockington, 2004), there are relatively few on
peripartal anxiety. Much of this research is based upon the co-occurrence of anxiety
in women already diagnosed with depression and often assessed by post-hoc factor
analysis of the few anxiety dimensions endorsed in the depression scale of choice.
Nonetheless, the research that does exist argues very strongly for a significant
relationship between the puerperium and the onset of anxiety disorders with or
without major depression.
Ross et ah, (2002), assessed depression and anxiety using the EPDS and Brief
Symptoms Inventory (BSI) in a community sample of 150 obstetric women, found
clinically significant anxiety present in 50% of clinically depressed women across all
test times (prenatal, 6 and 16 weeks postpartum). Moreover the three EPDS anxiety
questions (3, 4, and 5) accounted for approximately 40% of the total EPDS score. The
authors also noted significantly higher sub-clinical obsessive compulsive behaviors in
pregnant women versus non-pregnant controls and versus postpartum.
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A large Norwegian study (n=2730) evaluated the relative distribution and
prevalence of anxiety and depression in postpartum (n=416) and non-postpartum
(n=l,794) women. Using the Hopkins Symptom Checklist-25 (SCL-25), a self-report
tool that evaluates depressive and anxious symptoms, researchers found that anxiety
was equally likely in each group of women but that the risk for depression was higher
in the postpartum group (Eberhar-Gran et al., 2003). O f interest, researchers found
that crying easily and often did not confer a risk for other depressive symptoms.
Researchers speculated that crying, a symptom often attributed to depressive
symptomatology, particularly in PPD when assessed using the EPDS, should not be
considered an indicator of depression (Eberhar-Gran et al., 2003). These results
appear to contradict the findings of Ross et al. (2003) but Eberhar-Gran and
colleagues utilized different instruments and did not disclose test times relative to
gestation or parturition.
Using the State-Trait Anxiety Inventory, Britton (2005) found moderate
anxiety in 24% o f 422 new mothers, 1% of whom experienced severe anxiety. The
study was conducted prior to the patients’ release from a US maternity hospital,
sometimes within hours o f delivery. The mean length of hospital postnatal stay was
listed at 49.9 +/- 1 hour but the mean delivery to test time was not given. Britton
found that elevated anxiety was associated with lower maternal age, education and
income. As might be expected, first time mothers experienced greater anxiety than
multiparous women. Interestingly, mothers of male infants experienced more anxiety
than mothers of female infants and previous psychiatric diagnosis had no bearing on
anxiety levels except in women with pre-existing depression.
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Using a community based sample of 68 postpartum women, Wenzel, Haugen,
Jackson and Robinson (2003) found the prevalence of generalized anxiety disorder
(GAD) to be higher than major depression (4.4% versus 2.9%) at eight weeks
postpartum. Moreover, 27% of the participants endorsed sub-syndromal levels of
anxiety compared to 8.8% who endorsed mild non-clinical depression. In a similar
study by the same authors, the prevalence of GAD was found to be higher in
postpartum women than in a representative sample of other women (Wenzel et al.,
2005). Interestingly, in a previous study by Wenzel and colleagues (2001), it was
noted that the most common complaint of postpartum anxiety was autonomic
hyperactivity. This is similar to non-puerperal patients, except that postpartum
women did not associate those symptoms with fear of death.
Postpartum Obsessive-Compulsive Disorder

Over the last 15 years multiple retrospective studies have delineated the
prevalence of obsessive compulsive disorder (OCD) onset during pregnancy and
childbirth (for a review see Abramowitz et ah, 2003). OCD is an anxiety disorder
marked by recurrent distressing thoughts, ideas, or doubts (obsessions) combined
with urges to neutralize those thoughts via compulsive rituals (compulsions). In nonpostpartum OCD, the content of the obsessions varies across patients but typically
revolves around concerns of accidentally causing harm to oneself or others
(Abramowitz, et al. 2003; Brandes, Soares & Cohen, 2004). The primary
characteristic of perinatal OCD is uncontrollable and often violently aggressive
intrusive thoughts and images about harming one’s child (Wisner et ah, 1999).
Thoughts of harming one’s child are a common but relatively under-recognized
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component of postpartum psychological distress. In the only study of its kind,
Jennings, Ross, Popper and Elmore, (1999) measured the prevalence of intrusive
thoughts in recently delivered women and found that upwards of 41% of all depressed
mothers experienced intrusive thoughts while only 7% of non-depressed mothers
reported intrusive thoughts. Likewise Wisner et al. (1999) and Wenzel, Gorman and
Stuart (2001) found thoughts of harming one’s infant and fears of imminent danger to
be the most common obsessional content in postpartum women. This suggests that
intrusive thoughts may be in part engendered by the postpartum period.
In a comprehensive review of peripartal OCD symptomatology, Abramowitz
et al. (2003) speculated that pregnancy and postpartum confer a unique vulnerability
to the onset of OCD for some women. This is supported by numerous
epidemiological studies indicating that the women’s age of onset of OCD is bimodally distributed and temporally related to childbirth. Several studies show that the
number of new cases of OCD increases in females who have had children between
the ages of 22-24 and 29-32 versus those who have not. Estimates of peripartal onset
are approximately 39% (Neziroglu et al., 1992). Conversely, for women who have
never had children age of onset is typically much earlier and between the ages of 1316 years (Neziroglu et al., 1992). Although these data are impressive, the studies
listed are based upon retrospective self-report. Very few studies have actually
prospectively measured perinatal OCD.
Postpartum Psychosis and Bipolar Disorder

The nosological status of postpartum psychosis has vacillated widely over the
last 60 years. Prior to the emergence of formal classification systems and since
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antiquity, psychotic episodes temporally associated with parturition were recognized
as discrete nosological entities (Kumar, 2001). With the advent of modem operational
criteria the existence of this disorder has been called into question, presenting obvious
difficulties for clinicians and researchers alike. This is particularly so because most
research in this area has been retrospective, relying solely on the diagnostic
information ascribed in medical records.
Nevertheless, buried deep within this research, there are data suggesting that
postpartum psychosis is a distinct nosological entity. What comes to mind here are
the atypical symptom presentation and the research showing that 10-14% of cases of
puerperal psychosis occur in women with no previous or familial psychiatric histories
and no subsequent non-puerperal episodes (McGorry & Connolly 1990). For these
women, puerperal psychosis seems to be a discrete entity. Unfortunately, new onset
puerperal psychosis has not been investigated thoroughly.
When reading the case literature and research on postpartum psychosis one is
left with a nagging sense of discordance between the disorder that supposedly does
not exist and subsequent diagnostic criteria assigned thereto. Indeed, many
professionals in the field argue postpartum psychosis is easily and blindly identified
by its atypical presentation (Brockington, 2004; Hays & Douglas, 1984). That
notwithstanding, the symptoms of postpartum psychosis are marked by several
factors that differentiate it from its non-puerperal counterparts.
First, postpartum psychosis is marked by rapid onset of symptoms following
parturition (Klompenhouwer, 1991). The rapidity of onset makes classification
difficult, especially in the early stages of the syndrome when its duration has not yet
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met specified temporal criteria required for making particular diagnoses. Some
speculate that there is a prodromal period beginning in late pregnancy but this
supposition has not been established empirically (Dalton, 1994: Miller, 1999).
Moreover, the putative prodrome appears to include restlessness, insomnia and mood
lability, symptoms with striking similarity to the normal physiological changes
associated with late pregnancy and postpartum (Hays & Doulgas, 1984). Frank
symptoms are reported to begin within two weeks of parturition with some
investigators reporting onset within days of delivery (Kumar et ah, 1995).
Unfortunately, researchers have variously identified postpartum psychosis as
beginning up through the first three months (Mowery & Lennon, 2001; Wisner,
Peindl & Hanusa, 1993; Wisner, Peindl & Hanusa, 1995), the first six months
(Pfixhlmann et ah, 1998; Sing & Kauer, 1999), and even a year postpartum making
arguments either for or against a separate disorder considerably weaker. If
postpartum disorders are truly nosologically distinct from other psychopathologies,
then their onset should be temporally related to the puerperium and should occur only
during subsequent pregnancies or hormonally similar events.
Symptoms of postpartum psychosis include confusion, perplexity, irrational
ideation and disorientation, instability or rapidly changing sensorium and psychotic
hallucinations, extreme mood lability, restlessness, and insomnia (Brockington &
Meakin, 1994; Hays & Doulgas, 1984; Klomenphauer, McCory & Connell 1990;
1991; Miller, 1999). The severe confusion and disorientation and rapidity of onset are
what have led many to argue for a separate disorder (Hays & Douglas, 1984;
Videbech & Gouliacv, 1995), while the apparent cycling of moods and restlessness
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(and perhaps the lack o f other suitable diagnostic criteria) have lead many researchers
to associate postpartum psychosis with bipolar 1 disorder. This even though there
does not appear to be the concomitant grandiosity or focused attention typically
associated with the bipolar disorders and the postpartum mood cycling looks to be
extremely rapid, consistent with extreme mood lability rather than the temporal
cyclicity evident in the bipolar disorders.
Bipolar Disorder and Affective Psychosis

A contingent of investigators and clinicians hold that postpartum psychosis is
a functional psychosis that can be sufficiently categorized under the diagnosis of
unipolar affective psychosis (major depressive disorder with psychotic features) or
bipolar disorder, presumably a bipolar 1, mixed episode. However, neither exact
classifications are given in the literature nor is justification for inclusion in or
exclusion from a particular diagnostic category elucidated.
The most consistent argument for the classification of postpartum psychosis
under the rubric o f bipolar disorders comes from epidemiological studies that suggest
women with histories of bipolar disorder have a 1 in 5 chance of having a psychotic
episode postpartum compared to the 1 in 500 chance of women without such histories
(Stewart et a l, 1991). In addition, approximately 39%, but upwards of 60%, of
women have their first manic episode after childbirth (Mowery & Lennon, 2001) with
a family history o f bipolar disorder increasing that risk substantially.
Most of this research has been done retrospectively on data collected from
medical records in Scandinavian and Norwegian countries (Dean, Williams &
Brockington, 1989; Klompenhouwer, 1991; Kumar et a l, 1995; Mower & Lennon,
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2001; Singh & Kauer, 1999; Wisner, Peindl & Hanusa, 1993; Wisner Peindl &
Hanusa, 1995). As discussed earlier, the ICD has not continuously provided for the
designation for either a discrete postpartum entity or even a postpartum specifier
(Kumar, 2001) so researchers must compare delivery records with psychiatric
admissions within a given period of time and cull together diagnostic and historical
information based upon those records (Dean, Williams & Brockington, 1989;
Klompenhouwer, 1991; Kumar et al., 1995; Mower & Lennon, 2001; Singh & Kauer,
1999; Wisner, Peindl & Hanusa, 1993; Wisner Peindl & Hanusa, 1995). Because the
prevalence of this disorder is small, psychiatric admissions within six months and
even 12 months of delivery are commonly included within the research criteria
(Dean, Williams & Brockington, 1989; Klompenhouwer, 1991; Kumar et al., 1995;
Mower and Lennon, 2001; Singh & Kauer, 1999; Wisner, Peindl & Hanusa, 1993;
Wisner Peindl & Hanusa, 1995). This methodological decision, while understandable
in light of the limited prevalence rate, necessarily compromises arguments either for
or against discrete nosological status. It is very difficult to make an argument that
postpartum psychosis is distinct from other psychoses when the criteria for inclusion
into a particular study or diagnostic group is so broad and allows women with
potentially non-childbirth related psychoses into the mix. Moreover, women with
previous histories of psychiatric disorder, either puerperal or non-puerperal, are
routinely included in analyses (Brockington & Meakin, 1994; Brockington, Oates &
Rose, 1990; Dean, Williams & Brockington, 1989; Sing & Kauer, 1999; Wisner,
Peindl & Hanusa, 1995). This is true of the few prospective projects as well
(McGorry & Connell, 1990). Again, without clear distinction between those with
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previous histories of serious psychiatric disorders and those without such histories, it
is difficult to distinguish this syndrome from its non-puerperal counterparts.
In addition to methodological problems in the research, there are logical errors
in the conclusions reached. Namely, the increased incidence in onset and recurrence
of bipolar disorder, particularly in women with familial or personal histories of the
disorder, does not demonstrate a nosological linkage between the two disorders.
Rather, it indicates that pregnancy is a significant stressor that brings with it a risk of
relapse or onset in women so disposed.
The research on prognosis or risk of relapse following a puerperal psychotic
episode, though no more consistent than the aforementioned research, provides some
evidence for separate disorders. It must be noted, however, that many of the studies
cited in the following section do not always distinguish between new onset or
recurrence, neither do they clearly elucidate symptom criteria. Thus, the numbers
presented below are merely estimates culled together from the various projects for the
purpose of discussion herein.
In women with histories of non-puerperal psychiatric affective psychosis there
is an increased risk of both puerperal and non-puerperal psychotic episodes and
functional prognosis is poor. The risks are consistent with those in the general
population except in the immediate puerperium where the risk of major psychiatric
illness increases several fold (McGorry & Connell, 1990). In women with family
histories (first degree relatives) of psychiatric disorder and a puerperal psychotic
episode there is an increased risk of future non-puerperal and puerperal episode.
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Prognosis is mixed. Moreover, there is a ten-fold increase in puerperal psychosis for
first degree relatives (McGorry & Connell, 1990).
In women who have had puerperal psychotic episodes with no personal or
familial history of psychiatric disorder, the risk of non-puerperal episodes is
increased, compared to women without puerperal psychosis, but the risk appears to
decrease over time (Hays & Douglas, 1984; Ramsey, 1994). However, the risk of
subsequent puerperal psychotic episodes has variously been found equal to or greater
than women without such histories with estimates of 20-60% recurrence of postpuerperal episode (Brockington & Roper, 1987; Davidson & Robertson, 1989;
Videbech & Gouliacv, 1995). Prognosis and post-episode functional ability in these
women is good, if there are no non-puerperal breaks, with estimates of upwards 96%
achieving full functioning compared to 47% of women with personal or family
histories (Dean, Williams & Brockington, 1989). The risk for subsequent puerperal
episodes is high with more than one third of women across studies having subsequent
episodes following parturition (McGorry & Connell, 1990).
Lacking from the above data are clear diagnostic criteria, delineation between
first onset versus previous history, and between subsequent puerperal versus nonpuerperal recurrences. What should be investigated is whether or not there are
women, for whom the puerperium only, confers a risk of psychosis.
Epidemiology and Psychiatric Admissions in Postpartum

Epidemiological studies on postpartum mental illness are focused largely on
postpartum depression and postpartum psychosis. There are very few studies that
address other psychological disturbances. O f those studies, most fit into one of two
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categories, the prevalence of presenting disorder in inpatient populations relative to
childbirth or the prevalence in outpatient referrals relative to childbirth. Very few data
exist regarding prospective prevalence of disorder in community samples.
Wisner and colleagues (1993) reviewed medical records for a large cohort
(n=1172) of women with both inpatient and outpatient psychiatric referrals relative to
childbearing status. The data were divided into two groups, childbirth related onset of
illness (CBROI) (n=168) and non-childbirth related onset of illness (NCBROI)
(n=1004). Pre-index episodes of psychiatric disorders were not identified.
Investigators found several significant demographic differences between the two
groups. The CBROI group was an average of five years younger and had fewer
children than the NCBROI group. The onset of illness in the CBROI group was
earlier, particularly for affective and non-affective psychosis, but nonetheless similar
to the NCBROI group with similar rates of prevalence in both groups for affective,
anxiety and psychotic disorders.
The women in the CBROI group were, however, more frequently diagnosed
with an adjustment disorder than the NCBROI group. The prevalence of adjustment
disorder in the CBROI group may represent a catch-all diagnosis insofar as these
women may not have met criteria for other disorders and might simply have been
diagnosed with the adjustment disorder for lack of a more appropriate category.
Wisner et al. (1993) also reported that of women who have ever had a child, the
prevalence of psychological disorders was somewhat higher than expected at 14%.
Based upon these findings the authors argued that postpartum women are as likely as
nulligravid women to experience a range of psychiatric difficulties, not simply
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depression, and may be at a higher risk for these disturbances following parturition,
particularly in the case of younger primigravid women.
In a study looking at both onset and co-morbidity, Kumar, Marks, Platz and
Yoshida (1995) found 56 out of 100 consecutive admissions to a mother-baby
psychiatric ward occurred within two weeks of delivery with a diagnosis of affective
psychosis. Twenty-four were diagnosed with non-psychotic disorders and 20 with
pre-existing schizophrenia. Of the 56 women diagnosed with affective psychosis, 26
were experiencing an acute, first onset of mental illness. As was observed by other
investigators, a consistent theme across disorders was the presence of intrusive
thoughts or delusions about harming their infants.
In'one of the very few prospective studies on perinatal mental illness, Wenzel
et al. (2001) reported prevalence rates for anxiety disorders in a community sample of
788 postpartum women. Approximately 11% of study participants reported having
had at least one panic attack in the previous 30 days. Eight and 9% reported having
obsessions and compulsions, respectively. Co-morbid depression and panic disorder
was reported in 1% of the population while co-morbid depression and OCD was
present in 2.4% of the participants. No data were listed regarding the prevalence of
depression alone. However, dysphoria was reported in all but 200 of the participants.
The definition of dysphoria was not elucidated.
Time Course o f Perinatal Psychiatric Disorders

Over the last 20 years numerous studies have addressed the prevalence and
time course of perinatal depression (for a review see Gavin et al., 2005). The
consensus appears to be that antenatal depression is highly associated with postnatal
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depression and that symptoms from pre-existing conditions remain stable
longitudinally (Beeghly et ah, 2002; Gavin et ah, 2005). What has not been addressed
is whether there is stability in symptoms for new onset antenatal or postnatal
depression cases. However, there are some indications that the time course is quicker
and the prognosis is better for new onset puerperal psychosis versus non-puerperal
psychosis or mania. Moreover, the incidence of a non-puerperally based relapse is
significantly less following puerperal psychosis than it is following non-puerperal
psychosis (Williams & Brockington, 1989).
For other psychiatric disorders, such as panic disorder and OCD, there are a
few reports suggesting that symptoms follow a similar pattern as has been found in
perinatal depression, although there has been speculation that pregnancy provides a
protective effect. That is, pregnancy hormones (presumably, progesterone because of
its anxiolytic capacity, although not ever tested) are believed to prevent the onset or
recurrence of anxiety. Cohen et al. (1996) investigated this hypothesis in a small
sample (n=10) o f pregnant women with a pre-existing diagnosis of panic disorder and
found that pregnancy was not protective. Symptoms remained stable in each of the
trimesters for seven of the ten women tested. The group was followed through the
first three months postpartum. At the postpartum evaluation, 9 of 10 women met
diagnostic criteria for panic disorder and 7 of 10 had to increase medication over
previous levels.
Consistent with his previous work Cohen and associates (2005) found that the
state of pregnancy did not protect women with long standing histories of depression
from relapse. In this study, 201 women (mean age 34.1 years) with lifetime histories
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of major depression ranging from five years to over 20 years were tracked through
pregnancy. Criteria for entry into the study included; that these women had a history
of major depression; were less than 16 weeks pregnant; were euthymie from the last
menstrual period through the proceeding three months; and were currently receiving,
or had within the last 12 months received antidepressant medication.
Approximately 92% of the participants entered the study while taking a
variety of serotonin reuptake inhibitors. The remaining participants were on tricyclics
or a combination o f medications. During the course of the study 43 women were able
to decrease or discontinue medication without relapse. Seventy-two women prevented
relapse by maintaining or increasing current dosages. Eighty-six women relapsed
during the course of the study, of those 56 had either decreased or discontinued
medication. The remaining 30 women either maintained or increased their
medication dosages and still relapsed. These data suggest that in women with lifetime
histories o f major depression, pregnancy does not confer protection against an
episode o f major depression.
The authors argue that in light of the risk of relapse, antidepressant medication
should be maintained throughout the pregnancy. There were, however, several
limitations to this study. First, although standardized diagnostic and measurement
instruments were used for assessment, namely the Structured Clinical Interview (I/P)
(SCID-I/P) and the Hamilton Depression Rating Scale for Depression (HAM-D),
there were no data given on baseline scores compared to relapse, severity of relapse,
time from discontinuation to relapse, time to re-medication, pattern of discontinuation
(abrupt or tapered). Nor was information given regarding which medications
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generated higher rates of relapse or whether or not chronicity and/or severity of
disorder predicted relapse.
Using a prospective/retrospective mixed design, Wisner and colleagues (1996)
evaluated the relationship between panic attacks and childbearing using psychiatric
records of 22 women over the course of five years and 45 combined pregnancies. In
each of these cases, the onset of panic disorder predated the pregnancy. As was the
case in Cohen et al. (1996), neither panic intensity nor frequency changed during
pregnancy for the majority of women (69%). But contrary to Cohen’s findings, if
there was a change, symptoms typically improved during pregnancy (27%). For most
patients (69%), assessed at un-specified times postpartum, there was no change in
symptom intensity or frequency. However, approximately 31% experienced an
increase in panic attacks postpartum. But again, at what point participants were
assessed was not disclosed, nor was the absolute difference in intensity, frequency or
quality of the panic during the puerperium.
In perhaps the largest study to date. Heron et al. (2004) prospectively tracked
the prevalence and course of anxiety and depression from pregnancy to eight months
postpartum in 8323 English women. The study, part of the Avon Longitudinal Study
of Parents and Children (ALSPAC), was conducted via self-report questionnaire.
Eighty-five percent o f eligible women completed the survey at all test times.
Depression was estimated based upon a score of >10 on the EPDS while anxiety was
measured by the Crown-Crisp Experiential Index (CCEI) and indicated by a score of
9 out of 16 points. Over the course of the study, antenatal and postnatal depression
scores were moderately correlated at each test time. At 8 weeks postpartum only
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8.9% of the women exhibited depression and a third of those women were new cases.
Additionally, 11% of the participants experienced depression only during pregnancy.
The prevalence o f anxiety followed a pattern similar to that of depression,
with correlations between antenatal and postnatal test times. Seventy-three percent of
the total population reported no elevation in anxiety at any test time. However, at
eight weeks postpartum, 8.1% reported elevated anxiety, of which approximately one
fourth of the cases were new. In each instance antenatal psychological distress
predicted postnatal distress.
Cognitive Sequelae o f Pregnancy and Childbirth

Similar to the research on puerperal mood changes, the research on puerperal
cognitive changes is plagued by methodological inconsistencies. With few
exceptions, research in this area focuses upon subjective perceptions of memory
impairment, usually during pregnancy and the immediate postpartum. O f the few
studies utilizing objective measures, most have not measured concurrent hormone
values and none have been able to substantiate what is commonly referred to as the
“pregnancy brain drain” (Brett & Baxendale, 2001) or “maternal amnesia” (Brett &
Baxendale, 2001) or the more technical term “benign encephalopathy of pregnancy”
(Poser, Kassierer & Peyser, 1986).
Jarrahi-Zadeh et al. (1969) measured both subjective and objective cognitive
and affective modalities in 86 women at various times during their last trimester and
on the 3‘^‘^day postpartum. These data were compared to data obtained from a group
of 21 controls. The cognitive measures included Trails B and the Porteus Maze test.
Both are tests o f executive function and processing speed. Investigators found a
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significant difference between pregnant and non-pregnant controls and between
postpartum and non-pregnant controls in Porteus Maze completion times and
concluded that pregnant and postpartum women showed difficulties in concentration
and planning compared to non-pregnant controls. The authors also noted a high
prevalence of memory complaints amongst pregnant and postpartum women.
Brindle et al. (1991) found that pregnant women showed significant deficits in
implicit but not explicit memory at 36 weeks compared to controls and reported a
significantly higher subjective rating of impairment (59% vs. 11%). In 1993, Sharp
and colleagues found similar results reporting that pregnant women were significantly
impaired in incidental learning tasks, in word list recall, and word-stem completion
when compared to controls. Sharp et al., (1993) Jarrehi-Zaddeh et al. (1969) and
Brindle et al., (1991) also collected subjective reports of memory which revealed that
81% of the pregnant women rated their memory as impaired compared to 16% of the
control subjects.
Eidelmen, Hoffinan and Kaitz (1993), using a between subjects design, looked
at memory deficits in 100 postpartum (days 1-3) women using the Weschler Logical
Memory Test and the Weschler Visual Reproduction Test. They found that though
significant memory deficits on both scales appeared on day one they resolved by day
three. Interestingly, they tested fathers and found that they too showed impaired
performance on the logical memory test but not on the visual reproduction test on day
one, perhaps indicating that stress, exhaustion and all of the other overwhelming
emotions that occur immediately after delivery may influence memory function.
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In a longitudinal case-control study assessing memory in 10 pregnant and 10
non-pregnant women, Keenen et a l, (1998) found that pregnant women performed
significantly worse during the third trimester as compared to controls in the paragraph
recall task. The investigators noted no other differences in performance at either the
first or second trimester or postpartum test times. Moreover, although the control
group demonstrated significant practice effects across time, the performance of the
pregnant women declined from the first until the third trimester, but improved
somewhat during the second trimester. Recall scores improved between the third
trimester and postpartum, returning to first trimester scores. The authors failed to note
when postpartum testing occurred.
Deficits in selective attention were noted by de Groot, Adam and Homstra
(2003) at 36 weeks pregnancy but had resolved by 32 weeks postpartum. The data
demonstrated that pregnant women performed significantly worse than did controls
and showed little to no priming effect. Crawley, Dennison and Carter (2003) found no
differences between pregnant and non-pregnant controls in three cognitive modalities
tested during the second and third trimesters as well as at six weeks and one year
postpartum.
The measures used by these investigators included the Stroop test. Trails A
and a self-designed text memory task. In addition to these objective measures,
Crawley et al. (2003) assessed subject perception of memory impairment and found
that a significant portion of the women tested reported a higher incidence of
perceived memory deficit during the third trimester than compared to other trimesters,
non-pregnant controls and postpartum. A second study by the same authors and
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published within this manuscript confirmed the subjective assessment results. The
authors concluded that perceptions of cognitive impairment are likely subtle and may
be associated with either depressed mood or the expectation of cognitive decline.
In perhaps the largest and most comprehensive work to date, Vanston (2005)
measured cognitive performance and salivary hormones in 45 pregnant and 45 non
pregnant age- and education-matched controls five times, three during pregnancy (12
weeks, 24 weeks and 37 weeks) and on two occasions postpartum (six weeks and at
the resumption of menstruation). The cognitive tests included the WAIS III Symbol
Search (perceptual speed and accuracy) and Digit Symbol Coding (visual motor
coordination), Purdue Pegboard (motor processing speed), California Verbal Learning
Test (CVLT) (verbal memory), Silverman Eals Object Location Memory Task (object
location memory). Listening Span (verbal working memory). Computation Span
(arithmetic working memory) and the Shepard-Metzler Mental Rotation Test (MRT)
(spatial working memory). The results indicated no significant differences between
the pregnant and non-pregnant group on any of the tests for cognitive performance
and no significant correlations between any of the hormones measured (progesterone,
DHEAS, testosterone estrone, estriol and estradiol) and any of the cognitive tests. In
fact the mean scores for the pregnant participants were higher, though not
significantly, than the non-pregnant controls during pregnancy and at both postpartum
test times.
Determining whether the lack of difference between groups in cognitive
performance demonstrated that both groups were equally proficient or equally
impaired is difficult inasmuch as only partial sections of various cognitive tests were
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administered. However, comparison of the mean score for the first three CVLT trials
administered in this study, show that both groups scored above the normative mean
with an average of 12 of 16 words retained per list. Likewise performance on the
WAIS III symbol search and symbol coding suggested slightly above average
performance with percentile ranking in 58-60* percentile.
These performance levels are consistent with the 14 years of education
averaged by both groups and seem to challenge the anecdotally accepted perception
of pregnancy-related cognitive deficits. However, methodological issues may have
limited the interpretive validity of these findings. The inclusion of multiparous
women in both the experimental and control groups was particularly troubling. If
some aspect o f pregnancy were to have deleterious effects on cognitive ability, it
would be expected during the initial pregnancy when the mother has yet to adapt to
either her new physiological status or to the psychosocial stressors associated with
motherhood that await her.
The researcher did find that when the gender of the child was assessed in
relation to performance, women who had been pregnant with males performed better
on tasks of working memory (the listening and computation span tasks and the MRT),
than did women who had been pregnant with females. Interestingly, the researcher
was unable to identify significant differences in the androgenic hormone
concentrations between the groups and the improved performance for the mothers of
male children persisted through the postpartum test sessions, long after the effects of
puerperal hormone changes would have dissipated.
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The discrepancy between the perceived deficits and what is empirically
measurable has led some researchers to speculate that either mood disruptions
commonly associated with pregnancy and postpartum underlie the perceived memory
deficits (Crawley, Dennison & Carter, 2003) or that the perinatal memory deficits are
just not salient (Crawley, 2002). Crawley (2002) found that only 2% of a sample of
198 pregnant women spontaneously reported memory deficits. Based upon this
finding, the author argued that perinatal memory deficits must not be that important.
This is contrary to accounts by professional women who report impaired job
performance during the latter stages of pregnancy and early postpartum and suggest
that “the maternal amnesia syndrome is a reality that most mothers are too frightened
to admit.. .and yet will talk of with obvious relief when they realize it is common,
normal and temporary” (Baildam, 1991). It is also contrary to findings of Buckwalter
et al. (1999) and Marrs (2006), where significant decrements in cognitive ability
were identified across multiple domains and perceptions of cognitive ability tended to
overestimate performance postpartum (Marrs, 2006).
Buckwalter and associates (1999) measured cognitive performance, mood and
serum cortisol, progesterone DHEA, testosterone and estradiol concentrations using a
standard battery of neuropsychological instruments in 19 women at 36 weeks of
pregnancy and at one month postpartum. They found that pregnant women performed
significantly worse on several aspects of the CVLT compared to normative data for
women of similar age and education. They were particularly impaired on trials 1 and
5, scoring in only the 6* and 5* percentiles respectively and showed significantly
lower learning slopes ranking only in the 32"*^ percentile. Accordingly, subjects
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performed significantly worse in both the short and long free recall tasks (17*
percentile for both) indicating potential problems in either retention and/or attention.
They also performed more poorly on short and long cued recall tasks (21®‘ and 16*
percentiles, respectively) and had a higher than normal number o f intrusions.
In addition to the deficits listed above, the pregnant women showed
significant impairment on Trails A, 2U‘ percentile, but not Trails B. They also
performed more poorly on Trails B , the Stroop test, the Boston naming test and
Digit Span Backward when pregnant(46*, 47*, 16* percentiles respectively), but the
change in performance levels from pregnancy to postpartum failed to reach statistical
significance.
The Marrs (2006) study measured cognitive performance using a complete
battery of neurocognitive instruments in a cohort of healthy primi gravid women at 37
weeks of pregnancy and within 10 days postpartum and found cognitive deficits
across multiple domains when compared to age, gender and IQ-matched normative
data. In tests of verbal memory as measured by performance on the CVLT-II,
participants scored below the 20* percentile on the immediate and long term recall
tasks in late pregnancy and early postpartum. Spatial memory, as measured by the
Rey Complex Figure Test (CFT), was similarly impaired for many of the participants
with mean rankings for recall during pregnancy in the 29* percentile and in the 4U‘
percentile postpartum.
To put these scores in perspective, the scores observed by Marrs (2006) and
also by Buckwalter et al. (1999) were similar to or below scores that have been
observed in patients with moderate closed head injuries (Bigler, Rosa, Schultz, Hall
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& Harris, 1989), obsessive compulsive disorder (Roh et al., 2005), schizotypy
(Gooding & Braun, 2004), and schizophrenia (Penning, Mottes, Ricter-Levin, Treves
& Levkovitz, 2002) and were marked by a consistent failure to organize information
appropriately. Marrs also noted mild decrements in attention, cognitive and motor
processing speed. Although psychiatric disturbances were present in over half of the
participants in the Marrs study, they were not consistently related to poor cognitive
performance. In fact depression levels were positively correlated to verbal memory.
These findings were in stark contrast to the research by Crawley and associates
(2002; 2003) who claimed that because women did not readily offer concerns
regarding cognitive impairment that the impairment was not salient or some how
associated with either mood changes or the expectation of cognitive impairment
rather than impairment itself.
Summary
Puerperal Mental Illness

It is evident that much work is still needed. There is a relative paucity of data
that addresses puerperal psychiatric co-morbidity and even fewer studies that have
investigated the onset and longitudinal course of these symptoms. O f the reports that
do exist, all suggest that co-morbidity is the rule rather than the exception, but when
these symptoms emerge and how they progress is unknown.
While the onset of postpartum psychosis is generally accepted as being rapid
and the prognosis is typically viewed as being good, the research is flawed relying
heavily on retrospective data gleaned from hospital or psychiatric referral records.
Women with previous psychiatric illnesses were included in the analyses and
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diagnostic or inclusion criteria frequently varied from project to project making
delineation between the strictly pregnancy-related disorders from the re-emergence of
pre-existing disorders difficult at best. Finally, the research presented thus far does
not address the possibility that endocrine factors might contribute to or precipitate
these disorders.
Puerperal Cognitive Changes

Puerperal cognitive changes are anecdotally accepted but have thus far largely
eluded consistent empirical measurement. Some investigators have identified deficits
(Brindle et al. 1991; Buckwalter et al., 1999; de Groot, Adam & Homstra, 2003;
Jarrahi-Zadeh et al., 1969; Marrs, 2006; Sharp, 1993) and others have not (Crawley,
Dennison & Carter, 2003; Vanston, 2005). The discrepant findings are likely related
to methodological differences between studies. Although puerperal cognitive deficits
are commonly attributed to either mood and/or hormone changes associated with
pregnancy and postpartum, only three studies to date have investigated the relatedness
of these three variables (Buckwalter et al., 1999; Marrs, 2006; Vanston, 2005) and
none was able to provide strong support either for or against those associations.
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The Endocrinology of Pregnancy and Parturition
The temporal association between psychiatric disturbances, cognitive
impairment and pregnancy and postpartum is clear and generally supported by the
literature. What has not been addressed is how pregnancy might precipitate these
changes. Some have argued that psychosocial factors adversely influence puerperal
mental health (Andrews-Fike, 1999). Others have suggested that changes in the
reproductive hormones such as progesterone and estradiol trigger pre-existing
conditions (Bloch et al., 1999; 2000; 2005). While neither possibility can be disputed
fully, the research has yet to account for the substantially increased risk for mental
illness during the two years surrounding pregnancy and birth in otherwise healthy
women or for the temporal proximity to the onset of these disorders with the vast
changes in puerperal internal chemistry.
If the argument is to be made that puerperal endocrine changes somehow
mediate puerperal psychiatric and even cognitive disturbances then the basic
components of the endocrine and central nervous systems must be shown to interact
with each other. Provided below is an overview of basic endocrinology relative to
pregnancy and parturition. Emphasis is placed upon the hormones potentially
associated with puerperal psychiatric and cognitive disturbances and their respective
interactions with central nervous system activity.
Basic Endocrinology

The endocrine system utilizes hormones as chemical messengers for
communication between cells to regulate metabolism, reproduction and growth.
Together with the central nervous system, the endocrine system is responsible for
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maintaining biological homeostasis. Hormones are synthesized in the endocrine
glands and secreted into the circulatory system where they then may bind with
receptors located exterior or interior to the cell from which they were released
(autocrine regulation), with receptors on adjacent cells (paracrine regulation) or they
may travel great distances to interact with other endocrine glands and target tissues
(endocrine regulation). The synthesis of individual hormones is dependant upon
enzyme availability and, thus, other peripheral tissues including adipose can
synthesize great quantities of some hormones. Both the peripheral and central
nervous systems also synthesize hormones and in some cases produce larger
quantities than those found in circulation (Baulieu & Robel, 1990).
The hypothalamus integrates signals from both the external and internal
environment to control the stimulation and inhibition o f the trophic hormones
released by the pituitary gland. Together the hypothalamus and pituitary and other
adrenal glands form three endocrine circuits that regulate homeostasis, reproduction
and growth: the hypothalamus-pituitary-adrenal (HPA) axis, the hypothalamuspituitary-gonadal (HPG) and the hypothalamus-pituitary-thyroid (HPT) axis
respectively. The HPG sometimes called the HPO (ovarian) when referring to female
physiology regulates reproduction and will be the focus of this discussion.
Non-Conception Cycles

The HPO circuit regulates the female menstrual cycle and supports pregnancy
through a series o f positive and negative feedback loops. The hypothalamus
stimulates the pituitary's release of luteinizing hormone (LH) and follicle stimulating
hormone (FSH) by releasing the gonadotropin-releasing hormone (GnRH). The
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release of hypothalamic GnRH elicits the pituitary release of FSH and LH. As the
follicle development proceeds, FSH and LH stimulate the release o f estradiol which
ultimately inhibits continued FSH secretion. Concurrently, the release of estradiol
causes the increase of LH, which in turn causes the release of more estradiol.
Estradiol concentrations are thought to peak immediately before ovulation. The peak
in estradiol then signals the decline of GnRH and LH following ovulation on about
day 15 of the cycle (Kaplan, Pesce & Kazmierczak, 2003).
After ovulation, during the luteal phase, estradiol concentrations wane prior to
reaching a second and ultimately higher peak (Kaplan, Pesce & Kazmierczak ,2003;
Schultheiss, Dargel & Rohde, 2003). During this time, progesterone concentrations
increase until day 21-23 when the corpus luteum forms. If fertilization did not occur
at ovulation, within a few days of luteal formation, luteolysis occurs, the
endometrium sheds and menstruation begins.
Hormone Changes from Conception and Pregnancy through Parturition

After ovulation and fertilization, the 2-8 cell embryo travels through the
fallopian tubes into the uterine cavity and within 3-6 days following conception, the
blastocycst now floating within the uterine cavity, unattached to the endometrium,
begins secreting chorionic gonadotropin hormone (p-hCG) to hasten endometrial
maturation and strengthen its ultimate implantation. After implantation, the embryo
continues to secret P-hCG to maintain the biosynthetic capacity of corpus luteum and
endometrium. The corpus luteum produces progesterone, 17a-hydroxyprogesterone,
(17a-0H progesterone) estradiol and androstenedione for the first 6-8 weeks of
pregnancy. Between weeks six and eight, a period called the fetal-placental shift.
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corpus luteum function declines and placental and eventually fetal steroidogenesis
take over.
Pregnancy steroidogenesis is a multi-compartment process (Figure 1).
Cholesterol in the form o f low density lipoproteins (LDL) and very low density
lipoproteins (VLDL) from maternal circulation binds with placental receptors that are
up-regulated by estradiol and cross into the placenta (Carr 2001). The side chains of
the cholesterol molecule are cleaved by the enzyme CYPl 1A1 and converted into
pregnenolone. Progesterone is derived from pregnenolone as are maternal and
placental androgens and estrogens, glucocorticoids and mineralcorticoids.
From conception until parturition maternal plasma progesterone
concentrations, derived primarily from placental steroidogenesis (90%), increase from
less than l-2ng/mL at conception to 100-300 ng/mL at term (Braunstein, 2003; Carr,
2001). The role o f progesterone during pregnancy is to suppress myométrial
contractions (Challis & Lye, 1998) although researchers are finding that testosterone
may also be involved in this process (Perusquia, Navarrete, Jasso-Kamel & Montano,
2005). Maternal ovaries are mostly quiescent from approximately eight weeks of
pregnancy until menstruation begins following parturition but provide a major source
of 17a-0H progesterone through-out the pregnancy, nevertheless. Concentrations of
this hormone increase from approximately 1-2 ng/mL at conception to approximately
7 ng/mL at term (Mooney & Giudice, 2002).
The placenta is the major source of estradiol and estrone but because it lacks
the CYP 17 enzymes 17a-0H and 17, 20 lyase, placental estrogens are derived from
both maternal and fetal adrenal androgens rather than progesterone (Challis & Lye,
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1998). Research suggests that maternal DHEA and fetal DHEA contribute equally to
the production o f estradiol and estrone (Challis & Lye, 1998; Rainey, Rehman &
Carr, 2004). Estradiol and estrone concentrations increase throughout gestation with
values for both hormones ranging from .1-.4 ng/mL at conception to 6-30 ng/mL at
term (Mooney & Guidice, 2002).
Estriol, synthesized by hepatic and peripheral conversion of the adrenal
androgens, typically circulates at very low concentrations during non-conception
cycles (Carr, 2001). During pregnancy however, the fetal adrenals produce vast
quantities of DHEA and DHEAS, from which 90% of estriol is derived (Challis &
Lye, 1998; Rainey, Rehman & Carr, 2004). Since most of the estriol is released into
circulation, maternal estriol concentrations increase from less than . 1 ng/mL at
conception to 10-30 ng/mL at term (Mooney & Giudice, 2002). Estriol, because of
its fetal origins, is often used as a marker of fetal health and survival (Challis & Lye,
1998).
With fetal contributions to DHEA/DHEAS production, maternal circulating
concentrations of those hormones are thought to increase in first two trimesters but
plateau in the third (Milewich et al., 1978; Soldin et al., 2005; Tagawa et al., 2004).
As a fimction of the increased DHEA, maternal testosterone concentrations are
believed to increase throughout pregnancy (Bamman, Coulam & Jiang, 1980). It is
postulated that as the pregnancy progresses more fetal DHEA is converted to
testosterone and to the estrogens, to support the growing fetus and ultimately initiate
parturition and thus lower circulating concentrations of DHEA are noted at term
(Gant, Hutchinson, Siiteri & MacDonald, 1971). The control of human parturition is
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complex process involving multiple hormones and systems and is beyond the scope
of this discussion (for a review see Challis, Matthews, Gibb & Lye, 2000), however,
there are data suggesting that the withdrawal of progesterone, together with a surge in
estradiol, estriol and cortisol initiates uterine contractility in animal models (Olson,
Mijovik & Sadowsky, 1995). In human parturition the data are inconclusive (Challis,
Matthews, Gibb & Lye, 2000).
With the delivery of the fetus and placenta, maternal sources of steroid
production are lost and circulating concentrations of most steroid hormones drop to
pre-pregnancy values within 2-4 days of parturition (Illingworth & McNeilly, 1998).
Resumption of menstruation and the cyclical production of progesterone and estradiol
is reported to occur within two months in non-lactating women and can occur in some
women while lactating, but typically does not resume until lactation ceases or is
diminished significantly (Bolaji, Talion, Meehan, O’Dwyer & Fottrell, 1992;
Illingworth & McNeilly, 1998).
Hormone Synthesis and Protein Binding

All steroids are synthesized from cholesterol (Figure 2). Cholesterol can be
synthesized from acetate in many tissues including the skin and the intestines but the
main site of production is in the liver (Niewoehner, 1998). During pregnancy, neither
the fetus nor the placenta contains sufficient enzyme activity to convert acetate to
cholesterol and thus require maternal cholesterol for steroid synthesis (Challis & Lye,
1998). From cholesterol, the CYP 450 see (side chain cleavage) also denoted as the
CYPl 1A l, 20,22-desmolase and/or 20,22 lyase cleave either part or all the carbon
side-chain converting the 27-carbon cholesterol skeleton into the 21-carbon
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pregnenelone (C21 pregnane group, progestins and corticosteroids). Total removal of
the side chain results in the androstane (androgens) group of hormones (Cl 9).
Pregnenelone is the precursor hormone for the ovarian production of
estrogens, the testicular production of androgens and the adrenal production of
glucocorticoids, mineralcorticoids, androgens and estrogens. Ovarian and testicular
production of steroids is subject to control by pituitary LH, whereas adrenal activity is
modulated by pituitary adenocorticiotropin hormone (ACTH) (Niewoehner, 1998).
Conversion from pregnenelone to the respective pregnane and androstane hormones
is dependant upon the presence or absence of four enzymes that are widely distributed
through-out the periphery and within the central nervous system. These enzymes
include desomalase (lyases) which catalyze cholesterol side chain cleavage;
hydroxylase, which adds a hydroxyl group to the steroid; hydroxysteroid
dehydrogenase which catalyze reversible oxidation/reduction reactions and
aromatase, catalyzes a series of reactions that ultimately remove Cl 9 methyl group
necessary for the conversion of androgens to estrogens (Kaplan, Pesce &
Kazmierczak, 2003).
Steroid hormones synthesized in the various endocrine glands and secreted
into circulation are highly lipophilic and can be metabolized and eliminated easily in
the liver. As such, steroids circulate tightly bound to carrier proteins such as sex
hormone binding globulin (SHBG), corticosteroid binding globulin (CBG) and
albumin or they travel as conjugated hormones (sulfates or glucuronide derivatives)
(Faigle & Schenkel, 1998). Only a small percentage of steroid hormone circulates
free and unbound to proteins. The fraction of circulating free hormone is estimated to
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range from 1-8% of the total concentration of hormone (Faigle & Schenkel, 1998). It
is argued that only free hormone or that which is not bound to protein, is capable of
binding to the hormone receptor and initiating a cellular response and/or being
metabolized into constituent compounds. Recent discovery of a transporter protein
that facilitates the endocytosis of bound hormone through the cell membrane may
challenge this notion in the future (Hammes et al., 2005).
Consideration of free/bound ratio is important nevertheless. Much of the
research involving hormones is conducted using plasma/serum. Hormone
concentrations from plasma/serum represent the total amount of hormone in
circulation, including that which is protein bound (Virming, McGinnley & Rice,
1983). Both procedural and mathematical manipulations have allowed investigators to
estimate the ratio of free to bound hormone, but with inconsistent results (Vermeulen,
Verdonck & Kaufrnan, 1999). Although the free versus bound ratio is tightly
controlled, there are instances where the equilibrium is altered and/or difficult to
assess such as in some disease states and potentially during pregnancy (Vermeulen,
Verdonck & Kaufrnan, 1999).
Binding protein concentrations and functionality are suspected of changing
significantly during pregnancy and presumably again following parturition
(Vermeulen, Verdonck & Kaufinan, 1999; Margarson & Soni, 1998). These changes,
if empirically supported (there is a woeful paucity o f research of these factors in
pregnant/postpartum women), would affect the ratio of free to bound hormone and
could alter the interpretative validity of hormone data depending upon the method of
measurement.
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To more accurately reflect the free fraction of steroid hormone and in fact to
provide a less invasive means by which to measure steroid hormone values, assays
were developed that quantify hormone concentration in saliva. Inasmuch as most
steroids are small neutral molecules, they freely pass through the membranes of the
salivary gland via passive diffusion and are not suspected of being affected by flowrate. However, some reports indicate that progesterone values increase as a function
of salivary flow-rate (Lequin, van den Boogaard, Vermeulen & Danhof, 1986). More
polar molecules such as DHEAS move through the tight junctions of acinar cells into
the oral cavity via ultrafiltration, a process that is flow-rate dependent (Vinning,
McGinley & Rice, 1983). Salivary stimulation decreases DHEAS concentrations
measured from saliva (Vinning, McGinley & Rice, 1983). Thus, care must be taken to
minimize the potentially confounding variable of salivary stimulation when
investigating this and other hormones, a factor minimally addressed in the literature.
Measurement of steroid hormones in saliva provides an accurate measure of
the free fraction of the hormone, when proper controls are employed. Correlations
between free and bound hormone are significant and range from .5- .9 depending
upon methodology, the lab and the hormone being measured, but are not absolute
(Hoffman, 2001). This may suggest that the equilibrium between free and bound
hormone is more dynamic than currently accounted for and/or may reflect the lack of
inter-laboratory procedural standardization.
Neuroactive Steroids and Neurosteroids

If an argument that peripheral changes in endocrine parameters due to
pregnancy affect psychiatric well being is to be made, then peripherally synthesized
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steroid hormones must have access to and bind with central nervous system (CNS)
receptors and elicit some cellular response in regions not associated directly with
reproduction. Indeed, the highly lipophilic steroid hormones cross the blood brain
barrier (BBB) easily and freely where they bind to both membrane and nuclear
receptors dispersed throughout the brain. It is well established that the brain is both a
major target for and source of steroid hormones (for a review see Baulieu, 1998).
Researchers have thus far identified progesterone, androgen and estrogen
receptors in the hippocampus, amygdala, cerebellum, basal forebrain, locus ceruleus,
raphe nucleus, hypothalamus and pituitary in the both central gray and glial cells
(Stomati, Genzzani, Petraglia & Genzzani, 1998). Steroid hormone receptors have
also been located in and shown to exert significant trophic affects when bound to their
cognate ligand in peripheral myelinated nerve tissue (Baulieu, 1999). Accordingly,
pharmacological and genetic manipulation of circulating hormone concentrations
and/or central hormone binding capacities demonstrates significant hormone/behavior
effects, particularly in rodent social behavior and learning (Birzniece et al., 2006;
Chestler & Juraska, 2000; Frye & Sturgis, 1998; Johansen, Birzniece, Lindhlad,
Olson & Backstrom, 2002) but also in human models (Hampson, 1990; Kampen &
Sherwin, 1994; Maki, Zonderman & Resnick, 2001).
In addition to the neuroactive actions of peripherally synthesized steroids,
many steroids are synthesized in the brain itself and act locally within the brain or
efflux into circulation to modulate peripheral events (Asaba et al., 2000;
Steckelbroeck et al., 2004). The concept of neurosteroids, postulated by Baulieu and
colleagues in the early eighties, was developed in recognition of the fact that brain
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concentrations of some steroids, such as DHEA would remain elevated weeks after
peripheral sources were removed. Researchers have since identified most of the
enzymes required for de novo steroidogenesis within the central nervous system
suggesting that the brain is a major source of steroid production (Martini, Melcangi &
Maggi, 1993; Steckelbroek et al., 2004).
Neurosteroids, Neurotransmitters and Behavior

The effects of steroid hormones are mediated through a variety of extra
cellular and intracellular mechanisms. Original theories of endocrine mediated
behavior change stressed the long term changes in cellular function generated by
transcription. The recognition of rapid and quickly dissipating cellular change led to
the discovery of extra-cellular steroid receptors. Finally, recent investigations have
identified “ligand-independent” steroid receptor and intra-cellular signaling pathway
activation whereby environmental factors stimulate receptor mediated protein
transcription, up-regulating receptor expression in the absence of the cognate ligand
binding (Braustein, 2004).
Because of their lipid status, unbound hormones easily diffuse through the cell
membrane where it binds to heat shock proteins (Hsp) and is shuttled to the cell
nucleus. After dissociating from the Hsp, the hormone binds with a nuclear receptor.
The hormone-receptor complex then enters the nucleus, binds to hormone response
elements on the DNA, activates or suppresses transcription factors and triggers RNA
dependent protein synthesis to regulate changes in cell structure and function.
Transcriptional effects develop over an extended course and as a consequence, the
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hormone/behavior relationship was thought to involve only long term changes in cell
activity (Birzniece, 2006).
Among the steroid hormones estradiol is a particularly potent transcriptional
regulator controlling the activity of 438 genes with 132 genes up-regulated in its
presence and 306 down-regulated (Frasor et al., 2003). Estradiol, through its two
receptors the ERa and ERP, with area specific distribution in the CNS (ERa:
hypothalamus and amygdala; ERp: hippocampus, entorhinal cortex and thalamus) is
thought to influence autonomic activity, reproduction (ERa) and memory and motor
functions (ERP). Indeed rodent studies have demonstrated that estradiol
administration induces female sexual receptivity through ERa (for a review see
Osterlund & Hurd, 2001) but also hippocampal synaptogenesis through ERP
(McEwen, et al., 2001) and learning (Chestler & Juraska, 2000; Frye & Sturgis, 1998;
Johansen, Birzniece, Lindhlad, Olson & Backstrom, 2002; Shors & Leuner ,2003).
Estradiol’s role in rodent learning involves, the enhancement of long term
potentiation via n-methyl-d-aspartate (NMDA) binding (Shors, Falduto & Leuner,
2004; Smith & McMahon, 2005) and/or aceytltransferase induction (McEwen, 1998).
Similarly, studies in postmenopausal women show estrogen administration improves
verbal memory and well-being (de Noaves-Suarez et al., 2001; Maki, Zonderman &
Resnick, 2001; Hogervorst et al., 1999). In pre-menopausal women estradiol
concentrations during the follicular phase of the cycle correlate with better verbal
memory but poor spatial memory (Hampson, 1990).
O f note, the two estrogen receptors express similar binding domains but
distinctly different activation patterns with ERP requiring 100-1000 greater
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concentrations of estradiol to activate transcription than ERa (Osterlund & Hurd,
2001). Researchers propose that ERp binding suppresses ERa expression and
transcriptional activation. Behaviorally, the relationship between receptor expression
and binding has not been investigated, but poses some interesting possibilities
regarding estradiol’s role in emotional learning. Continued activation of the ERa and
the ensuing sexual receptivity ultimately activates the ERp in areas where learning is
thought to occur and ultimately inhibits ERa mediated sexual receptivity.
Pharmacological antagonism of ERa also blocks receptivity (Osterlund & Hurd,
2001). In states of elevated estradiol such as pregnancy, the balance between these
two receptors could have evolved to align reproductive proclivities with fertility
(ovulation) and to limit reproductive behavior once pregnant with the cognitive
consequences simply an artifact of this process.
In recent years ligand-dependent extra-cellular receptors that mediate rapid,
short-term responses have been identified and are closely linked with mood states.
Most notably are those associated with the y-aminobutryic acid (GABA) receptor
complex, the NMDA glutamate receptors and dopamine (DA) receptors.
Pregnenelone, pregnenelone sulfate, progesterone, allopregnanolone, DHEA and
DHEAS all bind with and exert differential influence over the GABAa receptor
complex (Charalampopoulos et al,. 2005; Gullinello & Smith, 2003; Sousa & Ticku,
1997; Valle et al., 1997). Progesterone, estradiol, DHEA and DHEAS modulate
glutamate and DA and estradiol and DHEA modulate serotonin (5HT) (Birzneice et
al., 2006; Cabrera et al., 2002; Cabrera & Navarro ,1996; Charalampopoulos et al.,
2005; Compagnone & Mellon, 1998; Fink et al., 1999; Hou et al., 2003).
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Regulation of GABA and glutamate activity because of their control over
neuronal excitability may represent the most pervasive examples of the relationship
between steroid hormones and brain function and subsequent changes in behavior.
The GABAa receptor in particular exhibits distinctive binding/activity patterns with
each of the aforementioned hormones based upon the chronicity of exposure and
perhaps also the CNS location of the GABA cells (Birzneiece et al., 2006). The
GABAa receptor complex is composed of 18 subunits, currently divided into five
functionally distinct families (Birzneiece et al., 2006). The conformation of these
subunits alters the behavior of the GABA cell by rendering the receptors more or less
susceptible to endogenous GABA and other endogenous or synthetic compounds
(Birzniece 2006; Fuji & Mellon, 2001; Hsu & Smith, 2002; Gullinello & Smith,
2003).
Although multiple hormones bind to and exert influence with the GABAa
receptors, the influence o f progesterone, DHEAS and to a lesser degree DHEA are
the most clearly elucidated and will be the focus of the discussion. Progesterone,
either alone or via its metabolite allopregnenelone, like the benzodiazepines (BDZ)
and alcohol, is a potent sedative-hypnotic and anxiolytic. Similar to BDZ and alcohol,
acute administration o f progesterone increases GABA chloride (CI-) channel open
time to produce sedation, even anesthesia and respiratory failure (Arafat et al., 1988;
Concas et al., 1998; Selye, 1941). These effects are mediated by binding with the a-1
subunit (Gulinello & Smith, 2003; Gulinello, Gong & Smith, 2001). The anxiolytic
effects of these compounds are believed to be mediated by a-2, a-3, a-4 subunits
(Gulinello & Smith, 2003; Gulinello, Gong & Smith, 2001). Chronic exposure to
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progesterone, its metabolites, BDZ or alcohol up-regulates the activity of a-4 and a-6
subunits. When the a-4 and a-6 subunits are expressed in greater numbers than a-1
through a-3 subunits and in combination with other subunits, BDZ and progesterone
do not bind as effectively to the receptor and GABAa Cl- channel open time is
reduced significantly (Concas et al., 1998; Costa, Spence, Smith & French-Mullen,
1995). The net behavioral effect is CNS hyper-excitability and anxiogenesis.
Benzodiazepine research suggests that tolerance to chronic administration
develops in phases with the gradual change in GABAa receptor confirmation and
binding preferences. The sedative properties of the drug are lost initially (a-1)
followed by the loss of anticonvulsant and anxiolytic subunits (a-2, a-3, a-4).
Concomitantly, a-amino-3-hydroxy-5-methyl-4-isoazole proprionic acid (AMPA)
receptor density increases and glutaminergic transmission is enhanced, particularly in
the hippocampus and the frontal and occipital cortices (Izzo et al., 2000). It is
reasonable to suspect that progesterone tolerance in pregnancy develops similarly.
Thus, based upon this research, chronic exposure to progesterone and its
metabolites, as occurs during pregnancy would be expected elicit anxiety via
conformational changes in the receptor, reduced GABA inhibition (Concas et al.,
1998; Costa et al., 1995; Gulinello & Smith, 2003; Gulinello, Gong & Smith, 2001)
and enhanced glutaminergic transmission (Cabrera & Bregonzia, 1995; Cabrera &
Navaro, 1996; Cyr, Ghribi, DiPaolo, 2000). Moreover, as is the case with BDZ and
alcohol withdrawal, the cessation of progesterone exposure following parturition,
should precipitate some degree of mood instability characterized by agitation and
anxiety. The behavioral manifestations of these changes alone (absent other major
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endocrine mediated responses) could represent the commonly reported and transient
postpartum mood lability. As will be discussed in the subsequent sections, there is
some research to support this hypothesis.
However, pregnancy is marked by significant endocrine changes that when
combined seem to exert disproportionate influence on the GABAergic and
glutaminergic systems. Briefly, Marrs (2006) reported a marked increase in
postpartum concentrations of DHEAS that was associated with increased psychiatric
distress. DHEAS is a potent GABAa antagonist blocking GABA transmission with
similar efficacy and from a proximally located receptor as that of picrotoxin, a potent
convulsant (Sousa & Ticku, 1998). DHEAS also influences NMDA mediated release
of norepinephrine (NE) and DA (Charalampopoulos et al., 2005). Against the
backdrop of the expected rise and fall of progesterone and estradiol, large changes in
DHEAS would fundamentally alter CNS excitability, particularly in the immediate
puerperium when neither the compensatory enzymatic changes responsible for
clearing the excess DHEAS will have occurred nor will the pre-progesterone
exposure mediated conformational changes in the GABAa receptor have returned.
Finally, it appears that the expression of both genomic progesterone (PR) and
estradiol and probably also androgen receptors (AR) can be controlled independently
of cognate ligand binding (for a review see Braunstein, 2004). Environmental stimuli,
especially those involved with sexual and parenting behaviors, activate a number of
intracellular signaling pathways including protein kinases A, G and MAPK absent
hormone-receptor binding. Dopamine, insulin and other growth factors have been
investigated thus far and have been shown to up-regulate and mediate steroid
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hormone receptor regulated transcription in the absence of the cognate ligand without
inducing the associated hormone synthesis. The D1/D5 DA receptor agonists, in
particular, can substitute for progesterone in the facilitation sexual behavior in mice.
Other examples include NE induced neural PR and ER up-regulation and muscarinic
mediated ER up-regulation (Braunstein, 2004).
Puerperal Hormones and Psychiatric Symptoms

Based upon the supra-physiological concentrations of progesterone and
estradiol during pregnancy, the chronicity of exposure to these hormones and their
respective actions on individual neurotransmitter systems, but particularly
progesterone’s actions on GABAa receptor, one might expect signs of tolerance
towards the end o f pregnancy, with withdrawal symptoms evident in the early
puerperium. Based upon models of addiction and withdrawal to synthetic compounds
that elicit similar changes in neurotransmitter and receptor availability, suggest these
symptoms would likely be marked by agitation and/or anxiety type symptoms.
Unfortunately, over the last 30 years relatively few investigators have explored the
connection between these reproductive hormones and psychiatric disturbances and
most have focused upon the measurement of depressive symptoms.
The results are equivocal but suggest a relationship between the magnitude of
change from pre- to postpartum concentrations of progesterone, estradiol and/or
estriol and the ambiguously defined baby blues. As was the case with the previously
cited non-endocrine investigations of postpartum mood, methodological differences
abound making direct comparison between individual projects difficult.
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In one of the earliest attempts to connect reproductive hormones and mood,
Nott et al. (1976) measured serum estradiol and progesterone in 27 primiparous and
multiparous women three times at weekly intervals from 2-6 weeks pre-delivery and
intermittently through 5-10 post-delivery. Their results indicated that higher pre
delivery estradiol was correlated with increased antenatal irritability and lower post
delivery estradiol was correlated with increased postpartum sleep disturbances. The
magnitude of change from pre-delivery progesterone to post-delivery progesterone
correlated with depression at 10 days postpartum but was negatively correlated with
postnatal sleep disturbances.
O'Hara, Schechle, Lewis and Wright, (1991) and Metz et al. (1983), measured
plasma progesterone and estrogen concentrations at various times both pre- and
postnatally. O'Hara and colleagues found a significant positive relationship between
antepartum free and total estriol levels and postpartum blues. Metz, et al. found no
direct correlation between ovarian hormones and mood, but did show that the
magnitude of fall in hormones was positively correlated with a2-adrenoreceptor
binding capacity, which was in turn correlated with measures of postpartum mood
lability. The a-2 adrenoreceptors are inhibitory autoreceptors located on NE cells in
the locus ceruleus. When bound to the ligand, a-2 limits the cell firing and
neurotransmitter release. Increased binding capacity of these receptors would indicate
a compensatory response by the cell to limit neurotransmitter release. The association
observed by Metz et al. (1983) between increased a-2 binding capacity and hormone
magnitude of change and mood lability suggests a connection between puerperal
hormones and NE production.
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Kuevi, et al. (1983) reported a trend towards higher follicle stimulating
hormone and lower estrogen and progesterone concentrations in women with the
blues, particularly those women who showed a consistent state of 'blues' versus
women who experienced brief periods of mood lability. Gard, Handley, Parsons and
Waldron, (1986) reported a higher incidence of postpartum blues with the birth of a
male child and/or a previous history of gynecological disorder.
The Cardiff study, (Harris et al. 1994) assessed salivary concentrations of
progesterone and cortisol from 120 women over a period from two weeks pre
delivery through four weeks post-delivery. With almost 10,000 salivary samples
collected, Harris and colleagues demonstrated a positive relationship in the magnitude
of change between antenatal and postnatal progesterone and depression scores
measured by EPDS, the Stein Scale for Maternity Blues and the Beck Depression
Inventory. They found no relationship between cortisol and depression. Nappi et al.
(2001) identified a significant negative correlation between serum allopregnanolone
(progesterone metabolite) and blues when measured three days postpartum but was
unable to identify an association between progesterone and blues.
The research presented thus far suggests that there is some relationship
between hormone change and baby blues. Which hormone contributes to which type
of symptom is unclear because of the lack of specificity in the psychological
measures that were administered as well as differences in test time and in hormone
collection method. A more informative approach to characterizing the nature of
puerperal psychiatric symptoms and subsequent associations with hormones would
include assessment o f a broader range of symptoms and a larger complement of
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hormones. This was accomplished by Buckwalter and associates (1999) who
measured serum progesterone, estradiol, DHEA and testosterone concentrations at 36
weeks of pregnancy (n=19) and at 1-2 months postpartum (n=15). They found that
higher DHEA levels during pregnancy were correlated with better mood scores while
elevated postpartum testosterone was associated with negative mood. DHEA, unlike
DHEAS exerts only nominal influence over the GABAergic cells but is reported to
attenuate glucocorticoid induced glutamate cytotoxicity in rodent models (Herbert,
1998) suggesting that the balance between these DHEA and DHEAS is a factor in
CNS excitability.
Hohlagswandter et al., (2001) also found elevated serum testosterone levels to
be significantly associated with pre- and postpartum depression and with pre- and
postpartum anger. More recently, Paoletti et al. (2006) measured serum DHEAS and
cortisol levels in 14 healthy pregnant women across two menstrual cycles prior to
pregnancy and throughout the pregnancy and compared those data to psychometric
data from the SCL-90. They were unable to find any difference between non-pregnant
and pregnant SCL-90 scores and thus concluded that puerperal mental illness does not
exist,
Finally, Marrs (2006) measured salivary progesterone, DHEAS, testosterone,
estrone, estradiol and estriol at 37 weeks pregnancy (n=32) and within 10 days
postpartum (n-28) in a cohort of healthy primigravid women and found measurable
psychiatric disturbances associated with androgenic steroid concentrations. Elevated
prenatal DHEAS correlated positively with prenatal paranoia and psychoticism while
prenatal testosterone correlated negatively with prenatal phohia, psychoticism.
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somatization and the GSI. Diminished prenatal testosterone also heralded the onset
and exacerbation o f postnatal symptoms and was correlated with increased postnatal
anxiety, hostility, psychoticism, somatization, obsessive compulsive behavior,
interpersonal sensitivity, depression and the GSI. Following parturition both DHEAS
concentrations and the frequency and severity of psychiatric disturbances increased.
Postnatal DHEAS correlated positively with postnatal anxiety, phobia, paranoia,
psychoticism, somatization and the GSI. Progesterone, estrone and estriol were not
associated with psychiatric disturbances and associations with estradiol were limited
and inconsistent.
Both the Marrs and the Buckwalter findings are consistent with the putative
neuromodulatory actions of DHEA and DHEAS. Because DHEA is more consistently
associated with neuroprotection and stress reduction, positive correlations between
DHEA and improved mood are expected. Conversely, the actions DHEAS on
GABAa would predict CNS excitability producing a positive correlation between
elevated DHEAS and symptoms of anxiety. The apparent disparity in testosterone
findings are likely related to differences in matrix, serum versus saliva and the
measurement o f bound versus free hormone. While elevated total hormone
concentrations may indeed be related to increased symptomatology, as was suggested
by Buckwalter et al. (1999) and Hohlagswandter et al., (2001) the diminishment of
free or bioactive testosterone observed by Marrs (2006), may be also be linked to
psychiatric disturbances. These findings may suggest that changes in hormone
binding rather than absolute circulating concentrations underlie these correlations.
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The pattern of high DHEAS and low testosterone, combined with postpartal
increase in DHEAS values observed in the Marrs study could also point to altered
patterns of hormone metabolism wherein prenatal testosterone is simply an early
marker of the ensuing changes. Serum DHEAS values, investigated in relation to the
onset of labor, are reported to increase in the first two trimesters, remain stable in the
third and return to non-pregnant values following parturition (Milewich et al., 1978;
Soldin et al., 2005; Tagawa et al., 2004). In the Marrs study, salivary DHEAS
concentrations were high in late pregnancy and increased by an average of 34%
following parturition, with those participants exhibiting the largest increases, also
suffering the most severe psychiatric disturbances. Moreover, four participants of the
28 who completed the testing, exceeded and many others approached the laboratory
standards indicative adrenal pathology (>2500pg/mL) that typically merit further
investigation.
With elevated DHEAS concentrations in general, testosterone concentrations
are typically elevated as well. During pregnancy in particular, testosterone is
presumed to increase significantly but fall to pre-pregnancy concentrations following
parturition (Bammann, Coulam & Jiang, 1980). This appeared not to be the case in
the Marrs study. Both pregnancy and postpartum testosterone concentrations were
very low when compared to healthy non-pregnant women and were found to increase
rather than decrease in five women following parturition, although as a group
testosterone concentrations fell by 49%. In addition, low late pregnancy testosterone
concentrations were associated with a myriad of psychiatric symptoms during
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pregnancy but more importantly heralded the onset and exacerbation of postpartal
psychiatric disturbances.
This hormone pattern, high DHEAS and low testosterone, is unique insofar as
it not only conflicts with the published trends expected for these hormones when
measured in serum, but because it was so strongly associated with psychiatric
disturbance. Had these values been observed without consistent association to
psychiatric disturbances, one might question their accuracy, but when combined with
the symptomatology, they become evidence for a putative endocrine role in
postpartum psychiatric dysfunction. Thus, low late pregnancy testosterone combined
with elevated pre- and postpartum DHEAS concentrations not only represented an
atypical pattern in hormone metabolism but were linked with significant
psychopathology. When these data are combined with those of Buckwalter et al.
(1999) and Hohlagswandter et al. (2001), adrenal androgen regulation becomes a key
factor in peripartal mental health.
Puerperal Hormones and Cognition

In as much as the vast hormone changes associated with pregnancy and
parturition may elicit psychiatric distress, they may also alter cognitive function.
Indeed, from the research presented earlier, pregnancy related cognitive impairment is
widely expected and anecdotally accepted. Unfortunately, consistent empirical
measurement and characterization of pregnancy related cognitive decline has thus far
eluded investigators. Moreover, only three studies to date have actually measured
puerperal hormones in conjunction with cognitive performance. The Vanston (2006)
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study, which was discussed previously, found no evidence of impairment and no
association between cognitive performance and hormones.
Both Buckwalter et al. (1999) and Marrs (2006) identified significant
impairment in both pregnant and postpartum women across multiple cognitive
domains but were unable to show consistent trends between individual hormones and
specific cognitive modalities. However, the Marrs study did demonstrate a trend
between higher hormone values in general and poorer cognitive performance overall.
With so few investigations measuring puerperal hormones in conjunction with
cognitive assessment, it is difficult to entirely discount the possibility of a hormone to
cognition relationship, especially given the ample animal research that clearly
demonstrates associations between hormones and learning (Chestler & Juraska, 2000;
Frye & Sturgis, 1998; Johansen, Birzniece, Lindblad, Olson & Backstrom, 2002;
Shors & Leuner 2003).
Summary

The general presumption about reproductive hormones is that they increase
exponentially throughout the pregnancy and decrease rapidly following parturition.
Accordingly, most postpartum research is based upon and supports this hypothesis
(Dame, McGarigle & Lachelin, 1987; Harris, et al., 1993; Harris et al., 1994)
including work by Marrs. The Marrs study found that progesterone estrone, estradiol
and estriol were elevated in late pregnancy and generally declined following
parturition. Estrone and estradiol concentrations increased in a few participants (one
and three respectively) following parturition. Inasmuch as these changes are
considered normal and have been associated, at least inconsistently, with the baby
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blues some argue that pregnancy hormone changes are not directly responsible for the
more serious symptoms o f puerperal mental illness, but merely provide the backdrop
for the re-emergence o f a pre-existing condition and/or trigger an aberrant
psychosocial response (Bloch et a l, 2000). While it cannot be disputed that puerperal
hormone changes might trigger the re-emergence of pre-existing conditions and might
also elicit an ill-adapted stress response in some women, this hypothesis cannot
explain the onset of serious psychiatric disturbances in previously healthy women
immediately coincident with parturition.
A more accurate hypothesis, particularly in light of the unique pattern in
adrenal androgen values reported by Marrs (2006), would be that the large changes in
reproductive hormones either unmask a pre-existing endocrine condition and/or
trigger an aberrant compensatory reaction in steroidogenesis. In either case,
psychiatric symptoms might simply represent the outward manifestation of a
disrupted internal chemistry. O f the questions that need to be addressed is whether
either of those reactions is physiologically possible. Inasmuch as this pattern of
circulating adrenal androgens has not been identified in other clinical disorders and
adrenal androgens in general have not been considered to be a major determinant of
pregnancy related psychiatric disturbances, a review of the literature pertaining to
both the biological and pharmacological actions of these hormones is presented.
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Biological and Pharmacological Actions of DHEAS and Testosterone
DHEAS and Testosterone Synthesis in Women

DHEA and its sulfated ester DHEAS, are synthesized primarily in the zona
reticularis of the adrenal gland and, to a lesser extent, from ovarian granulosa and
theca cells (Bonser et al., 2000; Burger, 2002). DHEAS is the most abundant adrenal
androgen in human circulation (Hammer, et ah, Rainey et al. 2002; Roberts, 1999)
followed by cortisol and DHEA (Herbert, 1998). DHEA/DHEAS concentrations are
elevated at birth, surge during adrenarche and reach their peak in early adulthood,
declining substantially through senescence (Kroboth, 1999).
DHEA is the precursor for other adrenal androgens such as androstenedione
and testosterone and after aromatization estrone and estradiol (Hammer et ah, 2005;
Roberts, 1999). During pregnancy, fetal adrenals produce vast quantities of DHEAS,
from which estriol the most abundant estrogen of pregnancy, is derived (Challis &
Lye, 1998). DHEA synthesized in the adrenal gland, is rapidly inactivated via
conversion to its sulfate ester DHEAS (Bird et ah, 1978; Burger, 2002; Hammer et
ah, 2005; Roberts, 1999).
Conversion of DHEA to DHEAS is dependant upon cytosolic enzymes called
sulfotransferases, specifically identified as SULT2A1 (Hammer et ah, 2005; MensahNyagan et ah, 1999). SULT2A1 are expressed in the adrenal glands, the intestines
and the liver (Hammer et al,. 2005). Circulating DHEAS is converted back into
DHEA via the microsomal sulfatase (STS) (Hammer et ah, 2005; Mensah-Nyagan et
ah 1999). The sulfatase enzymes are widely distributed throughout the body and
have been found in the testes, ovaries, adrenals, prostate, skin, central nervous system
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(CNS), fetal lungs, placenta, synovial fluid, endometrial tissue, peripheral blood
lymphocytes, aorta, bone, kidneys and in breast cancer cells (Reed et a l, 2005).
Interestingly, STS activity is negligible in the adult liver (Hammer et al., 2005).
Conversion of DHEA to DHEAS and back varies across the life span, disease
states and reproductive states (Kroboth et a l, 1999; Salek, Bigos &Kroboth, 2002).
Concomitant changes in androgen and estrogen production often follow suit. In non
pregnant women, approximately 64% of DHEAS is converted to the biologically
active DHEA whereas only 13% DHEA is converted to DHEAS (Kroboth et al,
1999; Salek, Bigos & Kroboth, 2002). During pregnancy DHEAS production is
significantly up-regulated with both maternal and fetal adrenal glands contributing
substantially to its synthesis (Challis & Lye, 1998). The rates of
DHEA>DHEAS>DHEA conversion during pregnancy are not known, however,
conversion of DHEAS to DHEA during pregnancy is facilitated by the abundant
expression of placental STS (Dibbelt & Kuss, 1991).
The fraction o f testosterone produced by placental conversion of DHEAS
relative to maternal input is unknown. However, data based upon ratios of maternal
circulating levels to umbilical cord levels indicate that placental testosterone (Troisi
et al., 2003) and fetal adrenal contributions (Dharia et al., 2004) are minimal with
most aromatased to the estrogens. Accordingly, fetal and placental conversion of
DHEAS are responsible for 50%, 50% and 90% of estrone, estradiol and estriol
respectively (Challis & Lye, 1998) with remaining portions synthesized in maternal
adrenal and peripheral tissue. According to Kroboth et al. 1999, the DHEA/ DHEAS
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pathway accounts for up to 100% of active estrogens in menopausal women and 75%
of estrogen synthesis in non-pregnant, pre-menopausal women.
Pharmacodynamics o f DHEA and DHEAS

In addition to peripheral synthesis, DHEA and DHEAS are synthesized in the
brain de novo and interact with each of the neurotransmitters (Baulieu, 1998).
DHEAS is both a GABAa antagonist and dopamine DA agonist (Hansen, Fjalland &
Jackson 1999). Like many sulfated steroids, DHEAS inhibits GABAa chloride
channels (Mehta & Ticku 2001). DHEAS is also involved in both NMDA associated
release of NE and DA, as well as tyrosine hydroxylase induction, particularly with
long-term administration (Charalampopoulos et al., 2005).
The research on DHEA is less clear but suggests that DHEA has some
capacity to inhibit GABAa, and enhance NMDA mediated NE release, if only acutely
(Charalampopoulos, et ah, 2005). This has lead researchers to postulate that DHEA
requires conversion to DHEAS to exert its full neuromodulatory action
(Charalampopoulous, et ah, 2005). Other research suggests that DHEA and DHEAS
differentially modulate GABAa according to brain region and time course of
administration (Mehta & Ticku, 2001; Hanson, Fjalland & Jackson, 1999).
Accordingly, DHEAS but not DHEA binds to GABAa site proximal to the picrotoxin
binding site (Sousa & Ticku, 1997) whereas, DHEA, reportedly attenuates
glucocorticoid and glutamate cytotoxicity (Herbert, 1998). Lu and colleagues (2003)
reported that DHEA works synergistically with testosterone to prevent neuronal and
cell death in rodent models by up-regulating ARs. The putative mechanism of
neuroprotection is the testosterone-AR complex activation of the mitogen-activated
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protein kinase / extracellular signal regulated kinase (MAPK/ERK) pathway
(Nguyen, Yao & Pike, 2005). The MAPK/ERK is a signal transduction pathway
responsible for cell growth and differentiation, inflammation and apoptosis.
Conversely, DHEAS is not involved in AR receptor regulation (Mo, Lu & Simon,
2004).
If DHEA, but not DHEAS, offers neuroprotection against cytotoxicity and
DHEAS but not DHEA chronically antagonizes the GABA a receptor, then the
equilibrium between the two hormones becomes clinically relevant in both
physiological and psychological disease states. Changes in enzyme availability,
occurring during pregnancy, following parturition and perhaps even as breastfeeding
begins or ceases, would necessarily alter the hormonal milieu and by association,
central nervous system excitability. Although relevant evidence in the puerperium is
limited, changes in the circulating concentrations of either DHEA or DHEAS
observed in other endocrine pathologies reveal that both abnormally low and
abnormally high circulating concentrations adversely impact both psychological and
physiological well-being.
Adrenal Androgens and Mental Health

In conditions where DHEA/DHEAS are abnormally low such as in the
elderly, individuals with Addison’s disease (Hunt et al., 2000), rheumatoid arthritis,
systemic lupus erythematosus (Nordmark et ah, 2005), human immunodeficiency
virus (Schfitto et ah, 2000) or adrenal insufficiency syndromes (Arlt, 2003; Arlt et ah,
2005), supplementation improves mood, cognitive function and general well-being
(Bloch et ah, 1999; van Niekerk, Huppert & Herbert, 2001; Wolf, 2003; Wolf et ah.
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1998). Similarly, lower salivary DHEA levels have been noted in clinically depressed
older adults (Michael, Jenaway, Paykel & Herbert, 2000).
In adrenal disease states where DHEAS levels are abnormally elevated
(Dubrovsky, 2005) and in anabolic steroid use where excessive amounts of DHEA is
taken as a supplement coneomitant psychological disturbances and autonomic
hyperactivity have been reported (Cafri, et al., 2005; Trenton & Currier, 2005).
Moreover, a number of clinical case reports indicate that abnormally elevated DHEA
and/or DHEAS concentrations elicit symptoms of anxiety, mania and psychosis that
are in some cases resistant to traditional therapeutic approaches and abate only when
hormone concentrations are brought in check (Dean, 2000; Howard, 1992; Jacobs et
al., 1999; Markowitz, Carson & Jackson, 1999)
In patients with treatment refractory depressed psychosis, defined as resistant
to psychotropic medication and electroconvulsive therapy (ECT), both DHEA and
DHEAS levels were elevated compared to controls and predictive of ECT non
response (Maayan et al., 2000). Interestingly, the investigators found that neither prenor post-treatment DHEA and DHEAS changed significantly for either the responders
or non-responders, perhaps suggesting a third factor associated with the behavioral
outcome. It is also likely, that the substantial inter-individual variability commonly
observed in hormone concentrations were concealed by comparison of mean data.
Individuals with treatment refractory anxiety disorder, associated with lateonset congenital adrenal hyperplasia exhibited elevated DHEAS values that were
associated with increased anxiety scores on the Profile of Mood States questionnaire
(Jacobs et al., 1999). Upon adrenal suppression treatment via either ketoconazole or
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low dose glucocorticoids, anxiety scores decreased by 55%, concurrent with a 10%
reduction of DHEAS, returning DHEAS concentrations to within normal
physiological parameters. Depression scores were inconsistent and not related to
DHEAS in this study.
In the schizophrenic disorders, researchers have demonstrated aberrant
patterns in adrenal androgen concentrations, marked by elevated DHEA and/or
diminished DHEAS. Michele et al. (2005) found plasma DHEA concentrations
significantly increased in 23 schizophrenic patients versus 23 healthy controls. The
data remained significant even when the groups were divided by gender. Males
reportedly have higher circulating concentrations of DHEA (Roberts, 1999).
Similarly, Ritsner and colleagues (2006) found significantly elevated DHEA
concentrations in 21 male paranoid schizophrenics as compared to 14 healthy controls
combined with significantly lower DHEAS and higher androstenedione
concentrations in the patient group and normal coneentrations of progesterone and
testosterone. The researchers speculated that these patterns may represent a trait-like
marker of impaired HPA or HPG activity that is characterized by decreased
sulfotransferase and/or 17p-hydroxylase activity combined with increased 3phydroxysteroid dehydrogenase activity (Ritsner, Gibel, Ram, Maayan & Weizman,
2006).
Alternatively, a polymorphism in the enzyme that is responsible for the
metabolism o f many mixed oxidase reactions in the human liver the CYP3 A4, yields
a variation of the fetal enzyme CYP3A7 not normally present in adult livers that
results in up to a 50% reduction in DHEAS concentrations (Smit et al., 2005). As
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many of the medications commonly prescribed to patients with schizophrenia utilize
CYP3A4 metabolism (Dahl, 2002) individuals possessing this polymorphism might
present with anomalous reactions to medication in addition to the reduction in
DHEAS concentrations.
The data on DHEA/DHEAS role in depression is mixed. Fabian et al. (2001)
found that measurable decreases in both DHEA and DHEAS were associated with
remission of clinical depression in the elderly. Whereas Michael et al. (2000) found
that depression in the elderly was linked to lower levels of DHEA and DHEAS. The
disparity between these results is possibly explained by methodological differences
and/or by the kinetics of these hormones. DHEA has a very short half-life, (1-3 hours)
(Roberts, 1999), is susceptible to diurnal rhythms, food and medication intake and has
been reported to fluctuate wildly from hour to hour (Kroboth et al., 1999).
Conversely, DHEAS has a longer half-life (10-20 hours) (Carlstrom, Karlsson & Von
Schoultz, 2002) is more stable across time, but is susceptible to modulation by
medication (Kroboth et al., 1999; Salek, Bigos & Kroboth, 2002), a common
confounding variable in elderly populations.
Alternatively, the presence of depression in these populations could develop
secondarily to a disrupted autonomic system, characterized by both somatic and
psychiatric symptoms of anxiety. This was the case in Hsiao (2006) who measured
DHEAS in a non-age restricted cohort of patients suffering an episode of clinical
depression and found that DHEAS concentrations were significantly associated with
the severity o f co-morbid anxiety, but not associated with depression. Hsiao’s work
is consistent with other studies, including Marrs (2006) and case reports that have
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shown elevated DHEAS is more closely associated the agitated states ranging from
anxiety to mania and psychosis than with depressed states, even though depression
may co-occur and may be significant. Likewise, the antagonistic actions of DHEAS
at the GABAa receptor predict CNS hyper-excitability rather than depression.
Clinical Findings Associated with DHEA/DHEAS and Testosterone

In clinical disorders where DHEA/DHEAS concentrations are elevated,
testosterone and estrogen concentrations are typically elevated as well. In women,
elevated adrenal androgens result in a myriad of reproductive disorders often visually
identified by hirsutism and viralization (Carr, 2001; Elsenbruch, 2003; Yildiz, 2004)
with or without the concomitant diagnoses of polycystic ovarian syndrome (PCOS).
PCOS, which is characterized chronic anovulation and variety of metabolic disorders,
is thought to be caused by supra-physiological concentrations of DHEA/DHEAS,
testosterone and estradiol and is commonly associated with both mild and severe
psychiatric disturbances (Elsenbruch et al., 2003; Yildiz, 2004). Although it is not
clear if the risk for psychiatric disturbance in women with PCOS is higher than that of
the general population. O f note, there is a significantly higher incidence of PCOS in
women with either bipolar disorder or epilepsy who are treated with valproic acid
versus women treated with other compounds (Betts, Yarrow, Dutton, Greenhill &
Rolfe 2003; Klipstein & Goldberg 2006). Whether valproic acid causes or simply
triggers a pre-existing endocrine pathology remains to be elucidated. There are
currently no endocrine evaluations reported for medication naïve patients.
In clinical disorders with low testosterone only, patients are noted to show
decrements in mood and cognitive functioning (Arlt, 2003; Cherrier et ah, 2001;
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Wolf, 2003). It must be noted however, that research on low testosterone typically
involves elderly males with hypogonadal function (Beuna et ah, 1993; Burris, Banks,
Carter, Davidson & Sherins, 1992; Carani et ah, 1990). Of the research involving
women, most is performed on postmenopausal women with reduced libido (Burger et
ah, 1984; Sherwin, Gelfand & Brender 1985; Vermeulan, 1976). Research on military
performance, again with males, demonstrates that testosterone concentrations
decrease over the course of intense military training in relation to increased cortisol
production suggesting that low testosterone is a marker of hypothalamic-pituitary
activation (Lieberman et ah, 2005). Additionally, when under severe stress, elderly
patients exhibit diminished testosterone levels concurrent to elevated cortisol (Dharia
et ah, 2004).
Finally, Akhondzadeh et ah (2006), reported that significantly lower
testosterone concentrations were associated with symptom severity in male patients
with schizophrenia (n=54) either in general when compared to healthy controls (n=
25) and significantly lower testosterone concentrations were noted in those patients
with predominantly negative symptoms (n=27) when compared to those with
predominantly positive symptoms (n=33). Moreover, testosterone was inversely
correlated with negative symptom severity. The researchers also found other
endocrine abnormalities including significantly lower concentrations of follicle
stimulating hormone (required for sperm formation) and lutenizing hormone
(augments testosterone production) combined with significantly elevated prolactin
(associated with impotence and loss of libido) concentrations in the negative
symptom group when compared to the positive symptom and control groups.

77

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Since dopamine inhibits prolactin, dopamine receptor blockade by
neuroleptics often results in increased prolactin. However, all but three of the
schizophrenia group were on the same medication, risperidone (n=51) and thus the
difference in prolactin concentrations between the negative and positive symptom
groups is not likely accounted for by differences in medication. Those changes could,
however, be related to medication induced changes in other hormones that affect DA
concentrations.
A study by Van den Berghe and colleagues (1995) found that DA suppresses
DHEAS which in turn inhibits prolactin in critically ill patients. The complete circuit
has yet to be elucidated, but lower DA as would be expected with neuroleptic
treatment, could suggest higher DHEAS. If relatively less DHEAS is converted into
DHEA and subsequently testosterone then this reaction could account for the lower
testosterone concentrations in patients with negative schizophrenia. Additionally,
lower DA would increase DHEAS concentrations while concomitantly increasing
prolactin either via the relinquishment of the tonic inhibition the DA exerts over
prolactin in the tuberoinfundibular pathway or via some other mechanism moderated
by DHEA/DHEAS pathway. Alternatively, the decrease in FSH, LH combined with
the increase in prolactin in patients with negative versus positive symptoms of
schizophrenia could simply indicate a relative down-regulation of sexual/reproductive
function consistent with diminishment of other behavioral capacities.
Physiological and Pharmacological Actions o f Testosterone

The role o f increased testosterone in aggressive behavior has been thoroughly
investigated in both human and animal models, but a definitive neuroendocrine
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mechanism has not been articulated (Albert, Walsh & Jonik, 1993; Archer 2004).
Moreover, for as much as increased testosterone has been associated with aggression
in criminal populations, clinically this is has not been the case (Pope, Kouri &
Hudson 2007). Hypogonadal males given testosterone supplements rarely show
aggression even as testosterone concentrations increase to supra-physiological values
(Albert, Walsh & Jonik 1993). Although female hyperandrogenism is often associated
with psychiatric disturbances, concomitant elevations in testosterone are not
correlated with aggression (Weiner, Primeau & Ehrlmann 2004). The lack of
relationship between testosterone and aggression in non-criminal populations makes
sense in light of testosterone’s mechanism of action at the cellular level.
In very recent research, testosterone has been found to be a fairly potent
calcium channel blocker in the coronary artery and also in uterine myométrial cells
(Jones, Pugh, Jones & Channer 2003; Perusquia, Navarret, Jasso-Kamel & Montano,
2005). Subsequently, and contrary to popular belief, researchers are finding that
diminished rather than elevated testosterone confers a markedly increased rate of
coronary artery disease in men (Jones, et al., 2003). Further investigation suggests
testosterone decreases myocardial ischemia via vasodilation specifically via Lchannel calcium (Ca2+) blockade (Jones, English, Jones & Channer, 2004).
Similarly, in a study on uterine contractility, Perusquia and colleagues (2005)
showed that testosterone and testosterone metabolites reduced uterine contractility in
human pregnant and non-pregnant myométrial tissue (obtained via biopsy) even more
so than progesterone. The purported mechanism o f action was Ca2+ blockade but
researchers also noted increased potassium influx causing cellular hyperpolarization
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as well as some cell membrane fluidity. Moreover, testosterone and its metabolites
mediate these responses in the absence of identified nuclear androgen receptor
binding (Jones et ah, 2004).
In rodents testosterone acts through arginine vasopressin (AVP) and
corticotrophin releasing hormone (CRH) to mediate glucocorticoid effects on
neuronal response (for a review see Williamson, Bingham & Viau, 2005). Arginine
vasopressin is believed to enhance CRH responsivity to acute stress. Enhanced CRH
activates the pituitary hormone, adrenocorticotropin (ACTH). ACTH initiates the
release of corticoids. Increased corticoids then feedback to inhibit the continued
CRH/AVP synthesis to bring the system back into equilibrium. Williams et al. (2005)
found androgen receptors co-localized on A VP neurons. Binding of testosterone
effectively inhibits the stress related A VP up-regulation and expression which then
inhibits corticoid output. In the absence of testosterone or in states of diminished
testosterone, the negative feedback loop normally associated with this system is
altered, AVP expression increases, which in turn increases CRH and the downstream
release of corticoids. This reaction may be mediated by DHEA concentrations
inasmuch as DHEA not only provides the substrate for testosterone synthesis, but also
upregulates AR expression (Lu et al., 2003). Similarly, clinical research has shown
that DHEA and cortisol are inversely related across multiple populations (Genazzani
et ah, 2003; Ueshiba et ah, 2004). DHEAS on the other hand, has no effect on AR
receptors (Mo, Lu, Hu & Simon, 2004).
Testosterone, however, also upregulates it own receptors. Unlike other
hormones whose receptors down-regulate in the presence of ligand, ARs up-regulate
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(Patchev, Schroeder, Goetz, Rhode & Patchev, 2004) and thus more testosterone
elicits more ARs while lower testosterone reduce the expression of ARs. The
uniqueness of this positive feedback mechanism may have role in the presumptive
associations between male dominance and/or aggressive behavior and testosterone
concentrations with environmental factors reinforcing testosterone and AR activity.
Unfortunately, because testosterone is aromatized to estradiol and/or
converted to dihydrotestosteome via 5a-reductase (the same enzyme that catalyzes
the conversion of progesterone to allopregnanolone and/or shifts progesterone toward
the cortisol pathway), it is difficult to dissociate purely androgenic from estrogenic
CNS activity. Additionally, ARs and ERs show similar regional CNS distribution
patterns and sequence homology to other steroid receptors as well as multiple levels
of promiscuous interaction and target gene cross-regulation (Patchev et ah, 2004).
Moreover, both receptors demonstrate receptor-activated transcription in absence of
hormone-receptor binding, but in the presence of either environmental stimuli and/or
via binding with neurotransmitters (Braunstein, 2004). Nevertheless, when the
molecular actions of testosterone are compared to those of estradiol, testosterone is
generally inhibitory and estradiol is predominantly excitatory.
Summary

The research presented thus far provides clear evidence of an exceedingly
complex relationship between neural and endocrine factors in the development of
mental illness. Whether endocrine disturbances precede mental illness, develop
concurrently or subsequently or are a result of medication remains to be elucidated.
What is clear is that endocrine changes affect mental health.
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Pregnancy and parturition offer researchers a unique model from which to
study those associations. The hormone changes are vast and in some cases extreme.
The abrupt withdrawal from the supra-physiological concentrations of reproductive
hormones often coincides with the onset of psychiatric disturbances in previously
healthy women. With such significant changes in reproductive hormones,
compensatory reactions in other endocrine circuits are likely. Findings from Marrs
(2006) may support this hypothesis. The low late pregnancy testosterone followed by
the unexpected postpartal increase in DHEAS, not only represented a unique and
previously unidentified pattern in puerperal hormones, but also, provides the first
clear evidence of association between puerperal endocrine changes and the
development of psychiatric symptoms in previously healthy women. Since there are
no disorders currently documented that include this pattern of hormone values it is
worth determining whether the profile is physiologically possible and by what
mechanisms it might develop. While such a review is beyond the scope of the present
research, consideration o f the potential mechanisms that might produce elevated
DHEAS and diminished testosterone provides useful insight regarding the uniqueness
of the Marrs pattern and is included in the following section of this literature review.

Elevated DHEAS and Diminished Testosterone: Potential Mechanisms
Ideally, to investigate hormone synthesis patterns one would measure the
entire pathway between the precursor (DHEAS) and product (testosterone), as well as
measure the specific enzymes suspected o f dysregulation. Barring that, however, it is
possible to surmise which enzymes might contribute to a specific hormone profile
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based upon the presenting pattern of hormones compared with other known disorders
associated with those enzyme deficiencies. Discussed below is a review of each the
enzymes involved in metabolic process from DHEA/DHEAS through testosterone. In
the initial sections, it is presumed that DHEAS and DHEA are in dynamic
equilibrium and thus show parallel increases or decreases in circulating values. The
equilibrium between these hormones is often presumed and has been validated in a
number of clinical studies (for a review see Kroboth et ah, 1999). There are a number
of instances though where the equilibrium between these hormones is disrupted (Arlt
et ah, 2006; Reed et ah, 2005) and thus in second part of this review those cases are
considered.
Elevated or Normal DHEA Concurrent with Diminished Testosterone

Although, no disorders have been reported with high DHEAS and low
testosterone, there are disorders marked by normal/high DHEA and low testosterone.
Since DHEA and DHEAS concentrations are often highly correlated, the presumption
is made that DHEA/DHEAS change uni-directionally. While that interpretation will
be contended with regard to the Marrs (2006), it is worth investigating the disorders
with high DHEA and low testosterone if only to remove them from the list of possible
factors that could have contributed to the Marrs hormone profile and subsequent
psychiatric disturbances. Listed below is a systematic review of enzymatic
deficiencies potentially involved with high or normal DHEA and low testosterone.
Please refer to Figure 2 for the following discussion.
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1 7, 20 Lyase and 17a-Hydroxylase Activity

Two genetic variants of congenital adrenal hyperplasia (CAH) are associated
with normal and/or elevated DHEA and diminished testosterone, each mediated
through entirely different enzymes (Miller, 2005). Though not likely factors
contributing to the hormone profile observed by Marrs (2006), these disorders
provide a useful illustration of how enzymatic permutations fundamentally alter
hormone metabolism. In the first variant of CAH, 17, 20 lyase activity is up-regulated
while 17a-hydroxylase (17a-0H) activity is unchanged or diminished (Miller, 2005).
This shifts the adrenal metabolic pathway away from the conversion of 17a-0H
progesterone to androstenedione and towards the conversion of 17a-0H pregnenelone
to DHEA (Miller, 2005). This shift initially produces less cortisol concurrent with
increased DHEA. However, since DHEA is rapidly converted to DHEAS, rather than
to downstream derivatives, the upregulation of 17, 20 lyase results in a reduction in
testosterone concentrations. In this variant of CAH, called lipoid CAH, the primary
mutation is not in the CYP450 17 but rather in the CYP450scc (side chain cleavage),
steroidogenic acute regulatory protein (StAR), responsible cholesterol transport into
the mitochondria where it is converted to pregnenelone and other steroid hormones
(Miller, 2005). Males with this disorder are severely undervirilized, showing external
female genitalia as well as life-threatening salt-wasting and cortisol deficiencies.
Females, on the other hand, exhibit normal female anatomy and because the ovaries
do not begin synthesizing steroids until puberty, StAR independent steroidogenesis
remains functional until then (Miller, 2005). After puberty and with each subsequent
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menstrual cycle, cholesterol esters accumulate, the adrenal cells engorge, and become
less functional (Miller, 2005).
Researchers have termed the time-delayed “onset” of this disorder in females,
the “two-hit model”. The first hit, a genetic mutation that is present at birth does not
become fully activated until later when the second hit-puberty occurs (Miller, 2005).
It is conceivable that pregnancy may be a “second hit” for some women in a yet
unidentified endocrine reaction whose manifestations include psychiatric
disturbances.
S f- Hydroxysteroid Dehydrogenase Activity

Another enzyme involved in the conversion of DHEA to testosterone includes
3P- hydroxysteroid dehydrogenase (3p-HSD). The 3P-HSD enzyme converts 17a-0H
pregnenelone to 17a-OH-progesterone but also converts DHEA into testosterone. In
another rare CAH variant, a mutation in the gene that encodes 3|3-HSD globally
inhibits the conversion of precursor hormones to products within each zone of the
adrenal gland. This CAH variant is associated with salt-wasting (because of the
enzyme’s involvement in the aldosterone pathway), genital ambiguity (because of the
low testosterone) and hypogonadism (Carbunaru et al., 2004). It too can be ruled-out
as a contributing factor the hormone profile observed in the Marrs study insofar as it
would have been identified at birth.
However, researchers have speculated that a non-classical, late-onset variant
of the 3P-HSD deficiency is present in women with PCOS particularly in those cases
where insulin resistance is present (Carbunaru et al., 2004). Although a genetic
mutation has not been identified, a consistent phenotype has been presented that
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demonstrates compromised, but not totally inhibited 3P-HSD activity in the adrenal
cortex with the concurrent hypersecretion of lutenizing hormone and increased
ovarian production of testosterone. Thus, while hyperandrogenism is present in both
the non-compromised 3P-HSD and compromised 3P-HSD versions of PCOS,
testosterone concentrations in the compromised group were significantly lower
(similar to those in the CAH variant discussed previously) and were thought to reflect
up-regulated ovarian production rather than adrenal synthesis. Although this lateonset version of CAH can not be entirely ruled-out, the odds of this having been a
factor in the Marrs (2006) study are low. Inasmuch as compromised 3P-HSD is
associated with PCOS which is in turn associated with infertility and insulin
resistance, it is unlikely that even undiagnosed participants would have been included
in the study. However, this research illustrates that an enzyme need not be totally or
globally deficient to elicit aberrant hormone synthesis patterns. Sometimes subtle
changes in enzyme functionality produce clinical disruption.
17f-H ydroxysteroid Dehydrogenase Activity

The final enzyme involved in the conversion of DHEA to testosterone is 1?PHSD. The 17P-HSD enzyme conversts DHEA to androstendiol and androstendiol to
estrone. Since 17p-HSD deficiencies are typically associated with male
pseudohermaphroditism, this enzyme deficiency can be ruled-out as having caused
the low testosterone in the presence of high DHEA or DHEAS.
Whereas the complete abolition of a particular enzyme is not likely to have
been a factor in the Marrs hormone profile, transient changes in enzyme activity
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mediated by pregnancy or parturition and/or congenital deficits that only partially
compromise enzyme function, cannot be ruled out.
The relationship between DHEA and enzyme function is not fully understood
but suggests that DHEA regulates its own bioconversion and that of other hormones
both acutely and chronically via control of the local enzyme production (Labrie,
1997). For example, DHEA supplementation in both postmenopausal women and
elderly men increases testosterone and estradiol production while simultaneously
decreasing cortisol concentrations (Genzzani et al., 2006). It also influences the
production of other hormones through enzymatic up-regulation, such as
allopregnanolone (a progesterone derivative requiring 5a-reductase, the enzyme that
catalyzes the testosterone to dihydrotestosteome reaction) and 17ahydroxyprogesterone (17a -OHP) through the DHEA> 17, 20 lyase modulation
(Genzzani, et al. 2006; Roberts 1999). In the case of postmenopausal women,
researchers speculate that DHEA supplementation likely attenuates the age-related
declines in 17, 20 lyase activity (Genzanni et a l, 2006)
Interestingly, the exact opposite pattern with regard to DHEA and cortisol is
observed in both male and female patients with type 2 diabetes. In diabetics,
decreased 17, 20 lyase and increased 17a-0H expression are associated with
diminished DHEA and DHEAS concurrent with elevated ACTH and cortisol,
suggesting that 17a-0H expression is a key enzyme shifting DHEA synthesis either
towards (increased 17a-0H) or away from (decreased 17a-0H) cortisol production.
This pattern was reversed with diet, as was the insulin resistance (Ueshiba et al,
2002 ).
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From the research presented thus far it is evident that adrenal steroidogenesis
is modulated both by substrate and enzyme availability, and both factors are
intimately tied to DHEA concentrations. In the CAH variants discussed previously,
DHEA concentrations were elevated or left unchanged but mutations in genes
encoding the enzymes responsible for the conversion of DHEA into other metabolites
drastically reduced the circulating androgen and estrogen concentrations. In
postmenopausal women and elderly men, age related declines in 17, 20 lyase activity
correspond to age related declines in DHEA production as well as in androgen and
estrogen synthesis. In diabetic patients these factors are compounded by
increased 17a-0H expression and consequent cortisol up-regulation. Each of these
factors is ameliorated with DHEA supplementation indicating that DHEA plays a
prominent role in multiple metabolic pathways.
More importantly however, this research demonstrates that the onset of some
endocrine disorders is delayed and may only come to fruition under certain
circumstances. The two-hit model, similar to diathesis-stress model of mental illness,
suggests that the phenotypic expression of some endocrine disorders requires both
genetic and environmental contributions.

DHEA, DHEAS Disequilibrium
In the Marrs study (2006) DHEA concentrations were not measured but
DHEAS and testosterone concentrations were. Barring disruptions in the Sp-HSD,
17,20 lyase and/or 17a-0H enzymes, the only remaining enzymes capable of creating
high DHEAS and low testosterone are those involved with the bioconversion of
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DHEA>DHEAS>DHEA, the SULT2A1 and STS enzymes. Disequilibrium between
DHEA and DHEAS, where more DHEA is converted to DHEAS either by the upregulation of SULT2A1 activity or down-regulation o f STS activity would reduce the
substrate availability needed for the conversion of downstream androgens and
estrogens, but as was evidenced by the aforementioned research, might also alter the
expression of other enzymes. Since there are no reports of SULT2A1 up-regulation
(only down-regulation) the focus of this discussion will be on STS manipulation.
Congenital Sulfatase Disorders

The STS enzyme catalyzes the hydrolysis of the sulfate ester bond for
multiple steroids including cholesterol sulfate, pregnenelone sulfate, DHEAS and
estrone sulfate. The enzyme is encoded by a single gene located on the distal arm of
the X-chromosome (Hemandez-Martin, Gonzalez-Sarmiento & Unamuno, 1999).
Eighty to ninety percent o f the mutations involve complete deletions whereas
approximately 10-20% o f cases involve partial or point mutations (Reed et al., 2005).
Because the mutation is X-linked, the associated disorders develop only in male
children of female carriers. The most common of these disorders is X-linked
ichthyosis (X-LI) which develops in approximately 1-6000 male children (Bradshaw
& Carr, 1986). The gestational signs of X-LI are elevated DHEAS and diminished
estriol caused by placental a STS deficiency (Bradshaw & Carr, 1986). Androgen
concentrations are not typically measured.
Mothers of male infants with this disorder typically have longer pregnancies
as well as difficult and/or non-progressive labor related to the limited estradiol
conversion from estrone sulfate. Males bom with X-LI develop dark scaly patches of

89

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

skin due to diminished cholesterol sulfate to cholesterol conversion in the skin.
Cryptorchidism, which is marked by testicular mal-descent, is not considered a
congenital disorder related to STS activity, but appears to be more prevalent in male
X-LI babies (20-30%) than would be expected in the general population (Reed et al.,
2005). The prevalence of crytorchidism is also 1-6000 and is thought to develop
because o f diminished testosterone synthesis or androgen receptor insensitivity during
gestation (Bradshaw & Carr, 1986). Since diminished STS limits the substrate
availability required for testosterone biosynthesis, researchers have begun to
investigate partial or point mutations on STS gene that may be linked to
cryptochidism (Reed et al., 2005).
Although no male infants were reported by Marrs (2006) to have had these
disorders at 10 days postpartum, it can not be ruled out that the participants in this
study were not carriers of this particular genetic mutation and that elevated DHEAS
was not some how related to diminished sulfatase activity. Female carriers of this
genetic mutation, depending upon the degree and location of the mutation may or
may not develop the ichythosis skin condition themselves. It was previously believed
that acquired ichthyosis resulted from a de novo mutation in the STS gene. Re
examination of the mothers and grandmothers of male children with this disorder
suggests the presence of mutation is correlated with the degree and severity of female
symptom development (Cuevas-Coverrubias, Valdes-Flores, Orozco & Diaz-Zagoya,
1999). Researchers believed that the STS activity in female carriers of this mutation is
not impaired. When it was actually measured however, STS activity in female carriers
was significantly less than in normal females (Epstein & Leventhal, 1981). But only
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one such comparison of STS activity in carriers versus non-carriers has been
published to date with only five participants.
It has also been suggested that female carriers of this genetic mutation exhibit
an increased incidence of “psychoreactive” disorders (Hemandez-Martin, GonzalezSarmiento & Unamuno, 1999). Unfortunately, the original article claiming the
psychoreactive responses was unavailable for review and there is very little data on
the health status of female carriers. The extant research is focused entirely upon the
identification and classification of male patients. The possibility exists, however, that
female carriers of this mutation, likely exhibit diminished STS when compared to
their non-carrier counterparts and that up-regulation in pregnancy related DHEAS
production saturates the enzymes capacity catalyze hydrolysis thus un-masking a
previously latent disorder.
Endogenous Factors Regulating Sulfatase Activity

In addition to the congenital disorders associated with STS deficiency, recent
investigations have identified a number of endogenous and exogenous factors that
decrease STS activity and thus impair DHEAS>DHEA conversion. These include
interleukin P, estradiol and/or estradiol withdrawal and some synthetic progestins.
Progesterone, testosterone, estradiol, other synthetic progestins, retinoids, vitamin D3,
tumor necrosis factor a and interleukin 6 (IL-6 ), on the other hand, have all been
found to increase STS expression (Reed et al., 2005). Because o f its potential to
diminish the circulating concentrations of androgens and estrogens, STS activity in
hormone dependant cancers has been explored extensively in recent years. Data from
this line research, although potentially confounded by oncogenesis, provide important
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clues regarding mechanisms of STS inhibition as well as the subsequent hormone and
psychological changes associated therewith.
Cancer Research

Using human corticoadrenal carcinoma cells, Gell and colleagues (1998)
investigated the role of estradiol in DHEAS production in cell culture and found that
estradiol increased DHEAS production in a dose-dependant manner while
simultaneously decreasing 3P-HSD activity and cortisol production. Moreover,
estrogen receptor antagonism did not impede DHEAS production. Researchers
speculated that because o f the increase in DHEAS and concomitant decrease in 3PHSD activity and cortisol, estradiol mediated the hormone concentrations through the
3P-HSD enzyme. However, they did not measure DHEA or androstenedione, the two
hormones most likely to be altered by increased DHEAS concentrations and
concomitant changes in enzyme activity.
An alternative and more parsimonious explanation might be that estradiol
inhibits STS activity as part of a local negative feedback loop. By inhibiting STS
activity estradiol would limit the concentration estrone available for synthesis to
estradiol and also limit the amount of DHEA, androstenedione and testosterone. The
reduction in 3p-HSD activity might simply reflect a natural downregulation in
activity based upon the diminished availability of precursor or it could be mediated
by a third factor linked to cancer steroidogenesis. This hypothesis was partially
supported by Pasqualini and Chetrie (2001), who found estradiol inhibited estrone
sulfatase activity in breast cancer cells. In addition, multiple labs that have since
developed dozens of potent synthetic STS inhibitors by modifying the basic structure
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of the estradiol molecule (for a review see Nussbaumer & Billich, 2004).
Unfortunately, many of these compounds irreversibly inhibited STS and had very low
ED50 (4) and were thus not acceptable for human use. Dozens of molecular
manipulations yielded many reversible STS inhibitors that were safer but far less
effective (Nussbaumer & Billich, 2004).
The first STS inhibitor to reach phase 1 clinical trials was STX 64 (667
Coumate) (Stanway et al., 2006). Prior to clinical trials, Coumate administration in
male rodents demonstrated that STS inhibition resulted in increased DHEAS which
was associated with unprovoked aggression (Nicholas et al., 2001). STS inhibition
also enhanced long term learning in rodent models (Flood, Farr, Johnson, Li &
Morley, 1999).
In the phase 1 clinical trial, Coumate (5mg and 20mg) was administered to 13
postmenopausal women with either locally advanced or metastatic breast cancer in a
non-random, open-label, dose-escalation study over a period of six weeks. The
outcome measures included serum concentrations of DHEAS, DHEA,
androstenedione, androstendiol, testosterone, estrone, estrone sulfate, estradiol as well
as STS presence in peripheral blood lymphocytes (PBL) and in the tumor cell. With
STS inhibition, DHEAS concentrations increased significantly while DHEA,
testosterone and estradiol concentrations decreased. These changes paralleled drug
dosage with higher doses linked to larger changes in circulating hormone
concentrations (Stanway et a l, 2006).
As expected, the ratio of DHEAS/DHEA increased substantially (320%)
following drug administration. Estrone sulfate and the ratio of estrone sulfate to
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estrone increased as well but not as dramatically as DHEAS. Sulfatase activity was
dramatically inhibited in both the PBLs and within the tumors. O f interest the adverse
events associated with drug administrations included Grade 2 or moderate (on scale
of 0-none to 5-death) fatigue, hot flushes, mood alterations (details not listed),
arthralgia (STS are found in synovial fluid) and headache. Since psychiatric
disturbances were not measured as outcome variables, it is difficult to discern the
exact nature and scope of the mood alterations experienced by participants in this
trial, but it is important to note that psychiatric disturbances did occur. Thus, in
addition to its potential efficacy as a cancer treatment, Coumate administration
produced a hormone profile similar to the one observed in Marrs (2006) with high
DHEAS and low testosterone that was associated with mood instability and/or
negative behavioral changes (rodent) (Nicholas et al., 2001) providing preliminary
evidence that compromised STS activity could be associated with puerperal
psychiatric disturbances in some women.
Sulfatase and Pregnancy

This possibility was explored by Maayan and colleagues (2005) using a rodent
model of pseudo-pregnancy/withdrawal. Investigators exposed three groups of rats to
a period of hyper-physiological levels of estradiol or vehicle followed by an abrupt
withdrawal in order to proximate the pregnancy/postpartum experience. The rats
were ovariectomized to eliminate peripheral synthesis capabilities. Following
withdrawal both peripheral serum and cortical concentrations of DHEA, DHEAS,
pregnenolone, pregnenolone sulfate levels were assessed as was STS activity. There
were no differences between the groups in peripheral serum DHEA or DHEAS, nor

94

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

were there differences in serum pregnenolone or pregnenolone sulfate. This would be
expected because ovariectomy removed all peripheral synthesis capabilities. There
were however, significant differences in cortical DHEAS and STS concentrations
between the experimental and control groups. DHEAS concentrations were
substantially higher and STS concentrations were lower in the experimental group.
The authors speculated that rapid estradiol withdrawal, as occurs following
parturition, altered the equilibrium between cortical DHEA and DHEAS
concentrations via decreased STS activity. However, since the investigators did not
measure STS activity during the pseudo-pregnancy when the rodents were exposed to
supra-physiological concentrations of estradiol, it is impossible to determine whether
the STS impairment was mediated by elevated estradiol as was suggested by the
aforementioned cancer research or by the subsequent of withdrawal of the
reproductive hormone as was speculated by Maayan et al. (2005).
Based upon these cancer studies, it seems more likely that STS inhibition is
tied to estradiol concentrations rather than to estradiol withdrawal. This would
suggest that the compromised STS activity observed following parturition by Maayan
et al. (2005) reflected the diminished STS of late pregnancy and not necessarily a
postpartum decline. The time-course of systems re-regulation following parturition
could be related to oft reported 3-4 day postpartal clearance of the estradiol and other
reproductive hormones (Illingworth & McNeilly, 1998) and/or to the inherent time
course of STS transcription. There are no data on cortical or peripheral STS
transcription rates, but data from cultured human skin fibroblasts suggest that STS
synthesis takes at least two days to complete and that the STS half-life is four days
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(Conary et a l, 1986). This time course, along with the extended clearance of
puerperal hormones and the already limited STS activity in the adult human liver
(Hammer et al., 2005), would suggest that maternal STS activity is probably low in
late pregnancy, but is compensated for by placental contributions (Carr, 1998).
Following parturition, however, when the placenta is removed and as estradiol and
the other previously elevated hormones decline, there would likely be some delay
before STS activity returned to pre-pregnancy levels. This could result in a postpartal
increase in DHEAS and the degree to which DHEAS concentrations increased would
correspond to the severity of psychiatric symptoms as was postulated by Marrs
(2006).
Admittedly, the research is lacking and this hypothesis remains to be tested.
However, in light of the hormone profile and associated psychiatric symptoms
observed in the Marrs study, diminished STS activity provides a plausible hypothesis
for the development o f these symptoms. Whether the proposed changes in STS
activity are merely reactions to the puerperal endocrine environment or represent
some previously unidentified congenital deficiency is currently unknown and will
remain so unless and until a proper genetic study is undertaken.
However, a longitudinal analysis of postpartum hormones and psychiatric
disturbances could yield additional clues to the etiology and course of postpartum
psychiatric disturbances and its association with endogenous endocrine factors. The
degree to which these hormone factors change over time should correspond to
improvements or decrements in psychiatric symptoms. More specifically, if the
observed endocrine patterns noted in the Marrs study represent a primary
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endocrinopathy that is simply im-masked by pregnancy, further disturbances in
endocrine regulation and continued psychiatric distress are expected. Whereas if the
postpartal increase in DHEAS concentrations represent reaction to the abrupt changes
in the reproductive hormones, DHEAS and other hormone values should return to
normal and psychiatric symptoms are expected to diminish.
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CHAPTERS

METHODS
Participants
The twenty-eight healthy, primigravid women who completed the Marrs
(2006) study were re-contacted and recruited for this longitudinal follow-up study.
The Marrs (2006) study assessed cognitive, affective and hormonal variables
associated with pregnancy and parturition at both 37 weeks of pregnancy and within
10 days postpartum. The present study looked at those same variables at four, eight
and twelve months postpartum.
Only healthy, primigravid women without histories or current evidence of
drug or alcohol use or abuse or neurological or psychiatric disorders and who were
not taking medications that would confound with either psychological or hormone
measures were used as participants in Marrs (2006). In the present follow-up study,
there were no exclusionary criteria and all of the women involved in the Marrs (2006)
research who agreed to participate were included. Medications, illnesses,
breastfeeding and subsequent pregnancies were documented at the four, eight and
twelve month postpartum data collection times.
Of the 28 participants in the previous research, 14 women agreed to
participate in this follow-up. However, participation across the study was inconsistent
with different women being available for testing at each of the follow-up times.
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Twelve women were tested at four months, eight women were assessed at both eight
and twelve months and only five women were tested at all three test times.
In order to equate the number of participants at each test time for purpose of
data analysis, it was decided that participant data would be included in the final
analyses for those women for whom there was no more than one set of missing
variables (a single missed testing session). Nine participants met this requirement. For
those nine participants, the single set of missing data were estimated using the series
median of individual participant values. Data were estimated for one participant at
four months, two participants at eight months and one participant at 12 months.

Enrollment and Testing
Upon completion of the pregnancy and postpartum testing in Marrs (2006)
study participants were appraised of the possibility of a follow-up study and asked if
they would be interested in participating in the subsequent research. All 28 agreed to
be contacted. Approximately two-weeks before each participant reached four, eight
and twelve months postpartum, each participant was contacted by telephone. (Prior to
study approval from the hormone laboratory, four participants had passed the fourmonth test date and were not contacted initially until their eight-month assessment).
This study was approved by the University of Nevada, Las Vegas Institutional
Review Board (Appendix A)
Upon agreement to participate, new informed consents were mailed and
signed, salivary specimen collection kits and instructions (Appendix B) were mailed
and testing appointments were set for the participants. Additional consent forms were
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signed in the presence of the researcher at the first appointment. Testing occurred at
four, eight and twelve months postpartum +/- one week for each participant in the
participant’s home. Data collection occurred over a 15 month period.
The morning o f each testing session, pre-prandial, un-stimulated, salivary
specimen were collected by the participant and stored at room temperature until the
testing session. At each testing session, the following instruments were administered
in order: the Symptom Checklist 90-Revised (SCL-90-R), the California Verbal
Learning Test-II (CVLT-II) part one. Paced Auditory Serial Attention Test (PASAT),
the CVLT-II-part two, the Rey Complex Figure Test (CFT)- copy, the Finger Tapping
Test (FTT), the Purdue Pegboard, the Verbal Fluency Test, CFT-recall and the
Design Fluency Test.
Breaks were given to the participant as requested and when needed to allot for
down-time between tests. Testing at each session took approximately two hours. To
compensate for practice effects on cognitive measures, alternate test forms were
administered for the CVLT-II and the Rey CFT at each testing session.

Steroid Hormone Analysis and Neuropsychiatrie Measures
Steroid Hormone Analysis

Non-stimulated saliva specimen were collected for the quantification of
progesterone, DHEAS, testosterone, estradiol and estriol. Estrone, which was
quantified in Marrs (2006), was not quantified in the present study due to laboratory
financial considerations. However, since estrone did not appear to be a factor
affecting dependent variables in Marrs (2006), its impact on the present study was
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expected to be minimal. The morning of each test session, before eating drinking or
brushing her teeth, participant saliva was collected by expectoration over a 30-minute
period between 8:30 and 9:00 AM. Participants who were breastfeeding were further
instructed to avoid breastfeeding within two hours of the collection interval to prevent
feeding-stimulated hormone release that might confound results. Specimen were
shipped by two-day courier to the analytical facility (AllVia Diagnostic Laboratory,
Phoenix, AZ) where they were stored at -20 C° for <24 hours, then thawed and
analyzed for progesterone, DHEAS, estradiol and estriol concentrations by enzymelinked immunosorbent assays. Testosterone was measured using luminescence
immunoassay. The lower and upper bounds of quantification and inter-day variance
for each hormone were established prior to analysis of participant samples. The lower
and upper limits of quantification were as follows: Progesterone 10-3000 pg/mL;
DHEAS 100-12,000 pg/mL; testosterone .3-760pg/mL; estradiol .1-100 pg/mL;
estriol 1-4000 pg/mL.
Neuropsychiatrie Measures
Intelligence

Intelligence was estimated in Marrs (2006) using the Barona Index and those
scores were utilized in this investigation as part of the demographic data and for
comparison with appropriate age and IQ-matched normative data.
Psychiatric Symptoms

Nine clusters of psychiatric symptoms were assessed using the SCL-90-R.
The SCL-90-R is a 90-item psychiatric self-report inventory designed to measure the
severity and intensity o f psychiatric symptoms in both inpatient and outpatient
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populations (Derogatis, 1994). Participants rated the severity of distress experienced
during the prior seven-day period using a 0-4 Likert-type scale (0=no distress-“not at
all” to 4=extreme). Symptoms measured included: anxiety, hostility (aggression,
irritability, etc.) phobic anxiety, paranoid ideation, psychoticism, somatization
(perceptions of pain or other physical disturbances), obsessive-compulsive behavior,
interpersonal sensitivity (feelings of personal inadequacy), depression and the global
severity index (GSI), a composite score that reflects the overall symptom severity.
The GSI is calculated as a sum of all responses divided by 90 (the total number of
responses).
Cognitive Functioning

Marrs (2006) identified cognitive impairment across the puerperium that was
marked by particularly low verbal and spatial memory performance. To assess
changes in cognitive performance across the postpartum year, the present study
utilized the same neurocognitive measures as were administered in Marrs (2006) at
each test time. The tests administered included: the CVLT-II, PASAT, Rey CFT, the
verbal and spatial fluency tests, the Purdue Pegboard test and the finger-tapping test.
The CVLT-II assessed short and long-term memory as well as learning
strategy and conceptual organization using five trials of 16 words in four conceptual
categories (Lezak, 1995; Spreen & Straus, 1998). Results were evaluated based upon
total recall, short and long delay recall, proactive interference and semantic clustering
(Lezak, 1995; Spreen & Straus, 1998). Both Marrs (2006) and Buckwalter et al.
(1999) found significant verbal memory impairment in both pregnant and postpartum
women. Activation studies show that the CVLT activates the left inferior prefi-ontal
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cortex, the left dorsal lateral prefrontal cortex, the orbitofrontal cortex and the left
hippocampus (Savage et al., 2001).
The PASAT was used to assess the rate of information processing, sustained
attention and vigilance. The PASAT consists of a taped presentation of randomly
presented numbers. In each trial, the subject was asked to add pairs of numbers
together in sequence with the second number added to the first, the third number
added to the second, etc. There are four trials each with increasingly more difficult
presentation rates (Lezak, 1995; Spreen & Straus, 1998). The PASAT is believed to
be especially sensitive to subtle changes in attentional abilities. Marrs (2006) found
mild to moderate impairment in attentional capacities which may have contributed to
poor performance on the CVLT-II.
The CFT measured visual spatial and constructional ability as well as visual
memory, planning, organizational and problem solving (Lezak, 1995; Spreen &
Straus, 1998). Participants were asked to copy a complex figure and after a delay and
without prior warning were asked to produce it again from memory. The figure was
scored based upon accuracy and recall (Spreen & Straus, 1998). The CFT is argued
to be adept at identifying frontal cortex dysflinction (Cummings & Trimble, 1995).
CFT scores in Marrs (2006) were particularly low when compared to normative
means.
The verbal and spatial fluency tests were designed to measure lateralized
executive functioning. During the verbal fluency task subjects were asked to name as
many words as they could in a particular category in one minute. They were also
asked to name animals within a minute. Verbal fluency assesses left frontal cortex
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functioning. For the spatial fluency task subjects were asked to draw multiple novel
figures within a certain time frame. The spatial fluency test assessed right frontal
cortex functioning (Cummings & Trimble, 1995). Both tasks are difficult for
individuals with dorsal lateral prefrontal cortex injuries.
The Purdue Pegboard assessed fine motor dexterity and motor processing
speed as well as right-left dominance. Subjects were asked to take pegs from a cup
and place them in the pegboard, first with the dominant hand, then the non-dominant
hand, and finally with both hands. Each trial takes thirty seconds and is scored by
number of pegs placed during each time period (Spreen & Straus, 1998).
The finger tapping test measured fine motor speed and right-left dominance.
Subjects must tap a key with the index finger of each hand as quickly as possible for
five trials of 10 seconds each. Scores were computed for each hand and a mean for
the five trials was produced (Spreen & Straus, 1998).

Data Analysis
The primary goal of this study was to evaluate the longitudinal trends and
relative associations between postpartum hormones, psychiatric symptoms and
cognitive performance across the first postpartum year. To assess the trends in
hormone concentrations, psychiatric symptoms and cognitive performance, data from
each group of variables were compared at five test times: 37-weeks of pregnancy
(Tl), <10 days postpartum (T2), four-months postpartum (T3), eight-months
postpartum (T4) and one-year postpartum (T5) where data for T l and T2 were
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collected in Marrs (2006) and data for T3, T4, and T5 were collected in the present
study.
Data were analyzed using a series of repeated measures within-subject
univariate analyses of variance (ANOVA). Assumptions of spherieity for each
symptom scale, hormone value and cognitive variable were assessed using Mauchly’s
W statistic and when violated, significance levels were adjusted using the
Greenhouse-Geisser method. Differences between test times were calculated using
simple effects contrasts.
Performance on cognitive tests is susceptible to change over time due to both
the imprecision of the instrument and/or practice effects (Wilson, Watson, Baddeley,
Emslie & Evans, 2000). Thus, delineating functional change in individual scores
requires the accommodation of those factors. A common procedure for dealing with
this is to utilize reliable change indices (RCI). An RCI establishes the range of
expected scores across time to determine the number of points on each cognitive test
required in either direction for change scores to be considered to have not occurred by
chance. Typically a confidence interval of either 90% or 95% is used. However, upon
review of the RCIs established by Wood, Delis, Scott, Kramer & Holdnack (2006) for
the CVLT-II in a healthy control group (there are no RCIs established for the other
instruments used in this study) it was determined that the number of points required to
merit the designation “improved” would exceed the total points possible for this
instrument after a couple of trials and would not likely provide a useful reference.
Thus, measures of change were based upon statistical difference and comparisons
made to normative standards published for age, IQ and/or education-matched
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controls. Interpretation of change in these circumstances must be made cautiously and
with the understanding that practice may have accounted for a large percentage of any
observed improvement.
To assess the relatedness of hormones to psychiatric symptoms and cognitive
performance Pearson’s bivariate correlations were calculated. Because of the small
sample, data were not normally distributed and resisted transformation. It was
decided in advance that if normality assumptions were not met, parametric statistics
would still be used with the caveat that significance levels be interpreted cautiously.
As was case with Marrs (2006), those participants with the most severe symptoms
also typically exhibited the most extreme hormone values and, thus, represented the
clinical cases of most interest. To have removed these cases from data analysis would
have obfuscated the relational trends between non-normal hormone profiles and
psychiatric symptoms.
In Marrs (2006) post-hoc analysis of data revealed two distinct groups of
women, those who were considered symptomatic (T-score >60 on any one symptom
cluster of the SCL-90-R) and those who were asymptomatic. Because of the small
sample in the present study, statistical analysis of these two groups was not possible.
However, descriptive analyses of symptomatic versus asymptomatic participants were
conducted using the same criteria as Marrs (2006).
The large number of analyses performed necessarily increased the type 1 error
rate which might or might not have been counterbalanced by the limited power
associated with such a small sample size. Typically adjustments to the significance
level are made. It was decided in advance not to do this, so that all symptom trends
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would be identified, again with the caveat that significance should be interpreted
cautiously. It was also decided in advance, that while the complete battery of
cognitive tests would be administered, only those factors found to be most impaired
in Marrs (2006) and that continued to show impairment when pregnancy and
postpartum data were re-analyzed for this subset of nine women, would be analyzed
in the present study.
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CHAPTER 4

RESULTS
Participant Data
The average age of study participants was 31.6 years (SD 3.1), education was
15.8 years (SD 2.45) and the full scale IQ as estimated from the Barona index
administered in Marrs (2006) was 112.4, (SD 5.7). Pregnancy and health related data
for the nine participants who were followed across the postpartum year are given in
Table 1. Mean gestational length for these participants was 278 days (SD 2.7) and
each of the nine women had vaginal deliveries. Seven of these nine participants gave
birth to boys, compared to 50% of the total group of participants in Marrs (2006).
At the four month postpartum test time seven participants were breastfeeding
and four participants had begun menstruation. Three participants were taking oral
contraceptives and two participants were taking anti-depressants. At this test time
four participants were working part-time, three of whom worked in the home.
Comparatively, o f the nine women who declined to participate in the research, but
who returned our calls, seven were working outside the home full-time.
At the eight month postpartum test time, two women were still breastfeeding.
Six women had at least one menstrual cycle prior to this test session. The same four
participants that were working at four months were continuing to work part-time at
eight months and the same three participants who were previously taking oral
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contraceptives were still taking oral contraceptives. Both participants previously on
anti-depressants had ceased taking the medications.
At 12 months postpartum, only one participant was known to be
breastfeeding. Participant E was unavailable for testing and it was not known whether
she was still breastfeeding. The same three participants were taking oral
contraceptives and no other medications were reported. Each of the seven participants
known not to be breastfeeding at this time reported having mostly regular menstrual
cycles. Participant H was later found to be five weeks pregnant at this test time. Her
progesterone, DHEAS, testosterone and estriol values did not differ significantly from
those of the other eight participants. Her estradiol values were significantly greater
than those of the other participants at the 12 month testing session, but were lower
than either her own four month or eight month estradiol values, when she was known
not be pregnant. Thus, her data were included in the analyses.

Psychological Data
Longitudinal Trends in Postpartum Mental Health

Postpartum psychiatric distress has been described and investigated largely
under the rubric of three popularly but loosely defined depressive disorders
developing sometime within the first postpartum year. Accumulating evidence
suggests that postpartum psychiatric symptoms are not limited to depression and
develop in the immediate puerperium. The current research examined the breadth,
onset time and time course of these disturbances over one year in a cohort of nine
women. In order to characterize fully the spectrum of psychiatric symptoms across
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the postpartum year, the SCL-90-R was administered at four (T3), eight (T4) and
twelve (T5) months postpartum as the primary outcome measure. SCL-90-R data
previously collected during week 37 of pregnancy (Tl) and 10 days postpartum (T2)
(Marrs 2006) for these nine women were included in the longitudinal trend analyses.
Symptom Checklist 90-R

The SCL-90-R manual (Derogatis, 1994) provides normative T-scores for
both psychiatric and non-patient populations. All data comparisons in this study were
made to the normative scores for the female non-patient population. Each of the
symptom domains has a mean T-score of 50 with a standard deviation of 10. A Tscore of 60 is equivalent to a percentile rank of 84, suggesting that scores one
standard deviation above the mean are indicative of relatively high distress levels.
Listed in Table 2 are mean T-scores, standard deviations and percentage of
participants who were considered symptomatic for each of the symptom domains
measured by the SCL-90-R at each of the five test times.
As can be seen in Table 2 mean participant scores were close to or slightly
above normative means in each of the symptoms clusters at each test time suggesting
that the participants as a whole experienced mild to moderate distress. However,
obtained standard deviations and examination of individual scores belies this
generalization by exhibiting a large range of individual scores and symptom severity.
Looking at the percentage of women who were considered symptomatic (SCL-90-R
T-score >60) at each test time demonstrates for some symptoms a larger percentage
of participants suffered from psychiatric distress than was inferred from the mean
scores. This is illustrated in Figure 3 which plots the percentage of symptomatic
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women at each test time. Conversely, at each test time there were women for whom
pregnancy was a wonderful experience and who’s SCL-90-R T-scores remained
below 50 across all test times.
During pregnancy symptoms of distress were present in at least half of the
women tested. The depression, somatization and obsessive compulsive scales showed
the highest percentage of symptomatic women at this test time. Ten days following
parturition, the percentage o f symptomatic women increased for all but the paranoia,
somatization and obsessive compulsive scales. Four participants demonstrated
symptoms of obsessive compulsive behavior at both test times. Additionally, in the
immediate postpartum, one-third to over one-half of the women tested were
symptomatic in each of the anxiety symptom clusters (anxiety, phobia, obsessive
compulsive behavior and somatization). Four women showed evidence of sub
threshold psychotic disturbances absent concurrent elevations in paranoia and eight of
the nine women tested scored >60 in the depression scale, representing the largest
measure of psychiatric distress. Overall, five women were significantly distressed in
enough clusters to merit GSI scores >60.
At four months postpartum, both the frequency and severity of psychiatric
symptoms diminished with only one participant exhibiting a GSI score > 60 and two
additional participants showing signs of mild distress with intermittent elevations in
individual symptoms scales. Psychiatric distress increased again at eight months
postpartum with four participants exhibiting signs of depression, three participants
exhibiting obsessive compulsive behavior, two participants showing elevated
psychoticism scores and two participants showing elevated GSI scores. Depression
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scores wane again at one-year, but the GSI remains consistent with two participants
reaching the cutoff o f >60. It is interesting to note that by eight months postpartum
only two participants were still breastfeeding and seven participants had resumed
menstruation.
In order to determine if the symptom changes described above were
statistically significant a series of repeated measures ANOVAs were run. As shown in
the top row of Table 3 all of the symptoms showed significant improvement across
time except for anxiety, paranoia and interpersonal sensitivity which showed no
change. It should be noted, however, that paranoia was not a significant contributor to
psychiatric distress at any test time.
A trend analysis was performed to detect the direction and shape of these
trends in postpartum symptom change. Significant linear and cubic trends were
identified for a number of symptom clusters. With the exception of somatization,
which followed a consistent downward trend from pregnancy through the postpartum
year, each of the other symptom clusters exhibited some degree of curve in the trend
line, typically denoted by spikes in symptom severity both at 10 days postpartum and
again at four months postpartum, although symptoms increased to a much lesser
degree at the four month test time. The second and third rows of Table 3 show which
of these obtained trends reach statistical significance.
To determine when the largest change in symptom severity took place, paired
comparisons were made between each test time. These results are reported in Table 3
as well and illustrated in Figure 3. The largest number of significant changes in
symptom severity and frequency occurred between the immediate postpartum and
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four month test times with statistically significant differences occurring in all
symptom clusters except anxiety, paranoia and interpersonal sensitivity, which
improved but did not meet statistical significance. Thereafter, few statistical
differences are obtained between successive test times. This indicates that recovery
from symptoms experienced during pregnancy and immediately postpartum is largely
resolved by four months postpartum. Similarly, it suggests that symptoms appear to
peak in the immediate postpartum.
Summary

By way of overview it would appear that postpartum psychiatric disturbances
develop in late pregnancy, escalate in the immediate postpartum and diminish greatly
by four months postpartum. Symptoms may wax and wane over the course of the
postpartum year, and may develop in association with other life events, but
postpartum symptoms appear to be temporally related to childbirth. Thus, the
investigation postpartum symptoms in childbearing women should be conducted in
proximity to the precipitating event rather in the months and year that follows.
Moreover, in contrast to the current nomenclature and nosological distinctions that
are rather narrowly focused upon depression, postpartum psychiatric disturbances
seem to be characterized by a range of symptoms.

Cognitive Performance
Previously, Marrs (2006) observed moderate cognitive impairment across
multiple domains both during pregnancy and in the immediate postpartum. Cognitive
performance was particularly poor in both verbal and spatial memory with percentile
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rankings from only the single digits to the low double digits when compared to age
and IQ-matched normative data. The purpose of this study was to determine if and
when during the first postpartum year, cognitive performance returned to normal and
to track these potential longitudinal trends across the first postpartum year.
Longitudinal Trends in Cognitive Performance

Evaluation of T l and T2 cognitive tests for this group of nine women showed
significant impairment in verbal memory at both test times. However, spatial memory
did not appear to be impaired at 10 days postpartum as had been the case in Marrs
(2006). Similarly, performance on other cognitive tests such as the PASAT, the
verbal and spatial fluency tests were not impaired at either the pre- or postpartum
testing session for the current participants. Performance on the Purdue pegboard,
however, was below average at both of these test times whereas the finger tapping
test was not suggesting that manual dexterity may have been an issue during
pregnancy and in the immediate postpartum.
So as to minimize Type I error and maximize statistical power only verbal
memory performance was analyzed across the three postpartum testing sessions
carried out in this research. However, a descriptive overview of each of the cognitive
test results obtained across the first postpartum year is provided next.
As demonstrated by Table 4, and illustrated in Figure 4, performance on most
of the cognitive tests administered in this research showed a slight upward trend from
the end of pregnancy to the postpartum period which, for the most part, was
characterized by stable above average performance across all postpartum test times.
One exception was spatial memory, as measured by the recall portion of the CFT,
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spatial memory showed substantial improvement from pregnancy to postpartum but
declined again at four months and again at twelve months. The apparent
improvements in spatial memory correspond to the administration of Taylor’s
alternate CFT form. Comparability studies have found that while the copy scores of
each of the CFT forms is equal in healthy young adults, the Rey CFT standard form is
more difficult and typically merits a five point difference in scores (Spreen & Strauss
1998). When those points are accounted for, the data reveal that there was no
substantial improvement in the recall portion of the spatial memory task. Considering
that each woman was exposed to the Rey CFT standard form on three different
occasions, practice effects would have been expected. Indeed, in healthy young adults
an improvement of 10% or more per trial is expected (Spreen & Straus, 1998). In the
present research the overall improvement across the three administrations of the
standard form was less than 10%.
Unlike CFT scores from Marrs (2006) where the copy portion of the CFT was
equally as impaired as the recall portion, copy scores in the present study were
generally above the mean at each test time but did show slight downward trend across
test times. The difference in copy scores may be related to the small sample size in
the current study.
Performance on the Purdue pegboard was below average both during
pregnancy and following parturition but showed improvement across the remaining
test times. If both the finger tapping test and the pegboard had been impaired, motor
slowing would have been suspected. Since the Purdue pegboard demands significant
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fine motor dexterity it is possible the pregnancy related swelling contributed to the
poor performance.
As noted above, verbal memory was impaired at 37 weeks of pregnancy and
in the immediate postpartum period. Table 5 and Figure 5 show that when compared
to age and IQ-matched (based upon an estimated full-scale IQ of 112) normative data,
immediate, short and long delay verbal memory scores ranged from the <1®' to the
25* percentile during pregnancy and < F ‘ to the 32"'* percentile in the immediate
postpartum (Spreen & Strauss 1998). Normative data by age and IQ were not
available for the semantic clustering or learning slope variables. Accordingly, the
percentile ratings reported here for these measures may be higher than what have
been expected for this group based upon their performance on the recall scales.
Semantic clustering, the degree that words were categorized by meaning in the recall
measures, was above average at both Tl and T2, whereas the learning curve scores
fell considerable below average at both of these test times. Scores for this subset of
women were consistent with those for the entire group in Marrs (2006).
For the most part verbal memory improved across the postpartum year with
percentile rankings approaching or exceeding normative means. The lower scores
sometimes observed at 10 days postpartum and again at eight months postpartum
corresponded to the administration of the alternate test form although test designers
posit high correspondence between performance on the standard and alternate forms
(Dellis et al., 2000).
Irrespective any potential performance discrepancies between the standard and
alternate forms, verbal memory scores improved in each of the dimensions measured
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except for proactive interference, Trial B, which remained below 15% throughout the
postpartum. Trial B is a distracter list of words administered after the fifth trial of the
primary list, in the immediate recall portion of the exam and before either of the
delayed recall trials begins. It measures the degree to which previously learned
information hinders the acquisition of new information. While some proactive
interference is expected in non-clinical populations, the consistently low scores for
trial B observed across pregnancy and postpartum indicate a potential deficit in
working memory (Jonides & Nee, 2006). Consistent with that possibility, the
obtained learning slope scores, which measure the number of new words learned per
trial were relatively low and stable across most postpartum test times.
Deficits in working memory are suspected when the number of words learned
in Trial 1 is greater than the number of words learned in Trial B as measured by a
difference in z-score of >1.5 points (Bonders, 2006). This criterion was met at three
test times and just missed the cutoff at four months and at eight months where the
difference between the scores was 1.49 and 1.32 points, respectively. Interestingly, in
comparison to other individuals with similar difficulties in proactive interference,
overall recall scores (CVLT-II, Trial 1-5 total) were significantly better for
participants in the present study whose scores ranged from 52-62 total words recalled
across all test times versus a mean of 49 total words recalled (n=955) (Bonders,
2006). Similarly, mean semantic memory z-scores for this participant group were
very high, ranging from 0-3.59 across all test times and likely contributed to the
greater number of words recalled.
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Repeated measures analyses (Table 6), revealed significant main effects for
time for each of the primary measures of verbal memory except for Trial B which
was not significant and long delay recall which approached significance at p>.056.
Semantic clustering also improved significantly over time but the learning curve did
not. The trend analysis indicated significant linear trends for each of the primary
measures except long delay recall.
Change between test times was analyzed further using a series of repeated
measures ANOVA contrast tests. As is exhibited by Tables 6, verbal memory scores
improved in a mostly linear fashion across time. Improvement between test times was
not always statistically significant. However, improvement between T1 and T5 was
significant in most of the verbal memory measures, excluding Trial B, the learning
curve and long delay recall.
Inasmuch as neither a control group nor a reliable change index was used to
counter the effects of practice in short and long term verbal memory test performance,
these results must be interpreted cautiously. It is impossible to discern whether true
improvement or improvement mediated by repeated exposure was observed in the
present study. However, the lack of improvement in both the learning slope and in
performance on trial B suggests the possibility that improvement in the other aspects
of verbal memory may have come from practice.
Associations between Verbal Memory and Psychological Distress

Unlike in Marrs (2006) where psychiatric symptoms were inconsistently and
sometimes positively associated with cognitive performance, in the present study
several scales on the CVLT-II were consistently and negatively associated with SCL-
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90-R symptoms, predominantly at T l, T2 and T3. For example, anxiety was
negatively correlated with immediate recall trial 1 and recall total at one year
postpartum (r=-.716, p<.05; r=-.688, p<.05, respectively). It had previously been
associated with poor delayed recall during pregnancy (r=-.669, p<.05). Hostility was
associated with poorer immediate recall trial 1 and trial B during pregnancy but not in
subsequent testing session (r=-.713, p<.05; r=-.913 p<.001, respectively).
Somatization was a factor in both the long delay recall trial at T2 (r=-.671,
p<.05), T3 (r=-.730, p<.05) and on semantic clustering ability during pregnancy only
(r=-.709 p<.05). Obsessive compulsive behavior was related to poor performance on
the immediate recall total (r=-.679, p<.05), short delay free recall (r=-.666, p<.05) and
the long delay recall trial (r=-.723, p<.05) at four months postpartum. Increased
interpersonal sensitivity was also associated with performance on the long delay trial
(r=-.691, p<.05) at T3 as was depression at T2 and T3 (r=-.753, p<.05; r=-.691,
p<.05, respectively). Finally, the GSI was associated with poor long delay recall
abilities at T2 (r=-.682, p<.05) and T3 (r=-.813, p<.01).
Summary

The most robust findings concerning cognitive performance during pregnancy
and postpartum obtained herein were that deficits in spatial and verbal working
memory originally identified during pregnancy persist through the first postpartum
year. Moreover, psychiatric distress impaired verbal memory performance. At least it
was the case that each o f the significant associations obtained between verbal
memory and distress were negative and most prominent during pregnancy, the
immediate postpartum and four-months postpartum. As verbal memory improved.
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whether by practice or not, and psychiatric distress was ameliorated, the correlations
between the two dissipated.

Hormone Data
Results from Marrs (2006) demonstrated a strong relationship between the
adrenal androgens DHEAS and testosterone and psychiatric disturbances. Prenatal
testosterone was associated negatively with prenatal psychiatric distress, but also
heralded the onset and exacerbation of symptoms following parturition. Concurrently,
elevated DHEAS was associated positively with both pre- and postpartum distress.
Following parturition as DHEAS concentrations increased so too did the severity of
psychiatric distress. The current study investigated the time related trends in these
hormones relative to psychiatric distress and cognitive function.
Patterns o f Change

The inter-individual variance in hormone values observed in this study was
enormous, with standard deviations as large as or greater than mean values for some
hormones. These mean values and standard deviations are shown for each hormone
measured at each test time in Table 7 along with reference ranges for non-pregnant,
non-postpartum women. It should be noted that reference ranges for salivary hormone
values have not been established for either pregnant or postpartum women and these
reference ranges should be interpreted with caution. Mean data for each hormone are
plotted against test time in Figure 6.
Immediately following parturition mean progesterone, estradiol and estriol
decreased by 95%, 46% and 97% respectively. Mean DHEAS concentrations almost
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doubled following pregnancy showing a 99.24% increase at the first postpartum test
time and testosterone values increased by 10%.
Between the immediate postpartum and the subsequent three testing sessions
the pattern o f hormone change varied among the hormones. As may be gleaned from
Table 7 mean postpartum progesterone, estradiol estriol concentrations generally fell
within the normal range of expected values for non-pregnant women, non-postpartum
women and remained fairly consistent across the postpartum year.
Mean postpartum testosterone concentrations fell within the normal range of
expected values, but skewed toward the lower end of the normal range at four months
postpartum and then approached the median normative values for the remaining two
test times. Inter-individual variability was particularly large for postpartum
testosterone with concentrations ranging from as low as .4 pg/mL for Participant A at
T2, to as high as 80 pg/mL for Participant E at T4. Individual hormone values and
percent changes between successive test times are given for each participant in Table
8.

DHEAS showed the most unique pattern in that mean values increased from
pregnancy to postpartum and showed no tendency to decrease across the postpartum
year. Moreover mean DHEAS values were at the high end of the reported reference
ranges. Mean DHEAS concentrations across the postpartum year ranged from 1725
pg/mL to 2125 pg/mL compared to the 200-2500 pg/mL reference range. At each of
the four postpartum test times, at least two participants approached or exceeded the
clinical reference ranges. Overall four different women met or exceeded clinical
cutoffs for this hormone at least once during the year. As may be seen by reference to
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Table 8, participant E exceeded the cutoff on four occasions and Participant G,
exceeded the cutoff on two occasions. Participants D and H exceeded the clinical
cutoff on one occasion each.
DHEAS concentrations >2500 pg/mL are clinically indicative of adrenal
dysfunction and typically merit further diagnostic investigation. Moreover, elevated
DHEAS values are generally co-associated with elevated testosterone (Bulun &
Adashi, 2003) which did not occur in this research. Participants with supraphysiological concentrations of DHEAS were notified by the investigator and
encouraged to seek further testing. Only Participant E whose DHEAS values reached
>7200 pg/mL chose to do so.
Special note is taken that the mean postpartum estriol values, while relatively
stable across the postpartum trended toward the high end of the non-pregnant, non
postpartum reference ranges. Mean postpartum estriol concentrations observed in this
study ranged from 12-14 pg/mL compared to the laboratory reference range of .5-16
pg/mL (Table 7). Whereas individual postpartum values ranged from as low as 4.2
pg/mL to as high as 26.6 pg/mL, five different women on nine different occasions
exceeded the clinical cutoff (Table 8).
Estriol is the primary metabolite of fetal DHEAS during pregnancy. Fetal
adrenals produce large quantities of DHEAS, which are then metabolized into estriol
by the fetal liver via 16a-hydroxylation. With the occasional supra-physiological
DHEAS values observed in the present study, one might expect increased conversion
of DHEAS to estriol in the maternal liver. Correlations between hormones at each of
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the test times are given in Table 9. As can be seen therein a significant correlation
between DHEAS and estriol occurs only at T4.
Further examination of the hormone to hormone correlations shown in Table 9
reveals that while DHEAS was significantly correlated with testosterone at four, eight
and twelve months postpartum, testosterone concentrations were not correlated with
estradiol concentrations at any of the test times, but were correlated significantly with
estriol during pregnancy and postpartum and again at T4. The lack of association
between testosterone and estradiol is surprising insofar as testosterone and estradiol
are thought to be highly correlated, particularly in hyperandrogénie conditions (Bulun
& Adashi, 2003).
Longitudinal Trends in Postpartum Hormones

A series of repeated measures ANOVAs were performed to assess the
statistical differences in mean hormone concentrations across test times. Multiple
contrast measures were utilized to determine differences in mean hormone
concentrations between each test time and polynomial trend analyses were performed
to assess the shape and significance of trends across time.
As illustrated in Table 10 there were significant main effects for time for
progesterone and estriol with most of the effect accounted for by the significant
changes from pregnancy to the immediate postpartum (p<.000 for each). Neither
DHEAS nor estradiol showed significant main effects but did follow significant linear
and cubic trends, respectively, and showed some significant changes between
individual test times, particularly at T l and T5.
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Mean DHEAS values between test times did not show significant differences,
probably because o f the previously noted substantial inter-individual and intra
individual (between test times) variability observed for this hormone. Nevertheless,
the unique pattern obtained for this hormone merits its further consideration.
DHEAS values measured in serum, are reported to be high in early pregnancy
diminish in late pregnancy and return to non-pregnant concentrations following
parturition (Soldin et al., 2005; Tagawa et al., 2004). At one year postpartum, serum
DHEAS concentrations are expected to be within non-pregnant reference ranges
(Soldin et al., 2005). There are no published data on salivary DHEAS concentrations
either during late pregnancy or at any time during the first postpartum year. However,
the balance between serum values, which represent the fraction of hormone bound to
protein (DHEAS is tightly bound to albumin) and the salivary concentrations, which
represent the free fraction of hormone, that which is not bound to circulating proteins,
are highly correlated and reportedly maintained in dynamic equilibrium (Bolaji, 1994;
Lu et al., 1999; Meulenberg & Hofinan, 1989; Vinning & McGinley, 1987). Thus, it
would be expected that the trends in salivary hormones observed in this study
compared to others would be similar those obtained previously in serum. This
appeared not to be the case. With the exception of a slight decrease at eight months
postpartum, mean DHEAS concentrations increased from pregnancy through the first
postpartum year. It has also been reported that elevated DHEAS concentrations are
typically associated with elevated testosterone and estradiol (Kroboth et al., 1999).
This appeared not to be the case in the present study.
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Hormone to Symptom Associations

In Marrs (2006), the adrenal androgens DHEAS and testosterone were
uniquely and significantly associated with the full spectrum of psychiatric
disturbances measured by the SCL-90-R. Elevated puerperal DHEAS and diminished
late pregnancy testosterone were associated with pre- and postpartum symptoms
whereas progesterone and estriol were not associated with any symptoms and
estradiol was only correlated with a few dimensions. To determine what role these
hormones played in psychiatric symptomatology across the year, correlations between
hormone values and psychiatric symptoms were calculated for the current participants
at each test time.
Results from the correlation calculations are listed in Table 11. Correlations
between hormones and psychiatric symptoms during pregnancy and postpartum were
not significant. However, immediate postpartum DHEAS was significantly correlated
with increased postpartum anxiety, paranoia, psychoticism and the GSI. Progesterone
and estriol were not associated with symptoms at either of these two test times and
estradiol was not correlated with any symptom at any test time.
At four months postpartum, progesterone, DHEAS and testosterone were all
significantly and positively associated with a variety of psychiatric symptoms as
shown in Table 11. Most notable were the hormone to mood correlations for anxiety,
phobia, paranoia, psychoticism, obsessive compulsive behavior and depression.
Estriol was also significantly correlated with depression at this test time.
At eight months postpartum significant positive hormone to psychiatric
symptom correlations were found only for DHEAS, testosterone and estriol. As
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shown in Table 11, DHEAS was correlated with phobia, paranoia and psychosis and
testosterone was correlated with phobia. It is notable that the largest number of
correlations at eight months postpartum was found for estriol which was correlated
positively with anxiety, phobia, paranoia, psychoticism, obsessive compulsive
behavior and depression.
Finally, at twelve months postpartum, only progesterone was associated with
psychiatric symptoms. Progesterone was correlated with phobia, paranoia,
psychoticism and somatization as again shown in Table l l . l t must be noted that
hormone values and SCL-90-R scores for participant E were estimated for this test
time using the median value of her hormone values and scores from previous sessions
and thus correlations presented here must be interpreted with caution.
Hormone to Verbal Memory Associations

In Marrs (2006) the relationship between individual hormones and tests of
cognitive performance was inconsistent but did indicate that elevated hormone
concentrations were associated generally with poorer performance across multiple
measures. In the present study, no statistically significant associations were identified
between measures o f verbal memory and any hormone at any of the three postpartum
test times.
Summary

The hormone data presented herein suggest that inter-individual variability is
considerable and that trends changes in hormones across the postpartum period can be
concealed by analysis o f mean data alone. Nevertheless, the obtained mean data do
demonstrate that progesterone, testosterone, estradiol and estriol are elevated during

126

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

late pregnancy, decline after parturition, and stabilize across the postpartum year. On
the other hand, mean DHEAS values trended upward across the postpartum year.
Each of the hormones measured was correlated positively with psychiatric
symptoms at some time during the postpartum year except for estradiol, which was
not correlated with any symptoms at any test time. DHEAS was significantly
correlated with symptoms at T2, T3 and T4 showing the largest number of significant
correlations of any of the hormones measured. This was followed by progesterone
which was associated with symptoms at T3 and T5 while testosterone and estriol
were associated with symptoms at T3 and T4. The present study obtained no
significant hormone to cognitive performance correlations at any test time.

Case Histories
Two women within this cohort. Participants D and E, suffered significant
psychiatric distress in the immediate postpartum to merit a more detailed description
of their individual symptoms, hormone patterns and results from the
neuropsychological assessments. Participant D was 29 years old at the time of the
first testing session, married, pregnant with a male child, right-handed and employed
professionally, with 16 years of education. Participant E was 26 years old, married,
pregnant with a female child, left-handed, with 16 years of education. She had been
employed professionally until five months of pregnancy when persistent nausea had
precluded her continued employment.
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Participant D

Participant D reported a normal but extended pregnancy. She delivered
approximately two weeks after her scheduled due date with labor induction required.
Her labor was approximately 18 hours. At T l, she showed some signs of
psychological disturbance with elevated SCL-90-R T-scores in the following
symptom clusters: somatization, 62; obsessive compulsive, 72; depression, 62; and
GSI, 63. It was noted that during this testing session, her affect was unusually flat,
with little to no expression of either positive or negative emotion.
Performance on the battery of neuropsychological exams was marked by
below average short and long term verbal recall (45^ and 32"‘* percentiles,
respectively), very poor control of proactive interference (Trial B, l(f^ percentile) as
measured by the CVLT-II and poor spatial memory (9^'’ percentile) as measured by
the CFT. Attentional capacity as measured by the PAS AT was at or just below the
50^ percentile across all four trial speeds. Motor processing and fine motor skills as
measured by the FTT and Purdue were within normal ranges and performance on
both the verbal and design fluency tests was at or just below the 50* percentile.
Following parturition. Participant D experienced severe anxiety and panic
attacks. She exhibited autonomic instability without concomitant thoughts of harming
her child. Her SCL-90-R scores increased considerably. Her T-scores were as
follows: anxiety, 76; hostility, 61; phobia, 66; psychoticism, 69; somatization, 78;
obsessive compulsive behavior, 70; depression, 72; and her GSI was 70. Again, and
even with such active psychiatric disturbances her affect was unusually flat.
Concurrent with these symptoms DHEAS and testosterone concentrations went from
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640 pg/mL and 48 pg/mL respectively at Tl to 4555 pg/mL and 25 pg/mL
respectively, following parturition. Postpartum cognitive performance improved
minimally and/or remained consistent with performance during pregnancy, although
her CVLT-II total immediate recall declined somewhat from the 45* percentile
during pregnancy to the 42"^ percentile postpartum. Spatial memory remained poor at
the 9* percentile.
At approximately three weeks postpartum she sought help from a physician
and was prescribed escitalpram oxalate (Lexapro), a selective serotonin reuptake
inhibitor (SSRI) commonly prescribed for depression but also for generalized anxiety
disorder. By two months postpartum the participant reported feeling better and by
four months postpartum had begun to taper her medication. At four months
postpartum, her symptoms had subsided with only the somatization scale reaching Tscore above 60 (T=62). Her DHEAS and testosterone concentrations returned to
within normal ranges and her affect had returned to normal. Cognitive performance
across all tests improved slightly or remained consistent with previous performance
except for spatial memory which declined further to the 8* percentile.
At eight months postpartum, it was revealed that Participant D’s son had
recently undergone a procedure to correct testicular mal-descent. Testicular maldescent sometimes referred to as cryptorchidism occurs in 1-6000 births and is
thought to be caused by low gestational testosterone and/or testosterone receptor
insensitivity (Bradshaw & Carr, 1986). The surgery was successful and the child was
doing well. No other health related issues were reported. Symptom T-scores at this
time were slightly elevated: psychoticism, 60; obsessive compulsive behavior, 62;
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interpersonal sensitivity, 63; and depression, 62. Her GSI was 58. DHEAS increased
by 482 pg/mL from the previous test time but was within the normal range. Other
hormone values were also within the normal range. Cognitive performance continued
to improve. CVLT-II scores were all above the 50* percentile and spatial memory
scores improved to the 25* percentile.
At 12 months postpartum no SCL scores were above 60, DHEAS
concentrations fell -300 pg/mL. All other hormones remained within normal ranges.
Cognitive performance remained stable, except for spatial memory which declined to
the 10* percentile.
Participant E

Participant E had a difficult pregnancy and suffered from significant nausea
and vomiting throughout the entire pregnancy. At Tl she was showing signs of
distress with elevated SCL-90-R scores across several domains. Her T-scores were as
follows: anxiety, 73; hostility, 55; phobia, 76; paranoia, 60; psychoticism, 65;
somatization, 72; obsessive compulsive behavior, 73; interpersonal sensitivity 69;
depression, 72; and her GSI was 73. Despite the difficulties she reported being
excited about the birth and was particularly interested in having the nausea dissipate.
Her cognitive performance was below average during pregnancy, ranging from the
16* percentile in Trial 1 and Trial B, long delay recall measures to the 32"^ percentile
for short delay and the 47* percentile for total immediate recall in the CVLT-II. Her
attentional capacity and cognitive processing speed was somewhat below the mean
but her motor processing and fine motor skills were at or above normative mean
performance. Unlike Participant D who showed significant impairment in spatial
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memory, Participant E performed above average on this measure scoring in the 79*
percentile.
Following parturition Participant E suffered significant anxiety and was
immediately plagued by violent and aggressive thoughts typically involving the death
or injury of her infant or herself. The severity of her distress increased significantly as
is seen with the increase in SCL-90-R symptom T-scores: anxiety, 80; hostility, 61;
phobia, 76; paranoia, 57; psychoticism, 71; somatization, 80; obsessive compulsive
behavior, 80; interpersonal sensitivity, 67; depression, 74; and her GSI was 75.
Concurrent with the psychiatric distress, participant D experienced significant
changes in circulating androgens. Pregnancy DHEAS and testosterone concentrations
were 596 pg/mL and 19 pg/mL respectively. Postpartum DHEAS jumped to 2799
pg/mL while testosterone concentrations rose to 33 pg/mL.
In addition to the violent images, participant E suffered from periods of
autonomic instability (greater than twice daily) that were marked by increased heart
rate, chest pain, leg pain, difficulty breathing and night sweats for which she sought
medical attention. Various tests were run and all were negative. Detailed information
was not disclosed to this investigator. At 10 days postpartum she developed mastitis,
concurrent with a high fever and was prescribed the antibiotic Diaclox. She was
encouraged repeatedly by this investigator to seek treatment for her psychological
distress, but she declined to do so. Phone conversations with the investigator
indicated no remission in either physiological or psychological symptoms over the
course of the first month postpartum. At approximately one month postpartum, she
sought medical treatment and was prescribed citalpram hydrobromide (Celexa) but
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did not receive counseling. She remained on Celexa for approximately one month, at
which time she was prescribed Lexapro. Postpartum cognitive performance improved
or remained stable across all domains except for spatial memory, which declined
significantly from pregnancy to the 10 day postpartum testing session.
At four months postpartum. Participant E was still taking Lexapro and
suffering from psychiatric symptoms but she reported that the occurrence of
autonomic instability had diminished from twice daily to 2-3 times per week. The
participant also reported that the medication had helped with her “motivation to get
out of bed.” Although the autonomic instability had largely diminished she still
suffered from night sweats. Moreover, the occurrence of obtrusive thoughts and
subsequent compulsive avoidance behavior had remained the same or had increased.
She reported being plagued by images of her daughter being mauled by dogs, of
being stabbed, and of having the cable from the breast pump strangle her daughter.
Again she was encouraged to seek treatment and refused, claiming that her symptoms
had largely been minimized by the physician that had prescribed her the medication.
Her SCL-90-R T-scores at this time were: anxiety, 77; hostility, 61; phobia, 76;
paranoia, 67; psychoticism, 69; somatization, 66; obsessive compulsive behavior, 68;
interpersonal sensitivity, 68; depression, 68; and GSI, 72.
Concurrent with the elevated SCL90-R T-scores, some supra-clinical hormone
values were observed with the concentrations of DHEAS being almost three times
above normal clinical ranges at 7212 pg/mL while her progesterone was at 700
pg/mL. She was encouraged to follow-up with her physician regarding endocrine
function. It is not known which endocrine tests were completed but the patient
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reported no abnormalities were identified. Cognitive performance remained stable or
improved minimally. Verbal memory was at or just above average in all domains
except for Trial B, proactive interference which remained at the 16* percentile.
Spatial memory performance remained at the 42"*^ percentile.
At eight months postpartum, participant E’s psychiatric symptoms were still
elevated though not as severely as at previous test times. She had stopped taking
Lexapro at approximately five months postpartum and had not received counseling.
Her DHEAS were still above the clinical cut off at 5731 pg/mL, more than twice the
upper range of normal non-pregnant concentrations. In addition to the psychiatric
distress, she reported an unusual skin condition marked by excessively scaly skin on
her wrists, feet, ankles, knees and torso. Dermatological treatment had not provided
relief. Based upon her hormone values, she was again encouraged to follow-up with
her physician; the results o f which are unknown as she dropped out from the study
after this test time. Cognitive performance at eight months postpartum showed no
significant changes fi’om the previous test times and remained within or just below
average.
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CHAPTER 5

DISCUSSION
Trends in Postpartum Symptomatology
The purpose of the study was to examine prospectively the longitudinal trends
in postpartum psychiatric disturbances, cognitive performance and hormone values in
a cohort o f healthy, primigravid women. This study represents the first longitudinal,
cohort investigation o f these variables. Findings from this study confirm some, and
dispute other, commonly held hypotheses regarding pregnancy and postpartum that
had hereto not been tested. Perhaps the most important of these involves the onset and
course of psychiatric disturbances relative to puerperal hormone changes.
Postpartum mental illness has heretofore been classified along the spectrum of
mood disorders, predominantly based on unipolar depression not linked to organic
factors. The DSM-IV allows for the onset of postpartum disorders within 30 days of
parturition, but researchers regularly include cases as far out as one year post-delivery
(Andrews-Fike, 1999; Gavin et al., 2005; Mowery & Lennon, 2001; Pfuhlmann et al.,
1998; Sing & Kauer, 1999; Wisner, Peindl & Hanusa, 1993; Wisner, Peindl &
Hanusa, 1995).
Data from Marrs (2006) and the present study support the time-limited onset
put forth by the DSM-IV, by demonstrating that new cases of postpartum psychiatric
distress are not likely to originate beyond four months post-delivery. Even though
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symptoms may wax and wane somewhat over the postpartum year, the most
significant psychiatric symptoms emerge in the days following parturition and largely
dissipate in all but the most serious cases by four months postpartum.
This general finding is consistent with data from a recent Danish registry
study by Munk-Olsen et al. (2006) who reviewed the records of 1171 women over the
course of 30 years and demonstrated that women were at significantly greater risk of
needing either in-patient and/or out-patient psychiatric care in the first 19 days
following parturition than at any other period in their lives. Similarly, Stowe et al.,
(2003) found that 66% of all cases of postpartum depression develop within three
weeks postpartum and Klompenhouer and van Hulst (1991) who found that 70% of
all cases of postpartum psychosis develop within 10 days of parturition.
Findings from Marrs (2006) and the present study suggest that the limited
range of psychiatric symptoms considered by the DSM-IV and investigated by most
researchers needs to be expanded. Although depression was certainly present in both
Marrs (2006) and the current study and was, in both cases the most frequently
ascribed to symptom cluster, depression was not the most debilitating symptom
indicated by the obtained SCL-90-R T-scores. Rather, at four, eight and twelve
months postpartum the mean T-scores for phobia, psychoticism and obsessive
compulsive behavior scores generally exceeded depression T-scores. This may have
been related to the type of questions that load on the depression scale. After all many
depressive “symptoms” might be expected as a consequent of childbirth and even of
child care and not indicative of true psychiatric dysfunction. Be that as it may, the
data obtained in this study do indicate that anxiety type symptoms, including
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autonomie instability, phobia, obsessive behavior and some degree of psychoticism
are at least as evident as depression in the postpartum. This finding is consistent with
the few studies that have investigated co-morbid anxiety symptoms postpartum and
found anxiety symptoms to be prevalent in both the immediate and late postpartum
period (Austin, 2004; Reicher-Rossler & Fallahpour, 2003; Ross et al., 2002; Wenzel
et al., 2005).
Thus, it is suggested that postpartum psychiatric distress hinges more on the
anxiety than depressive disorders (Austin, 2004; Ross et al., 2002; Wenzel, Gorman
& Stuart, 2001; Wisner et al., 1999). When the individual scores from the present
study are considered, it is apparent that only elevated anxiety components persisted
beyond four months postpartum. With the two most serious cases of postpartum
psychiatric distress. Participants D and E, depression T-scores did not exceed anxiety
symptom T-scores at any postpartum test time, and the primary complaint reported by
both participants was anxiety with autonomic instability.
What distinguished these two participant’s cases from each other, was the
presence of violently aggressive and obtrusive images and the degree of psychoticism
in Participant E. Although both participants experienced similar levels of anxiety and
autonomic instability, only Participant E experienced the intrusive images and,
perhaps, as a consequence this extended her symptoms through eight months
postpartum. Jennings et al 1999 found that violent, intrusive thoughts were more
prevalent in postpartum women and contributed significantly to the severity of their
symptomatology. Thus, while depression certainly played a role in postpartum
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psychiatrie distress, it was neither the most prominent nor the most persistent
symptom and may in fact have been secondary to other symptoms.
In light of these findings, future research should be directed toward the
development of a postpartum-specific assessment tool that addresses both the breadth
and the depth of psychiatric symptoms, is capable of distinguishing between
postpartum and non-postpartum psychiatric distress and is administered in closer
proximity to the precipitating event.

Trends in Postpartum Cognitive Performance
Cognitive deficits are an anecdotally accepted consequence of pregnancy that
have thus far eluded empirical explanation. Research shows that upwards of 80% of
pregnant women perceive that they have memory deficits during pregnancy (Brindle
et al., 1991; Jarrahi-Zadeh et al., 1969; Sharp et al., 1993). However, very few studies
have empirically demonstrated pregnancy related cognitive deficits.
Investigations by Buckwalter et al. (1999) and Marrs (2006) demonstrated
significant verbal and spatial memory deficits during pregnancy and the immediate
postpartum when compared to age, IQ and gender matched normative data but did not
obtain consistent significant correlations between individual hormones or
psychological symptoms and cognitive performance. Conversely, Vansten (2006)
found no differences in cognitive performance between pregnant and non-pregnant
women and no correlations between mood symptoms (as measured by the Profile of
Mood States) and any aspect of cognitive performance.
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Review o f the data from the present and the previous study (Marrs, 2006)
indicates that some level of cognitive impairment may occur during pregnancy and
persist through the immediate postpartum. Although in the present study, any deficits
that occurred typically resolved in the course of the year-long postpartum period
observed. Verbal and spatial memory, as measured by the CVLT-II and CFT
respectively, were most notably impaired during pregnancy.
When compared to normative data, the mean data for spatial memory obtained
from the current participants showed no impairment in spatial memory measured at
10 days postpartum and at eight months postpartum but did show impairment at four
and twelve months postpartum. Further review of CFT performance demonstrated
that improvement occurred at those test times when the Taylor alternate form was
administered. Researchers speculate that the Rey CFT is more difficult than other
alternate CFT forms and that scores on the standard form are at least five points lower
than those observed on the alternate forms (Spreen & Strauss, 1998). When mean
scores on the alternate forms were adjusted for the five point difference, impaired
performance across all test times was observed. These obtained and adjusted low
scores across trials were particularly noteworthy insofar as only minimal practice
effects were exhibited. Despite having been exposed to the same figure on three
different occasions, recall scores improved by less than 10% per trial.
Verbal memory scores were substantially depressed during pregnancy and the
early postpartum. However, except for Trial B, the measure of proactive interference,
verbal memory scores generally showed a significant linear increase across the one
year postpartum period. Bolstering performance on the recall measures were semantic
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memory skills. Semantic memory scores across all trials, but especially at four, eight
and twelve months postpartum were significantly higher than individual verbal
memory recall measures.
The increasing trends in recall scores and semantic clustering across the
postpartum contrast with the uniformly poor learning slope measure and Trial B. Trial
B measures the individual’s ability to adequately suppress irrelevant information
influences the amount of information that can be retrieved from working memory
(Jonides & Nee, 2006). A discrepancy of greater than a 1.5 point difference in z-score
between Trial 1 and Trial B (Trial 1 > Trail B) is suggestive of impairment (Bonders,
2006). This criterion was met during pregnancy, postpartum and again at twelve
months postpartum and suggests the possibility of impairment in working memory.

Trends in Postpartum Hormones
Puerperal hormone concentrations are reported to increase during pregnancy,
decrease following delivery, and return to “normal” in the ensuing months as the
cyclicity of reproductive hormones returns (Illingworth & McNeilly, 1998). This
hypothesis has generally been confirmed for the reproductive hormones such as
progesterone, estrone, estradiol and estriol, but not for the androgenic hormones such
as DHEAS and testosterone. There is, however, a paucity of data regarding the
reproductive hormones in the months following parturition and basically no data
regarding postpartum trends the non-reproductive adrenal androgens. Accordingly,
the impact of these hormones on postpartum mental health is unclear.
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Marrs (2006) showed that progesterone, estrone, estradiol and estriol were
elevated in late pregnancy and decreased significantly by the 10 day postpartum
testing session. DHEAS and testosterone concentrations did not follow this pattern.
Testosterone concentrations were low in late pregnancy contrary to published reports
(Bammann, Coulam & Jiang, 1980), while DHEAS concentrations were somewhat
elevated in late pregnancy and then rose dramatically following parturition, again
contrary to published reports (Milewich et al., 1978; Soldin et al., 2005; Tagawa et
al., 2004). Moreover, both the low late pregnancy and the elevated puerperal DHEAS
concentrations were significantly associated with the breadth and severity of
psychiatric symptoms.
Thus, it was postulated in the present study, that the degree to which DHEAS
returned to within normal non-pregnant concentrations would coincide with
improvement in psychiatric symptomatology. Inasmuch as only low late pregnancy
and not postpartum testosterone concentrations were associated with psychiatric
symptoms in Marrs (2006), testosterone was not expected to be a factor in the present
study. It was also postulated that if DHEAS concentrations remained above the
normal clinical values, psychiatric symptoms would persist. Moreover, to the degree
that DHEAS and by association DHEA might affect the metabolism of other steroid
hormones, chronically elevated DHEAS concentrations were expected to elicit
unspecified changes in the circulating values of other steroids hormones.
The findings from this study, although preliminary and necessarily limited by
the small number of participants, support each of these hypotheses. In the present
study, DHEAS was the single largest contributor to postpartum distress across all test
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times with almost twice as many significant associations as any other hormone
measured. In the case o f the anxiety type disorders such as anxiety, phobia, paranoia,
psychoticism and obsessive compulsive behavior, DHEAS accounted for upwards of
80% percent of the variance in symptom severity. Although statistical significance
must be interpreted cautiously herein light of the small participant sample, these data
suggest that DHEAS plays an integral role in postpartum mental health.
Analyses of individual cases, illustrate both the impact of acutely elevated
DHEAS on psychiatric well-being and the persistence of psychiatric and
physiological distress associated with chronically elevated DHEAS. In current study,
DHEAS concentrations increased dramatically following parturition in seven of the
nine participants and for five of those seven, elevated GSI scores indicated
psychiatric distress. O f those five participants, DHEAS values of two participants
exceeded the upper limit (>2500 pg/mL) of what is considered normal for non
pregnant women.
The two participants, D and E, whose DHEAS values exceeded the clinical
cutoff in the immediate puerperium, were the most severely distressed of the group
and reported experiencing symptoms at least through the first couple of months
following delivery. Unfortunately, testing did not begin again until four months
postpartum. However, by four months postpartum, DHEAS concentrations in
Participant D and the other participants had returned to within normal ranges.
Participant D ’s DHEAS remained within the normal limits for the duration of the
study and her symptoms largely dissipated, whereas the DHEAS values of other
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participants increased beyond the reference range intermittently and in parallel with
symptom elevations.
DHEAS concentrations in Participant E, however, continued to increase and
by four months were at >7200 pg/mL, well beyond what is considered normal. In
conjunction, her psychiatric symptoms persisted and other hormone values began
showing signs o f irregularity. Namely, progesterone concentrations moved beyond
the normal luteal phase values (>600pg/mL) even though she had not yet begun to
menstruate. At eight months, although her DHEAS concentrations had decreased
somewhat, they were still well above the normal range and her testosterone and
estriol, had moved significantly above normal non-pregnant values at this time.
Concurrent with these hormone changes and possibly in large part because of
them, significant correlations between progesterone and psychiatric symptoms
appeared at four months and again at twelve months postpartum. In Marrs (2006)
progesterone was not associated with psychiatric symptoms at either test time and so
it was unexpected for progesterone to be significantly correlated with distress in the
present study. It is possible that the correlations between progesterone and symptoms
at twelve months were spurious. Participant E was not available for testing at this
time and thus, both her hormone values and symptom scores were estimated.
Inasmuch DHEAS, and by association DHEA, impact the synthesis of many
hormones via enzymatic regulation (Labrie et al., 1997: Genazzani et al., 2003;
Ueshiba et al. ,2002), it is speculated that elevated DHEAS observed at four months
postpartum, was associated with the increase in circulating progesterone. The
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consequent development of significant correlations between progesterone and
symptoms may support this hypothesis.
As the reservoir for DHEA, increased DHEAS values, often correspond to
increased DHEA, testosterone and estradiol and have been found to influence other
hormone values such as allopregnanolone concentrations (Genzanni et al., 2006).
Allopregnanolone is the primary metabolite of progesterone. It is speculated that
DHEA up-regulates 17, 20 lyase activity and shifts metabolism towards the
progesterone pathway (Genzanni et al., 2006) presumptively increasing progesterone
concentrations as well as concentrations of this metabolite. Barring complete
abrogation of STS activity, for which there is no evidence of in the current study,
high concentrations of DHEAS would be expected to increase DHEA values to some
degree. The spike in progesterone and concurrent associations with symptoms could
reflect this shift.
With elevated DHEAS, testosterone and estradiol concentrations are expected
to increase. This has been established with PCOS and hyperandrogénie women where
DHEAS, DHEA and the entire aromatase pathway is up-regulated significantly (Carr,
2001; Elsenbruch, 2003; Yildiz, 2004). This appeared not to occur here, with mean
concentrations for both hormones falling at the lower end of the non-pregnant, non
postpartum, reference ranges. However, since there are no established salivary
reference ranges for postpartum and lactating women, and data on menstrual cycle
phase was not collected in the present study, it is impossible to discern how these
factors might have influenced the observed hormone values.
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Nevertheless, with elevated DHEAS, elevated testosterone and estradiol are
expected. Review of the individual hormones values reveals that the women with the
highest DHEAS values also had the highest testosterone values. Even though their
testosterone values fell squarely within the non-pregnant range at 15-23 pg/mL, these
values were -100% greater than those of the of the other participants. Consequently,
DHEAS and testosterone were significantly correlated at this and the subsequent test
times.
Testosterone which had been negatively associated with onset of symptoms in
Marrs (2006) was positively associated with a myriad of symptoms at four months
postpartum. The directional shift in this correlation was particularly striking insofar as
mean circulating concentrations of testosterone at four months postpartum were 50%
lower than those observed during pregnancy when testosterone was associated
negatively with symptoms. As was speculated with progesterone, the testosterone to
behavior correlations may be more related to the associations between DHEAS and
symptoms and DHEAS and testosterone than to actual associations between
testosterone and symptoms, especially in light of the difference in testosterone values
between pregnancy and postpartum.
It is also possible that factors in pregnancy versus postpartum
pharmacokinetics account for the absolute difference in testosterone values that are
now associated with symptoms. The amount of testosterone required to elicit a
cellular or behavioral response during pregnancy could appear higher than what is
required postpartum because of the increased plasma volume during pregnancy. The
relative difference between the two values may actually represent similar
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concentrations of hormone per unit of volume, if that could be calculated. This would
suggest that there is a range of effective hormone values per unit volume that when
breached elicits compensatory reactions in other hormones or enzymes, of which
psychiatric symptoms are simply the outward manifestation. What this range is and
how it relates to the other hormones is unclear.
Estradiol, which is a direct metabolite of testosterone, was not correlated with
testosterone at any test time nor was it correlated with any other hormone. As in
Marrs (2006) estradiol was not correlated with symptoms. Mean estradiol values fell
within the normal non-pregnant, non-postpartum range, although the inter-individual
variability was great and may have been related to menstrual phase variation. Its lack
of association with testosterone may suggest an alternate metabolic pathway, perhaps
the bioconversion of estrone>estradiol. However, this pathway typically favors the
estradiol to estrone conversion versus the estrone to estradiol conversion (Stanczyk,
1998).
Estriol concentrations which had not been associated with symptoms either
during pregnancy or following parturition were significantly and positively associated
with a myriad o f symptoms at eight months postpartum even though circulating
values were some 98% less than during pregnancy. Again, the change in plasma
volume may have contributed somewhat to the relative change in estriol. However,
unlike pregnancy testosterone which is thought to represent mostly maternal synthesis
(Triosi et al., 2003), estriol is largely of fetal origin (Challis & Lye, 1998). Indeed,
expression of the hepatic enzyme 16a-0H that converts DHEAS to estriol is reported
to be extremely low in adulthood (Lacroix, Sonnier, Moncion, Cheron & Cresteil,
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1997; Leeder et al., 2005; Stevens et al., 2003). So it is particularly intriguing that
postpartum estriol concentrations observed in this study were not only at the high end
of non-pregnant clinical reference ranges but were also associated with symptoms.
Like the elevated progesterone, elevated estriol may represent a compensatory
reaction related to elevated DHEAS i.e. up-regulated hepatic enzymes to increase
metabolic clearance with the ensuing correlations between this hormone and
symptoms simply denoting that change.
The cause of the postpartal increase in DHEAS remains to be investigated, but
data from this study, when combined with the findings from the various cancer
studies cited previously and the work by Maayan et al. (2005) point to diminished
STS activity. Research on STS inhibitors for the treatment of hormone dependent
cancers, indicates that STS inhibition not only elicits an increased ratio of sulfated to
non-sulfated hormones, combined with a decrease in downstream androgens such as
testosterone and estradiol (Gell et al., 1998; Pasqualini & Chetrite, 2001; Stanway et
al., 2006), but also, mediates behavioral changes in rodent models (Nicholas et al.,
2001) and psychiatric distress in human patients (Stanway et al., 2006).
Maayan and colleagues found that withdrawal from elevated estradiol in
rodent pseudo-pregnancy was associated with diminished STS activity and a
consequent increase in cortical DHEAS, whereas Pasqualini and Chetrite 2001
demonstrated that elevated estradiol alone, could effectively diminish STS activity.
Based upon those findings, it is postulated that the continued increase in estradiol
concentrations through pregnancy negatively impacts STS activity, but because of
abundant placental STS (Dibbelt & Kuss, 1991), the affects are not observed fully
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until after parturition. The resultant increase postpartum DHEAS may simply reflect a
transient diminishment of STS activity that over time, will return to non-pregnant
levels.
It also possible, that for some women the physiological condition of
pregnancy unmasks a previously latent endocrine pathology. This hypothesis was
presumptively supported by the medical conditions of Participant D ’s son and
Participant E herself. Both participants disclosed the presence of disorders that if
genetically verified, are consistent with congenitally impaired STS activity.
Participant D ’s son had been bom with a disorder called crytorchidism or
testicular mal-descent, a condition that is present in 1-6000 male births. Participant E,
who had a female child, developed a skin condition strikingly similar to the X-linked
ichthyosis that is associated with STS deficiency in male children and occurs in 16000 births as well. Both conditions may be caused by similar genetic mutations that
impair STS activity (Bradshaw & Carr, 1986). Female carriers of this mutation do not
express the aforementioned disorders, but have been reported to acquire similar skinrelated conditions (Reed et al., 2005). Some evidence suggests that female carriers
express significantly less STS activity than women who do not carry this mutation
(Epstein & Leventhal, 1981). Unfortunately, there is only one published report where
STS activity was measured in the female carriers’ of the mutation and there are no
published reports regarding any other potential behavioral or physiological
manifestations. Nevertheless, the co-manifestation of STS related medical
conditions, elevated DHEAS and psychiatric symptoms points to compromised STS
activity in the etiology of postpartum psychopathology. Whether the enzyme changes
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are transient as much of the data in this study suggest or chronic, as was potentially
exhibited by participant E requires additional investigation.
Because multiple factors are capable of up- and/or down-regulating STS
activity, including estradiol, it is not clear how the menstrual cycle affects the balance
between DHEA and DHEAS. The intermittent increases in individual DHEAS values
observed in this study, combined with the consequent symptom elevations could
reflect menstrual cycle variations in STS. It might be that upon investigation of these
factors, STS activity is found to mediate the severity of premenstrual syndrome by
way of increased DHEAS. Inasmuch as women with premenstrual distress are
reported to have a higher incidence of postpartum psychiatric disturbances (Bloch et
al., 2005), it is possible that STS activity contributes to both disorders. Further
examination of the associations between DHEAS and/or STS and female
psychopathology might reveal such an association.
Conclusion

While a preliminary investigation with a limited number of participants,
results from this study provide several important insights regarding the onset, course
and hormonal correlates of peripartal psychiatric disturbances and cognitive
functioning. Results from this study show that psychiatric disturbances are more
prevalent and more severe in the immediate postpartum than in the months following
parturition. A large number of the psychiatric disturbances are associated with
elevated DHEAS, which in turn appears to influence the equilibrium of other
hormones. In some women the distress is transient and abates as DHEAS values
return to within normal reference ranges. In others, the increase in postpartal DHEAS
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is more drastic and chronic with corresponding symptoms that are more severe and
persistent. Whether transient or chronic, postpartum psychiatric symptoms develop in
association with puerperal hormone changes and cannot be relegated to the realm of
psychosocial stressor.
Data from this study also demonstrated that puerperal cognitive deficits,
although not associated consistently with puerperal hormone changes or mood
changes do exist, and appear to involve some aspect of working memory. Deficits in
both verbal and spatial memory were observed during pregnancy. Review of the
longitudinal trends in these cognitive dimensions suggests many aspects of verbal
memory improve, but that difficulties with proactive interference persist through the
year. Spatial memory does not appear to improve. Collectively, these data suggest
that motherhood negatively impacts working memory.
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Tables
Table 1: Participant Data
Participant pregnancy and health status across test times.
Participants
Trial
Length o f Pregnancy
Delivery Type
Gender
Breastfeeding

Medication

A

B

C

D

E

F

G

H

1

288

277

268

289

272

289

273

275

274

V

V

V

V

V

V

V

V

V

Girl

Boy

Boy

Boy

Girl

Boy

Boy

Boy

Boy

1
2

X

X

X

X

X

X

X

3

X

X

X

X

X

X

X

4

X

?

5

?

X

1
Smoking

Diaclox

2

Menstruation

X

3

Yasmin

Levora

4

Yasmin

Levora

5

Yasmin

Levora

Lexapro

Celexa

Yasmin

Smoking

Lexapro*

Yasmin

Smoking

Yasmin

Smoking

1
2
3

Working

X

X

X

X

X

X

X

X

X

X

X

X

X

X

4

X

5

X

X

1

FT

FT

. FT

FT

PT

PT

PT

PT

2
3

PT
PT
PT
PT
PT
PT
PT
5
Average length o f gestation 278 days. V: vaginal. No record o f breastfeeding status for Participant E at T5 or Participant F at T4.
•Participant E was taking medication until approximately five months postpartum. Diaclox is antibiotic. Lexapro and Celexa are antidepressants.Yasmin and Levora are oral contraceptives. Participant H was 5 weeks pregnant at T5.
PT

4
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Table 2: Symptom Checklist 90-R scores
Mean SCL-90-R scores across test times.
37-W eeks

< 10-D ays

4-M onths

8-M onths

12-M onths

P regnant___________ Postpartum __________ P ostpartum __________ Postpartum __________ Postpartum
Sym ptom

M ean

SD

M ean

SD

AN X

52.56

10.74

SYM
11%

56.22

14.25

HOS

54.67

5.79

0%

55.56

6.57

SYM

M ean

SD

33%

48.89

12.31

44%

46.33

7.16

55%

52.56

0% 47.83

PH O B

54.67

11.00

22%

57.79

10.93

PA R

50.22

6.42

11%

48.89

5.95

PSY

52.44

6.46

22%

59.67

7.42 ' 44%

51.44

SY M

M ean

SD

SY M

M ean

SD

11%

48.44

SYM

12.83

11%

0%

52.67

7.87

22%

11%

51.06

11.13

11%

50.56

6.52

9.39

11%

52.89

9.39

11%

51.67

9.92

11%

8.60

11% 49.72

6.51

11%

48.22

7.17.

11%

7.20

11%

51.22

7.12

22%

52.61

8.18

22%

SOM

60.11

IL82

66%

60.44

12.83

55%

46.72

12.41

22%

46.78

10.69

11%

46.89

11.45

11%

OC

61.89

8.19

44%

61.89

9.10

44%

50.79

11.57

22%

53.89

11.13

33%

52.44

12.47

33%

IS

56.22

6.67

33%

54.56

11.06

44%

53.78

10.23

33%

51.78

10.33

44%

51.5

10.33

22%

DEP

61.88

5.40

66%

65.33

5.83

88%

50.33

11.70

22%

53.61

10.78

44%

51

13.31

22%

59.44

7.52

44%

61.33

8.28

55%

49.33

11.64

11%

50.5

11.33

22%

45.17

20.49

22%

GSI
SYM : p ercen t sym ptom atic (T score >60); A N X : anxiety; HOS: hostility; PH O B : phobia; PAR: paranoia; PSY:

psychoticism ; SOM : som atization; DC: obsessive com pulsive behavior; IS: interpersonal sensitivity; DEP: depression;
GSI: global severity index.
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Table 3: Longitudinal trends in pregnancy and postpartum symptoms
Repeated measures, con trast and trend analyses f o r SCL-90-R sco res across the year.
ANX
M ain E ffect

HOS

PHOB

0.003

0.013

PA R

PSY

SO M

OC

DEP

G SI

0.000

0.000

0.000

0.000

0.000

IS

T rend T ype

C ubic

C ubic

L inear

Cubic

L inear

L inear

Significance

0.021

0.001

0.001

0.003

0.007

0.016

0.001

0.001

0.002

0.000

0.038

0.028

T l vsT 2
T2 vs 1 3

0.006
0.008

0.041

0.003

T3 vs 1 4
T4 vs T5
T l vs 1 5
0.030

T2 vs T5
T3 vs T5

0.010

0.001

0.011

0.016

0.036

0.002

0.004

0.005

0.016

0.042

0.039

T l vs T3

0.020

0.006

0.001

0.007

0.001

T l vs T4

0.037

0.005

0.005

0.022

0.020

T3 vs Previous

0.006

0.002

0.001

0.003

0.000

0.018

0.038

T 4 vs P revious

0.032

0.002

T5 vs Previous

0.043
0.046

T l: 37 w eeks pregnant; T2: < 1 0 days posptartum ; T3: four m onths postpartum ; T 4: eight m onths postpartum ; T5: tw elve
m onths postpartum ; A N X : anxiety; HO S: hostility; PH O B: phobia; PAR: paranoia; PSY: psychoticism ; SOM :
som atization; OC: obsessive com pulsive behavior; IS: interpersonal sensitivity; DEP: depression; GSI: global severity
index.
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Table 4: Longitudinal trends in pregnancy and postpartum cognitive performance

o'

3
O

Mean cogntive data across test times.

8

37 W eeks
Pregnant

(O '

33"
CD
CD

■D
O
Q.
C
a
o

Verbal Fluency

LA

8-M onths P ostpartum 12-M onths Postpartum

Norm ative
D ata

M ean

SD

%

M ean

SD

%

M ean

SD

%

M ean

SD

%

M ean

SD

%

Mean

SD

34.11

1.62

77.00

34.67

1.94

82.00

31.06

7.27

42.00

33.16

3.22

68.00

31.00

6.67

59.00

31.75

3.21

Recall

17.94

8.67

28.00

23.22

0.22

68.00

19.56

-0.34

25.00

20.72

5.94

45.00

19.50

8.59

37.00

21.8

6.56

2.4

41.11

7.34

43.00

49.56

7.20

73.00

51.06

3.63

77.00

52.11

6.45

81.00

53.22

4.76

82.00

43.40

10.20

2

39.33

7.65

39.00

46.00

6.12

66.00

48.00

0.60

73.00

47.61

7.79

70.00

49.06

6.98

77.00

41.90

10.20

1.6

32.22

4.76

47.00

36.78

6.12

61.00

39.22

0.50

73.00

41.11

7.66

75.00

41.78

9.81

77.00

33.10

12.20

1,4

24.33

6.26

47.00

29.56

6.00

66.00

28.56

0.35

63.00

30.94

8.97

72.00

30.89

6.68

72.00

24.90

10.60

FAS

44.67

8.26

50.00

47.89

12.29

61.00

48.56

13.01

63.00

50.56

12.35

70.00

49,61

11.99

68.00

44.70

11.20

Animal

20.33

6.89

61.00

21.11

5.53

66.00

21.56

4.50

70.00

22.22

4.81

73.00

21.44

4.55

68.00

19.00

5.20

Com plex Figure Test Copy

PASAT

4-M onths
Pospartum

<10-Days
Postpartum

3

■D
O

D esign Fluency

CD

Finger Tapping

Q.

C/)
C/)

18.89

7.54

70.00

23.67

6.82

91.00

26.56

9.15

96.00

23.00

9.90

88.00

22.56

8.73

87.00

15.50

6.10

Fixed

18.55

4.56

47.00

23.67

5.83

81.00

21.88

7.47

70.00

20.78

9.44

63.00

25.00

5.68

87.00

18.90

5.60

Preferred

44.91

4.96

55.00

46.82

5.73

67.00

45.17

3.90

55.00

46.00

4.20

61.00

45.13

3.84

55.00

44.30

5.80

N on-Preferred

41.16

3.50

55.00

41.82

3.24

59.00

41.00

1.90

54.00

41.62

2.59

56.00

40.74

3.01

50.00

40.60

5.60

Preferred

15.11

2.20

30.00

15.78

2.22

45.00

15.89

1.76

49.00

16.05

1.98

47.00

16.44

1.81

62.00

15.94

1.61

1.81
N on-Preferred 14.44
Normative scores from Spreen and Strauss, (1998).

26.00

14.22

1.79

23.00

15.05

1.67

39.00

15.22

1.56

41.00

15.67

1.58

49.00

15.63

1.89
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Table 5: Verbal Memory Performance

CVLT-II Scores and percentile rank compared to normative data across test times.

37 Weeks Pregnant

<10 Days Postpartum

4-Months Postpartum

8-Months Postpartum

12-Months Postpartum

IM

IM

Delayed

Delayed

Semantic

Learning

Recall 1

Recall Total Recall B

Short Free

Long Free

Clustering*

Slope*

Mean

7.00

52.00

10.33

11.78

1.42

1,27

IM

5.89

SD

2.00

6.52

1.90

1.93

2.28

1.90

0.59

Z-score

-0.67

-1.86

-2.21

-2.89

-0.96

0.00

-0.50

Centile

25%

3%

1%

0%

17%

50%

32%

Mean

7.22

53.22

5.78

10.67

11.44

2.30

1,33

SD

1.79

6.26

1.20

3,36

2,30

1,94

0.70

Z-score

-0.48

-1.61

-2.32

-2.61

-1.13

0,50

-0.50

Centile

32%

5%

0%

0%

13%

70%

32%

Mean

8.22

60.64

6.94

13.44

13.69

3,78

1.32

SD

1.86

7.86

1.13

2.40

2.16

2,51

0,75

Z-score

0.33

-0.13

-1.16

-0.30

-0.01

1.50

-0.50

Centile

63%

45%

12%

38%

50%

94%

32%

Mean

7.97

58.69

6.92

13.00

13.00

3.69

1.43

SD

1.52

7.34

1.47

2.63

2.10

2,23

0,67

Z-score

0.14

-0.52

-1.18

-0.66

-0.35

1,50

0,00

Centile

56%

30%

12%

25%

37%

94%

50%

Mean

9.03

62.39

7.00

13,83

13.31

3.59

1.26

SD

2.03

5.98

2.06

1.84

2.51

2,11

0.78

Z-score

1.02

0,21

-1.10

0.02

-0.20

1.50

-0,50

Centile

84%

58%

14%

51%

42%

94%

32%

IM: immediate; centiles derived from age and IQ-matched normative data reported in Spreen and Strauss (1998), IQ-matched
normative data not available for semantic clustering and learning slope (Delis et al., 2000). Alternate forms were used at 10 days and
8 months postpartum.
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Table 6: Longitudinal trends in pregnancy and postpartum verbal memory

Repeated measures, contrast and trend analyses fo r CVLT-II across test times.
IM Recall IM Recall IM Recall Delayed Delayed Semantic
1
1-5
B
Short Free Long Free
Short
Main Effect

0.001

0.000

Trend Type

Linear

Linear

Significance

0.000

0.001

0.000

0.001

Linear

Linear

Linear

0.041

0.000

0.005

Learning
Curve

Tl vsT 2
T2 vs T3

0.016

0.039

0.003

0.000

0.005

0.020

T3 vs T4
T4 vs T5

0.039

Tl vs T5

0.000

T2 vs T5

0.015

T3 vs T5

0.000

Tl vs T3
Tl vs T4

0.012

T3 vs Previous

0.043

0.004

0.008

0.004

0.014

0.008

0.015

0.004

T4 vs Previous
T5 vs Previous

0.009

0.007

0.006

IM: immediate; CFT: complex figure test; Tl: 37 weeks pregnant; T2: <10 days posptartum; T3:
four months postpartum; T4: eight months postpartum; T5: twelve months postpartum.
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Table 7; Mean hormone values
Hormone values across all test times and reference ranges.

Progesterone
DHEAS

37 Weeks
Pregnant

<10 Days
Postpartum

Mean
SD
pg/mL

Mean
SD
pg/mL

1454.36
865.98

537.68

73.47

19.81

4-Months
Postpartum
Mean
SD
pg/mL
171.47

231.69

8-Months
Postpartum

12-Months
Postpartum

Mean
SD
pg/mL

Mean
SD
pg/mL

64.53

38.79

95.96

Reference Ranges*
Follicular

128.63

Luteal

pg/mL
10-250

100-600

642.79 1725.34 1276.18 1979.02 2208.82 1851.31 1626.92 2125.79 1305.98 220-2500 220-2500

Testotsterone

22.82

24.11

25.1

26.74

9.23

8.01

25.44

25.65

19.32

8.66

3-49

3-49

Estradiol

13.38

7.36

7.24

8.69

14.57

10.65

12.77

17.69

4.74

8.39

1-25

.5-25

452.20
12.81
6.11
14.30
5.52
13.91
5.65
.5-16
.5-16
Estriol
24.10
9.05
4.30
’ Reference ranges for non-pregnant, non-postpartum women. The follicular phase occurs during the early part o f the cycle until
ovulation between days 14-16 and corresponds with a peak in estradiol. The luteal phase occurs during days 20-22 and corresponds
with a peak in progesterone.
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Table 8: Individual hormone values
Individual hormone values and changes across test times.
37 weeks
Pregnant

<10 Days
Postpartum

Participant A
Participant B
Participant C
Participant D
Participant E
Participant F
Participant G
Participant H
Participant I

1647.9
1226.4
1241.7
2272.3
1360.5
2063.1
433.4
1215.4
1628.5

93.7
51.6

-9229%

Participant A
Participant B
Participant C
Participant D
Participant E
Participant F
Participant G
Participant H
Participant I

135.5
316.2
1038.1
640.4
596.1
2118.6
1608.6
426.2
914.1

626.6
764.1
1393.9
4551.5
2799.2
1707.5
1965.3
1074.7
645.3

362.44%
141.65%
34.27%
610.73%
369.59%
-19.40%
22.17%
152.16%
-29.41%

Participant A
Participant B
Participant C
Participant D
Participant E
Participant F
Participant G
Participant H
Participant I

21.9
11.2
73.4
48.4
19.9
3.7
2.6
0.1
24.2

0.4
5.9
16.3
25
33.4
56.5
78.1

-98.17%
-47.32%
-77.79%

Participant A
Participant B
Participant C
Participant D
Participant E
Participant F
Participant G
Participant H
Participant I

6.5
28.7
13.1
6.6
17.3
19.7
9
11.3

5.6
1.9
8.3
1.5
6.8
1
11
28.3
0.8

214.44%
-92.92%

Participant A
Participant B
Participant C
Participant D
Participant E
Participant F
Participant G
Participant H
Participant 1

341.4
320.3
835.6
595.8
271.9
199.6
356.1
389
760.1

9.7
8.8
10.9
15.6
6.9
21.7
21
16.2
4.5

-97.16%
-97.25%
-98.70%
-97.38%
-97.46%
-89.13%
-94.10%
-95.84%
-99.41%

8.2

110
51.7
69.1
77.3
59.7
63.6

Percent
Change

84.5

6.8
3.5

-93.32%
-95.78%
-94.44%
-96.60%
-95.61%
-96.92%
-80.50%
-96.83%

-48.35%
67.84%
1427.03%
2903.85%
6700.00%
-85.54%

-13.85%
-76.83%
-71.08%
-88.55%
3.03%
-94.22%

-44.16%

4-Months
Postpartum

Percent
Change

8-Months
Postpartum

Progesterone pe'mL
36.5
-66.82%
53
2.51%
89.3
29.23%
58
-24.97%
755.5
1165.49%
125.3
97.01%
285.7
238.11%
88.5
-5.55%
51.4
-0.39%

Percent
Change

12-Months
Postpartum

Percent
Change

22.7
52.35
24.1
64.4
54.4
129.2
127.4
54.7
51.5

-37.81%
-1.23%
-73.01%
11.03%
-92.80%
3.11%
-55.41%
-38.19%
0.19%

174
24.1
14.9
17
407.6
99.2
22.7
83.3
20.8

666.52%
-53.96%
-38.17%
-73.60%
649.26%
-23.22%
-82.18%
52.29%
-59.61%

610.9
698.85
618.6
1669.3
5731.2
2035.6
1766.3
2672.7
858.3

22.45%
-34.16%
-12.74%
40.61%
-20.54%
77.19%
-54.99%
111.11%
6.95%

1112.9
633.6
1048.3
1315.1
4265.2
3411
3472.7
1457.4
2415.9

82.17%
-9.34%
69.46%
-21.22%
-25.58%
67.57%
96.61%

Testosterone pg'mL
2.2
450.00%
-61.02%
2.3
4.9
-69.94%
3.9
-84.40%
-31.14%
23
-89.20%
6.1
-74.14%
20.2
121.32%
15.05
5.4
54.29%

8.1
4.7
6.4
7.6
83.4
29.7
43
31.8
14.3

268.18%
104.35%
30.61%
94.87%
262.61%
386.89%
112.87%
111.30%
164.81%

9.9
3.5
18.9
17.6
17.9
31.4
23.3
23.2

195.31%
131.58%
-66.19%
-39.73%
-26.98%
-26.73%
62.24%

Estradiol pg/rrL
-23.21%
4.3
18.3
863.16%
30.2
263.86%
1.9
26.67%
10.4
52.94%
60.00%
1.6
16.6
50.91%
26.95
-4.77%
20.9
2512.50%

0.6
8.1
0.3
7.2
3.5
30.4
5.4
53.4
6.05

-86.05%
-55.74%
-99.01%
278.95%
-66.35%
1800.00%
-67.47%
98.14%
-71.05%

0.6
8
0.2
0.2
6.7
0.2
0.8
25.6
0.4

0.00%
-1.23%
-33.33%
-97.22%
91.43%
-99.34%
-85.19%
-52.06%
-93.39%

11.9
10.7
10.9
15.6
26.6
10.7
15.4
18.2
8.75

56.58%
160.98%
12.37%
95.00%
135.40%
181.58%
126.47%
5.81%
-32.69%

23.7
12.6
12.7
15
18.95
8.5
16.3
13.2
4.2

99.16%
17.76%
16.51%
-3.85%
-28.76%
-20.56%
5.84%
-27.47%
-52.00%

DHEAS pg'mL
498.9
-20.38%
38.92%
1061.5
708.9
-49.14%
1187.2
-73.92%
7212.7
157.67%
1148.8
-32.72%
3924.6
99.69%
1266.05
17.80%
802.5
24.36%

7.6
4.1
9.7
8
11.3
3.8
6.8
17.2
13

Estriol pg'rrL
-21.65%
-53.41%
-11.01%
-48.72%
63.77%
-82.49%
-67.62%
6.17%
188.89%

28.2
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-45.47%
181.48%

22.22%

-25.53%

Table 9: Hormone to hormone correlations

Hormone to hormone correlations.
Trial
PROG

PROG

DHEAS

TEST

982***

,818**

E3

1
2
3
4
5

DHEAS

1
2
3
4

.930***

5

TEST

1

.784*

2

.728*

3

E3

.818**

.868**

4

.936***

5

.740*

.849**

1
2
3
4

.930***

5
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Table 10: Longitudinal trends in pregnancy and postpartum hormones

Repeated measures, contrast and trend analyses fo r hormone values across test times.
Progesterone

DHEAS

Testosterone

Estradiol

Estriol

Main Effect

0.000

Trend Type

Linear

Linear

Cubic

Linear

Significance

0.000

0.049

0.044

0.000

Tl vsT2

0.000

0.000

0.000

T2 vs T3

0.490

T3 vs T4

0.031

0.022

T4 vs T5
Tl vsT5

0.000

0.008

0.000

T2 vs T5
0.000

T3 vs T5
0.000

Tl vs T3
Tl vs T4

0.000

T3 vs Previous

0.002

0.000

T4 vs Previous

0.000

0.000

T5 vs Previous

0.000

1 1.

0.021

w c c iv a y ic g iim iL , i

0.000
0.000
0.024

0.000

0.005

V uaya

postpartum; T5; twelve months postpartum.

160

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Table 11: Hormone to symptom correlations
Table 11. H orm one to m o o d correla tio n s a cro ss te st times.
T rial
P ro g e stero n e

ANX

HOS

PHOB

PAR

PSY

.795*

.684*

.990*** .745*

.821**

.817**

.752*

.772*

SO M

OC

IS

DEP

G SI

1
2
3
4
5

DHEAS

.721*

1
2

.774*

.734*

.757*

3

.740*

.987*** .692*

.779*

.922*** .703*

.714*

4

.667*
.741*

.667*

.693*

.813**

.705*

.684*

5

T esto stero n e

1
2
3

.669*

4

.852**
.958***

5

E stradiol

1
2
3
4
5

E striol

1
2
.730*

3
4

.776*

.909**

.705*

.697*

.676*

.705*

5
O C : o b se ssiv e co m p u lsiv e b e h a v io r; IS: in terp erso n al sensitivity; D E P : d ep ressio n ; G S I: g lo b al sev erity
index; * p < .0 5 ,* * p < .0 1 ,* * * p < .0 0 1 .

161

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

■CDD
O
Q.
C

gQ.
■CDD
C/)

o'

Figure 1 : Maternai fetal-placental steroidogenesis

3
O

MATERNAL

8

FETAL

PLACENTAL
P450SCC j

PRIiÜ

ci'

FE T A L
A D REN A LS

,J2aÆH,

LDI
P4S0SCC

PROG
ESTRONE L

33"
CD

111 I|5B

PROG

|.
STSgUU

i

DHEAS

DHEA

DHEAS

A D IO N E

TESTO

DHEA

ESTRADIOL

CD

■D
O
Q.

DHEAS

C

a
O
3
■D
O

AROM ATA SE i

S

Î

AROM ATASE

ESTRONE

CD

16a-OH

Q.

I SiRl'il

I6U-OHAD

I

DHEAS

DHEAS

ESTRIOL

AROM ATASE

■CDD

J

ESTRIOL

FE T A L
L IV E R

L .

■ l y i f « m u * ) iii,i > n i

I

W a -Q H

.

l6 a - O H
C/)
C/)

M A TE R N A L
L IV E R

;

PS

ESTRA D IO l I

I-1

16a-0H D

|

STS

LDL: low density lipoprotein; PREG: Pregnenolone; PROG: progesterone; PS: pregnenolone sulfate; D HEA: dehydroepiandrosterone; DHEAS:
dehydroepiandrosterone sulfate; A ’DIONE: androstenedione; T E S T O testosterone; 16a-OHAD: 16a-hydroxyandrostendione; 16a-O H A D : 16ahydroxydehydroepiandrosterone; 16a-O H D S : 16a-hydroxydehydroepiandrosterone sulfate;P450SCC: cholesterol side chain cleavage; STS:
sulfatase; SULT: sulfbtransferase; 17g-HSD: 17 p -hydroxysteroid dehydrogenase; 3p-HSD: 3p-hydroxysteroid dehydrogenase; 16a-O H : 16ahydroxylase.

■CDD
O
Q.
C

gQ.
■CDD
C/)

W
o"
3
0
3

F ig u re 2: A d r e n a l a n d p e r ip h e r a l s te r o id o g e n e s is
LUI

CD

P450SÇ C

I

8
G LO M ERU LO SA

ci'
3"

PR I'G

13

STSÆULT
U-

(D

PRO G

3.
3"
(D

P E R IP H E R A L
C IR C U L A T IO N

R E T IC U I A R IS

F A S IC U L A T A

PS

17U-OI1 PR E G

l7 a-O H PREO

n -u o c s

(D

T3

O
Q.

C O R T IC O

■HSD

11-D O C

ao
3

- * | A ’D IO L S

A D IO L

C

0\
U)

S T S /S U L T t

1 8 -O II-C O R T

T3

C O R T ISO I

O

I A ’D IO N E

î~

=M ."

A R O f^ T A S E I

ALDO

j~î-:STRO NE

(D

TESTO
A R O M A T A SE

J.1 e=

ES TRONE S

E ST R A D IO L

Q.
5 a -R

ALDO

C O R T ISO L

E ST R O N E

IZB-oi

E ST R A D IO L

DUT

T3
(D

(/)
C/)

S IS SI I I

lh ii- ( Il I

I ESTRO N K S j

E S rR lO I-

L D L : l o w d e n s it y lip o p r o t e in ; P R E G : P r e g n e n o lo n e ; P R O G : p r o g e s t e r o n e ; 1 1 - D O C : 1 1 - d e o x y c o r t i c o s t e r o n e ; C O R T I C O : c o r t ic o s t e r o n e ; 1 8 - O H C O R T : 1 8 - h y d r o x y c o r t ic o s t e r o n e ; A L D O : a ld o s t e r o n e ; 1 7 a - O H - P R E G : 1 7 c t - h y d r o x y p r e g n e n o lo n e ; 1 1 - D O C : 1 1 - d e o x y c o r t is o l; P S : p r e g n e n o l o n e
s u lf a t e ; D H E A : d e h y d r o e p ia n d r o s t e r o n e ; D H E A S : d e h y d r o e p ia n d r o s t e r o n e s u lf a t e ; A ’D I O L : a n d r o s t e n e d io l; A ’D I O L S : a n d r o s t e n e d io l s u lf a t e ;
A ’D I O N E : a n d r o s t e n e d io n e ; T E S T O : t e s t o s t e r o n e ; E S T R O N E S : e s t r o n e s u lf a t e ; D H T : d i h y d r o t e s t o s t e r o n e ; P 4 5 0 S C C : s id e c h a in c l e a v a g e ; S T S :
s u lf a t a s e ; S U L T : s u lf d t r a n s fe r a s e ; 1 7 c x /p -O H : 17ot/ P - h y d r o x y la s e ; 3 P - H S D : 3 P - h y d r o x y s t e r o id d e h y d r o g e n a s e ; 5 a - R : 5 a - r e d u c t a s e ; 1 6 a - O H : 1 6 a h y d r o x y la s e .

Figure 3: Percentage o f symptomatic women
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Figure 4: Longitudinal trends in pregnancy and postpartum cognitive performance
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Figure 5: Longitudinal trends in pregnancy and postpartum verbal memory
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Figure 6: Longitudinal trends in pregnancy and postpartum hormones
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Thank-you for participating in this study. Your participation will yield important
information about postpartum mental illness.

Instructions for Saliva Collection
1. Upon rising on the morning of testing, before eating, drinking, breastfeeding*
or brushing teeth, place specimen vial to bottom lip and spit into vial.
2.

Fill vial with at least 8 ml of saliva.

3.

Close vial.

4.

Clean vial with paper towel

5.

Label vial with your 6-digit identification code (first initiai, last initial, mm/yy of
birth date, ex; AB0264), date and time of specimen collection.

6.

Place vial in zip-iock baggie and refrigerate.

7.

Specimen will be picked-up during your scheduled

session.

Helpful Hints
*if you feel that you have to breastfeed prior to specimen collection, please wait 2
hours before attempting to spit into the vial. Please note on the label the time of
breastfeeding and the time that the specimen was collected.
If you have difficulty producing the desired amount of salvia, imagine sucking on
a sour lemon, or cut open a lemon (but dont eat it). The thought or sight of a sour
lemon will initiate salivation.
Some women prefer to wrap a paper towel around the vial while spitting so as to
collect any excess saliva.
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